KR101835020B1 - Electron transport material and organic electroluminescence element using same - Google Patents

Electron transport material and organic electroluminescence element using same Download PDF

Info

Publication number
KR101835020B1
KR101835020B1 KR1020137011642A KR20137011642A KR101835020B1 KR 101835020 B1 KR101835020 B1 KR 101835020B1 KR 1020137011642 A KR1020137011642 A KR 1020137011642A KR 20137011642 A KR20137011642 A KR 20137011642A KR 101835020 B1 KR101835020 B1 KR 101835020B1
Authority
KR
South Korea
Prior art keywords
compound
synthesis
following formula
formula
carbon atoms
Prior art date
Application number
KR1020137011642A
Other languages
Korean (ko)
Other versions
KR20130140709A (en
Inventor
요헤이 오노
다이스케 바바
Original Assignee
제이엔씨 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제이엔씨 주식회사 filed Critical 제이엔씨 주식회사
Publication of KR20130140709A publication Critical patent/KR20130140709A/en
Application granted granted Critical
Publication of KR101835020B1 publication Critical patent/KR101835020B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/22Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/16Electron transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/17Carrier injection layers
    • H10K50/171Electron injection layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/626Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K2102/00Constructional details relating to the organic devices covered by this subclass
    • H10K2102/10Transparent electrodes, e.g. using graphene
    • H10K2102/101Transparent electrodes, e.g. using graphene comprising transparent conductive oxides [TCO]
    • H10K2102/103Transparent electrodes, e.g. using graphene comprising transparent conductive oxides [TCO] comprising indium oxides, e.g. ITO

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

본 발명의 식 (1)로 표시되는 화합물은, 유기 EL 소자의 전자 수송 재료로서 유용하고, 이 전자 수송 재료를 사용함으로써 유기 EL 소자의 장기 수명화 등에 기여한다.

Figure 112013039443236-pct00130

식 (1)에 있어서, Py는 독립적으로 식 (2), (3) 또는 (4)로 표시되는 기이며;
Figure 112013039443236-pct00131

m 및 n은 0 또는 1이지만, m+n=1이며;그리고, 식 (1) 중의 벤젠환, 나프탈렌환 및 피리딘환의 수소 중 적어도 하나는 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬로 치환되어 있다.The compound represented by the formula (1) of the present invention is useful as an electron transporting material of an organic EL device, and the use of the electron transporting material contributes to the longevity and the like of the organic EL device.
Figure 112013039443236-pct00130

In the formula (1), Py is independently a group represented by the formula (2), (3) or (4);
Figure 112013039443236-pct00131

m and n are 0 or 1, and m + n = 1; and at least one of the benzene ring, naphthalene ring and pyridine ring hydrogen in formula (1) is substituted with alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms .

Description

전자 수송 재료 및 이것을 사용한 유기 전계 발광 소자{ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME}TECHNICAL FIELD [0001] The present invention relates to an electron transporting material and an organic electroluminescent device using the same. BACKGROUND ART [0002]

본 발명은, 피리딜기를 가지는 신규한 전자 수송 재료, 이 전자 수송 재료를 사용한 유기 전계 발광 소자(이하, 유기 EL 소자 또는 단지 소자로 약기하는 경우가 있음) 등에 관한 것이다.The present invention relates to a novel electron transporting material having a pyridyl group, an organic electroluminescent device using the electron transporting material (hereinafter sometimes abbreviated as an organic EL element or an element), and the like.

최근, 차세대의 풀 컬러 평판 디스플레이로서 유기 EL 소자가 주목을 받고 있으며, 이에 대한 활발한 연구가 행해지고 있다. 유기 EL 소자의 실용화를 촉진하기 위해서는, 소자의 구동 전압의 저감, 장기 수명화가 불가결한 요소이며, 이러한 것들을 달성하기 위해 새로운 전자 수송 재료의 개발이 행해져 왔다. 특히, 청색 소자의 구동 전압 저하, 장기 수명화는 필수적이다. 특허 문헌 1(일본 특허출원 공개번호 2003-123983호 공보)에는, 페난트롤린 유도체 또는 그 유사체인 2,2'-비피리딜 화합물을 전자 수송 재료에 사용함으로써 유기 EL 소자를 저전압으로 구동시킬 수 있다고 기재되어 있다. 그러나, 이 문헌의 실시예에 보고되어 있는 소자의 특성(구동 전압, 발광 효율 등)은 비교예를 기준으로 한 상대값뿐이며, 실용적인 값으로 판단할 수 있는 실측값은 기재되어 있지 않다. 그 외에, 2,2'-비피리딜 화합물을 전자 수송 재료에 사용한 예가, 비특허 문헌 1(Proceedings of the 10th International Workshop on Inorganic and Organic Electroluminescence), 특허 문헌 2(일본 특허출원 공개번호 2002-158093호 공보) 및 특허 문헌 3(국제 공개 2007/86552 팜플렛)에 개시되어 있다. 비특허 문헌 1에 기재되어 있는 화합물은 Tg가 낮고, 실용적이지 않았다. 특허 문헌 2 및 3에 기재된 화합물은 비교적 저전압으로 유기 EL 소자를 구동시킬 수 있지만, 실용화하기 위해서는 더욱 장기 수명화가 요구되고 있다.BACKGROUND ART [0002] In recent years, organic EL devices have attracted attention as a next-generation full-color flat panel display, and active research is underway. In order to promote the practical use of the organic EL device, reduction of the driving voltage of the device and long-term longevity are indispensable factors. To achieve these, a new electron transporting material has been developed. In particular, it is essential to lower the driving voltage of the blue element and to prolong the life span of the blue element. Patent Document 1 (Japanese Patent Application Laid-Open No. 2003-123983) discloses an organic EL device which can be driven at a low voltage by using a phenanthroline derivative or a 2,2'-bipyridyl compound as a substituent in an electron transporting material . However, the device characteristics (drive voltage, luminous efficiency, etc.) reported in the embodiments of this document are only relative values based on the comparative example, and actual values that can be judged as practical values are not described. In addition, examples in which 2,2'-bipyridyl compounds are used as electron transport materials are disclosed in Non-Patent Document 1 (Proceedings of the 10th International Workshop on Inorganic and Organic Electroluminescence), Patent Document 2 (Japanese Patent Application Publication No. 2002-158093 And Patent Document 3 (International Publication 2007/86552 pamphlet). The compound described in Non-Patent Document 1 had a low Tg and was not practical. The compounds described in Patent Documents 2 and 3 can drive the organic EL device at a comparatively low voltage, but in order to put the compound into practical use, longer life is required.

일본 특허출원 공개번호 2003-123983호 공보Japanese Patent Application Laid-Open No. 2003-123983 일본 특허출원 공개번호 2002-158093호 공보Japanese Patent Application Laid-Open No. 2002-158093 국제 공개 2007/86552 팜플렛International publication 2007/86552 Brochure

Proceedings of the 10th International Workshop on Inorganic and Organic Electroluminescence(2000) Proceedings of the 10th International Workshop on Inorganic and Organic Electroluminescence (2000)

본 발명은, 이와 같은 종래 기술이 가지는 문제점을 감안하여 행해진 것이다. 본 발명은, 유기 EL 소자의 장기 수명화 등에 기여하는 전자 수송 재료를 제공하는 것을 과제로 한다. 또한, 본 발명은, 이 전자 수송 재료를 사용한 유기 EL 소자를 제공하는 것을 과제로 한다.The present invention has been made in view of the problems of the prior art. An object of the present invention is to provide an electron transporting material contributing to long-term longevity and the like of an organic EL device. It is another object of the present invention to provide an organic EL device using the electron transporting material.

본 발명자들은 검토를 거듭한 결과, 9-(2-나프틸)-10-페닐안트라센의 나프틸 또는 페닐 중 어느 한쪽에, 피리딜, 비피리딜, 또는 피리딜페닐을 가지고, 또한 벤젠환, 나프탈렌환 및 피리딘환의 수소 중 적어도 1개가 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬로 치환된 화합물을 유기 EL 소자의 전자 수송층에 사용함으로써, 장수명으로 구동할 수 있는 유기 EL 소자를 얻을 수 있는 것을 발견하고, 이 지견에 따라 본 발명을 완성했다. 상기의 과제는 이하에 나타내는 각 항에 의해 해결된다.As a result of extensive investigations, the inventors of the present invention have found that when naphthyl or phenyl of 9- (2-naphthyl) -10-phenylanthracene has pyridyl, bipyridyl or pyridylphenyl, By using a compound in which at least one of naphthalene ring and hydrogen of pyridine ring is substituted with alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms in the electron transporting layer of the organic EL device, an organic EL device capable of driving with a long life is obtained The present invention has been completed based on this finding. The above problems are solved by the following respective items.

[1] 하기 식 (1)로 표시되는 화합물.[1] A compound represented by the following formula (1).

Figure 112013039443236-pct00001
Figure 112013039443236-pct00001

식 (1)에 있어서,In the formula (1)

Py는 독립적으로, 식 (2), (3) 또는 (4)로 표시되는 기이며;Py is independently a group represented by formula (2), (3) or (4);

Figure 112013039443236-pct00002
Figure 112013039443236-pct00002

m 및 n은 0 또는 1이지만, m+n=1이며;그리고,m and n are 0 or 1, but m + n = 1;

식 (1) 중의 벤젠환, 나프탈렌환 및 피리딘환의 수소 중 적어도 하나는 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬로 치환되어 있다.At least one of the benzene ring, the naphthalene ring and the hydrogen of the pyridine ring in the formula (1) is substituted with an alkyl having 1 to 6 carbon atoms or a cycloalkyl having 3 to 6 carbon atoms.

[2] 하기 식 (1-1) 또는 (1-2)로 표시되는, 상기 [1]항에 기재된 화합물.[2] The compound according to the above item [1], which is represented by the following formula (1-1) or (1-2)

Figure 112013039443236-pct00003
Figure 112013039443236-pct00003

식 (1-1) 및 (1-2)에 있어서,In the formulas (1-1) and (1-2)

Py는 식 (2), (3) 또는 (4)로 표시되는 기이며;Py is a group represented by the formula (2), (3) or (4);

Figure 112013039443236-pct00004
Figure 112013039443236-pct00004

그리고, 식 (1-1) 및 (1-2) 중의 벤젠환, 나프탈렌환 및 피리딘환의 수소 중 적어도 하나는 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬로 치환되어 있다.At least one of the benzene ring, naphthalene ring and hydrogen of the pyridine ring in the formulas (1-1) and (1-2) is substituted with alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms.

[3] 하기 식 (1-3), (1-4), (1-5), 또는 (1-6)으로 표시되는, 상기 [1]항에 기재된 화합물.[3] The compound according to the above item [1], which is represented by the following formula (1-3), (1-4), (1-5) or (1-6)

Figure 112013039443236-pct00005
Figure 112013039443236-pct00005

식 (1-3)∼(1-6)에 있어서,In the formulas (1-3) to (1-6)

Py는 식 (2), (3) 또는 (4)로 표시되는 기이며;Py is a group represented by the formula (2), (3) or (4);

Figure 112013039443236-pct00006
Figure 112013039443236-pct00006

그리고, 식 (1-3)∼(1-6) 중의 벤젠환, 나프탈렌환 및 피리딘환의 수소 중 적어도 하나는 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬로 치환되어 있다.At least one of the benzene ring, naphthalene ring and hydrogen of the pyridine ring in the formulas (1-3) to (1-6) is substituted with alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms.

[4] 하기 식 (1-7) 또는 (1-8)로 표시되는, 상기 [1]항에 기재된 화합물.[4] The compound according to the above-mentioned [1], which is represented by the following formula (1-7) or (1-8).

Figure 112013039443236-pct00007
Figure 112013039443236-pct00007

식 (1-7) 및 (1-8)에 있어서, Py는 식 (2), (3) 또는 (4)로 표시되는 기이며;In formulas (1-7) and (1-8), Py is a group represented by formula (2), (3) or (4);

Figure 112013039443236-pct00008
Figure 112013039443236-pct00008

R은 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬이며;그리고, p는 1∼5의 정수이다.R is alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms; and p is an integer of 1 to 5.

[5] 하기 식 (1-9) 또는 (1-10)으로 표시되는, 상기 [1]항에 기재된 화합물.[5] The compound according to the above-mentioned [1], which is represented by the following formula (1-9) or (1-10).

Figure 112013039443236-pct00009
Figure 112013039443236-pct00009

식 (1-9) 및 (1-10)에 있어서,In the formulas (1-9) and (1-10)

Py는 식 (2), (3) 또는 (4)로 표시되는 기이며;Py is a group represented by the formula (2), (3) or (4);

Figure 112013039443236-pct00010
Figure 112013039443236-pct00010

R은 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬이며;그리고,R is alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms;

q는 1∼5의 정수이다.q is an integer of 1 to 5;

[6] 하기 식 (1-11) 또는 (1-12)로 표시되는, 상기 [1]항에 기재된 화합물.[6] The compound according to the above-mentioned [1], which is represented by the following formula (1-11) or (1-12).

Figure 112013039443236-pct00011
Figure 112013039443236-pct00011

식 (1-11) 및 (1-12)에 있어서,In the formulas (1-11) and (1-12)

Py1은 식 (2'), (3') 또는 (4')로 표시되는 기이며;Py 1 is a group represented by the formula (2 '), (3') or (4 ');

Figure 112013039443236-pct00012
Figure 112013039443236-pct00012

식 (2'), (3') 및 (4')에 있어서, R은 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬이며;그리고, s는 1∼4의 정수이다.In the formulas (2 '), (3') and (4 '), R is alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms; and s is an integer of 1 to 4.

[7] 하기 식 (1-13) 또는 (1-14)로 표시되는, 상기 [1]항에 기재된 화합물.[7] The compound according to the above-mentioned [1], which is represented by the following formula (1-13) or (1-14).

Figure 112013039443236-pct00013
Figure 112013039443236-pct00013

식 (1-13) 및 (1-14)에 있어서,In the formulas (1-13) and (1-14)

Py1은 식 (2'), (3') 또는 (4')로 표시되는 기이며;Py 1 is a group represented by the formula (2 '), (3') or (4 ');

Figure 112013039443236-pct00014
Figure 112013039443236-pct00014

식 (2'), (3') 또는 (4')에 있어서, R은 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬이며;그리고, s는 1∼4의 정수이다.In formula (2 '), (3') or (4 '), R is alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms; and s is an integer of 1 to 4.

[8] 하기 식 (1-15) 또는 (1-16)으로 표시되는, 상기 [1]항에 기재된 화합물.[8] A compound according to the above item [1], which is represented by the following formula (1-15) or (1-16).

Figure 112013039443236-pct00015
Figure 112013039443236-pct00015

식 (1-15) 및 (1-16)에 있어서,In the formulas (1-15) and (1-16)

Py는 식 (2), (3) 또는 (4)로 표시되는 기이며;Py is a group represented by the formula (2), (3) or (4);

Figure 112013039443236-pct00016
Figure 112013039443236-pct00016

R은 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬이며;그리고, t는 1∼4의 정수이다.R is alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms; and t is an integer of 1 to 4.

[9] 하기 식 (1-7-26)으로 표시되는, 상기 [1]항에 기재된 화합물.[9] The compound according to the above-mentioned [1], which is represented by the following formula (1-7-26).

Figure 112013039443236-pct00017
Figure 112013039443236-pct00017

[10] 하기 식 (1-7-74)로 표시되는, 상기 [1]항에 기재된 화합물.[10] The compound according to the above-mentioned [1], which is represented by the following formula (1-7-74).

Figure 112013039443236-pct00018
Figure 112013039443236-pct00018

[11] 하기 식 (1-7-98)로 표시되는, 상기 [1]항에 기재된 화합물.[11] The compound according to the above-mentioned [1], which is represented by the following formula (1-7-98).

Figure 112013039443236-pct00019
Figure 112013039443236-pct00019

[12] 하기 식 (1-7-96)으로 표시되는, 상기 [1]항에 기재된 화합물.[12] The compound according to the above-mentioned [1], which is represented by the following formula (1-7-96).

Figure 112013039443236-pct00020
Figure 112013039443236-pct00020

[13] 하기 식 (1-14-14)로 표시되는, 상기 [1]항에 기재된 화합물.[13] The compound according to the above item [1], which is represented by the following formula (1-14-14).

Figure 112013039443236-pct00021
Figure 112013039443236-pct00021

[14] 하기 식 (1-11-1), (1-11-2), (1-11-3), (1-11-4), (1-11-5), (1-11-6), (1-11-8), (1-11-18), (1-11-39), (1-14-2), (1-14-3), (1-14-11), (1-14-12), (1-14-13), (1-14-15), (1-14-16), (1-14-17), (1-14-18), 및 (1-14-20) 중 어느 하나로 표시되는, 상기 [1]항에 기재된 화합물.[14] A compound represented by any one of the following formulas (1-11-1), (1-11-2), (1-11-3), (1-11-4), (1-11-5) (1-11-8), (1-11-18), (1-11-39), (1-14-2), (1-14-3), (1-14-11) , (1-14-12), (1-14-13), (1-14-15), (1-14-16), (1-14-17), (1-14-18), and The compound according to the above-mentioned [1], wherein the compound is represented by any one of (1-14-20).

Figure 112013039443236-pct00022
Figure 112013039443236-pct00022

Figure 112013039443236-pct00023
Figure 112013039443236-pct00023

[15] 상기 [1] ∼[14] 중 어느 한 항에 기재된 화합물을 함유하는 전자 수송 재료.[15] An electron transporting material containing the compound according to any one of [1] to [14].

[16] 양극 및 음극으로 이루어지는 한쌍의 전극과; 상기 한쌍의 전극 사이에 배치되는 발광층과; 상기 음극과 상기 발광층의 사이에 배치되고, 상기 [15]항에 기재된 전자 수송 재료를 함유하는 전자 수송층 및/또는 전자 주입층;을 가지는 유기 전계 발광 소자.A pair of electrodes made of a positive electrode and a negative electrode; A light emitting layer disposed between the pair of electrodes; And an electron transport layer and / or an electron injection layer disposed between the cathode and the light emitting layer and containing the electron transporting material according to the item [15].

[17] 상기 전자 수송층 및 전자 주입층 중 적어도 하나는, 퀴놀리놀계 금속 착체, 비피리딘 유도체, 페난트롤린 유도체 및 보란 유도체로 이루어지는 군으로부터 선택되는 적어도 하나를 더 함유하는, 상기 [16]항에 기재된 유기 전계 발광 소자.At least one of the electron transporting layer and the electron injection layer may further comprise at least one selected from the group consisting of a quinolinol-based metal complex, a bipyridine derivative, a phenanthroline derivative, and a borane derivative. Lt; / RTI >

[18] 전자 수송층 및 전자 주입층 중 적어도 하나가, 알칼리 금속, 알칼리 토류 금속, 희토류 금속, 알칼리 금속의 산화물, 알칼리 금속의 할로겐화물, 알칼리 토류 금속의 산화물, 알칼리 토류 금속의 할로겐화물, 희토류 금속의 산화물, 희토류 금속의 할로겐화물, 알칼리 금속의 유기 착체, 알칼리 토류 금속의 유기 착체 및 희토류 금속의 유기 착체로 이루어지는 군으로부터 선택되는 적어도 하나를 더 함유하는, 상기 [16]항 또는 [17]항에 기재된 유기 전계 발광 소자.At least one of the electron transporting layer and the electron injecting layer may be at least one selected from the group consisting of alkali metals, alkaline earth metals, rare earth metals, alkali metal oxides, alkali metal halides, alkaline earth metal oxides, alkaline earth metal halides, rare earth metals Of the above [16] or [17], further comprising at least one selected from the group consisting of oxides of rare earth metals, organic complexes of alkali metals, organic complexes of alkaline earth metals and organic complexes of rare earth metals. Lt; / RTI >

본 발명의 화합물은 박막 상태에서 전압을 인가해도 안정적이며, 또한, 전하의 수송 능력이 높은 특징을 가진다. 본 발명의 화합물은 유기 EL 소자에 있어서의 전하 수송 재료로서 적합하다. 본 발명의 화합물을 유기 EL 소자의 전자 수송층 및/또는 전자 주입층에 사용함으로써, 긴 수명을 가지는 유기 EL 소자를 얻을 수 있다. 본 발명의 유기 EL 소자를 사용함으로써, 풀 컬러 표시 등의 고성능 디스플레이 장치를 제조할 수 있다.The compound of the present invention is stable even when a voltage is applied in a thin film state, and has a high charge transport ability. The compound of the present invention is suitable as a charge transporting material in an organic EL device. By using the compound of the present invention for the electron transporting layer and / or the electron injecting layer of the organic EL device, an organic EL device having a long lifetime can be obtained. By using the organic EL device of the present invention, a high-performance display device such as a full color display can be manufactured.

이하에서, 본 발명을 보다 상세하게 설명한다. 그리고, 본 명세서에 있어서는, 예를 들면, "식 (1-7-26)으로 표시되는 화합물"을 "화합물 (1-7-26)"으로 칭하는 경우가 있다. "식 (1-7-74)로 표시되는 화합물"을 "화합물 (1-7-74)"로 칭하는 경우가 있다. 그 외의 식 기호, 식 번호에 대해서도 마찬가지로 취급된다.Hereinafter, the present invention will be described in more detail. In the present specification, for example, the "compound represented by the formula (1-7-26)" may be referred to as "the compound (1-7-26)". The compound represented by the formula (1-7-74) may be referred to as the compound (1-7-74). Other expression symbols and expression numbers are handled in the same manner.

<화합물의 설명><Description of compound>

본원의 제1 발명은, 하기 식 (1)로 표시되는, 피리딜, 비피리딜 또는 피리딜페닐을 가지는 화합물이다.The first invention of the present application is a compound having pyridyl, bipyridyl or pyridylphenyl represented by the following formula (1).

Figure 112013039443236-pct00024
Figure 112013039443236-pct00024

식 (1)에 있어서, Py는 독립적으로, 식 (2), (3) 또는 (4)로 표시되는 기이며, m 및 n은 0 또는 1이지만, m+n=1이다. 그리고, 식 (1) 중의 벤젠환, 나프탈렌환 및 피리딘환의 수소 중 적어도 하나가 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬로 치환되어 있는 것이, 본 화합물의 특징이다.In the formula (1), Py is independently a group represented by the formula (2), (3) or (4), and m and n are 0 or 1, but m + n = 1. It is a feature of the present invention that at least one of the benzene ring, naphthalene ring and pyridine ring in the formula (1) is substituted with an alkyl having 1 to 6 carbon atoms or a cycloalkyl having 3 to 6 carbon atoms.

식 (2)로 표시되는 피리딜은, 구체적으로는 2-피리딜, 3-피리딜 또는 4-피리딜이다.The pyridyl represented by the formula (2) is specifically 2-pyridyl, 3-pyridyl or 4-pyridyl.

식 (3)으로 표시되는 비피리딜은, 구체적으로는 2,2'-비피리딘-5-일, 2,2'-비피리딘-6-일, 2,2'-비피리딘-4-일, 2,3'-비피리딘-5-일, 2,3'-비피리딘-6-일, 2,3'-비피리딘-4-일, 2,4'-비피리딘-5-일, 2,4'-비피리딘-6-일, 2,4'-비피리딘-4-일, 3,2'-비피리딘-6-일, 3,2'-비피리딘-5-일, 3,3'-비피리딘-6-일, 3,3'-비피리딘-5-일, 3,4'-비피리딘-6-일, 3,4'-비피리딘-5-일, 4,2'-비피리딘-3-일, 4,3'-비피리딘-3-일, 또는 4,4'-비피리딘-3-일이다.Specific examples of the bipyridyl represented by the formula (3) include 2,2'-bipyridin-5-yl, 2,2'-bipyridin-6-yl, , 2,3'-bipyridin-5-yl, 2,3'-bipyridin-6-yl, , 4'-bipyridin-6-yl, 2,4'-bipyridin-4-yl, 3,2'-bipyridin-6-yl, Bipyridin-6-yl, 3,3'-bipyridin-5-yl, 3,4'-bipyridin-6-yl, 3,4'- Bipyridin-3-yl, 4,3'-bipyridin-3-yl, or 4,4'-bipyridin-3-yl.

식 (4)로 표시되는 피리딜페닐은, 구체적으로는 4-(2-피리딜)페닐, 4-(3-피리딜)페닐, 4-(4-피리딜)페닐, 3-(2-피리딜)페닐, 3-(3-피리딜)페닐, 3-(4-피리딜)페닐, 2-(2-피리딜)페닐, 2-(3-피리딜)페닐, 또는 2-(4-피리딜)페닐이다.Specific examples of the pyridylphenyl represented by the formula (4) include 4- (2-pyridyl) phenyl, 4- (3-pyridyl) phenyl, 4- 2- (3-pyridyl) phenyl, 3- (3-pyridyl) phenyl, 2- -Pyridyl) phenyl. &Lt; / RTI &gt;

식 (1)에 있어서, Py가 연결하는 것은 페닐에 있어서도, 2-나프틸에 있어서도 임의의 위치라도 되지만, 페닐에 있어서는 4번 위치 및 3번 위치인 것이 바람직하고, 2-나프틸에 있어서는 6번 위치 및 7번 위치인 것이 바람직하다. 특히 페닐의 3번 위치는 공역계를 넓히지 않는다는 점과, LUMO의 준위를 내리지 않는 점에 있어서 바람직하다. 또한, 2-나프틸의 6번 위치는 원료가 입수하기 쉬운 점에서 특히 바람직하다.In the formula (1), the linking of Py may be at any position in the phenyl or in the 2-naphthyl, but preferably at the 4-position and the 3-position in the phenyl, and in the 2-naphthyl is preferably 6 Position and the seventh position. Particularly, the position 3 of the phenyl is preferable in terms of not expanding the conjugated system and not lowering the level of the LUMO. Further, the 6-position of 2-naphthyl is particularly preferable in view of the availability of raw materials.

식 (1) 중의 벤젠환, 나프탈렌환, 및 피리딘환으로 치환되는 탄소수 1∼6의 알킬의 예는 메틸, 에틸, n-프로필, 이소프로필, n-부틸, 이소부틸, tert-부틸, n-펜틸, 이소펜틸, 2,2-디메틸프로필, n-헥실, 및 이소헥실이다. 이 중에서 바람직한 알킬은, 메틸, 에틸, 이소프로필, 및 tert-부틸이며, 메틸 및 tert-부틸이 보다 바람직하다. 탄소수 3∼6의 시클로알킬의 예는 시클로프로필, 시클로부틸, 시클로펜틸, 시클로헥실이다. 이 중에서 바람직한 시클로알킬은, 원료 입수의 용이성, 합성의 용이성을 고려하면, 시클로헥실이다.Examples of the alkyl having 1 to 6 carbon atoms substituted with a benzene ring, a naphthalene ring and a pyridine ring in the formula (1) include methyl, ethyl, n-propyl, isopropyl, n- butyl, isobutyl, Pentyl, isopentyl, 2,2-dimethylpropyl, n-hexyl, and isohexyl. Among these, preferable alkyl is methyl, ethyl, isopropyl, and tert-butyl, and methyl and tert-butyl are more preferable. Examples of the cycloalkyl having 3 to 6 carbon atoms include cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. Among them, preferable cycloalkyl is cyclohexyl, considering ease of raw material availability and ease of synthesis.

식 (1)로 표시되는 화합물은, 구체적으로는 하기 식 (1-1) 또는 (1-2)로 표시되는 화합물이다.The compound represented by the formula (1) is specifically a compound represented by the following formula (1-1) or (1-2).

Figure 112013039443236-pct00025
Figure 112013039443236-pct00025

식 (1-1) 및 (1-2)에 있어서의 Py의 정의는 전술한 바와 같다.The definition of Py in the formulas (1-1) and (1-2) is as described above.

식 (1)로 표시되는 화합물은, 보다 구체적으로는 하기 식 (1-3)∼(1-6) 중 어느 하나로 표시되는 화합물이다.More specifically, the compound represented by the formula (1) is a compound represented by any one of the following formulas (1-3) to (1-6).

Figure 112013039443236-pct00026
Figure 112013039443236-pct00026

식 (1-3)∼(1-6)에 있어서의 Py의 정의는 전술한 바와 같다.The definition of Py in the formulas (1-3) to (1-6) is as described above.

식 (1)로 표시되는 화합물은, 보다 구체적으로는 하기 식 (1-7)∼(1-10) 중 어느 하나로 표시되는 화합물이다.More specifically, the compound represented by the formula (1) is a compound represented by any one of the following formulas (1-7) to (1-10).

Figure 112013039443236-pct00027
Figure 112013039443236-pct00027

식 (1-7)∼(1-10)에 있어서의 Py 및 R의 정의는 전술한 바와 같다.The definitions of Py and R in the formulas (1-7) to (1-10) are as described above.

식 (1-7) 및 (1-8)에 있어서의 p는 1∼5의 정수이며, 1∼2의 정수인 것이 바람직하고, 1인 것이 보다 바람직하다. R이 치환되는 페닐의 위치에 제약은 없지만, 3번 위치 또는 4번 위치인 것이 바람직하다. 식 (1-9) 및 (1-10)에 있어서의 q는 1∼5의 정수이며, 1∼2의 정수인 것이 바람직하고, 1인 것이 보다 바람직하다. R이 치환되는 나프틸의 위치에 제약은 없지만, 6번 위치 또는 7번 위치인 것이 바람직하다.P in the formulas (1-7) and (1-8) is an integer of 1 to 5, preferably an integer of 1 to 2, more preferably 1. There is no restriction on the position of the phenyl substituted by R, but it is preferably the position 3 or 4. Q in the formulas (1-9) and (1-10) is an integer of 1 to 5, preferably an integer of 1 to 2, more preferably 1. There is no restriction on the position of the naphthyl substituted by R, but it is preferably a position 6 or 7.

또한, 식 (1)로 표시되는 화합물은, 보다 구체적으로는 하기 식 (1-11)∼(1-14) 중 어느 하나로 표시되는 화합물이다.More specifically, the compound represented by the formula (1) is a compound represented by any one of the following formulas (1-11) to (1-14).

Figure 112013039443236-pct00028
Figure 112013039443236-pct00028

식 (1-11)∼(1-14)에 있어서의 Py1의 정의는 전술한 바와 같다. 전술한 식 (2'), (3') 또는 (4')에 있어서의 R의 정의는 전술한 바와 같다. s는 1∼4의 정수이며, 1 또는 2인 것이 바람직하고, 1인 것이 보다 바람직하다. R이 치환되는 피리딜의 위치에는 특별히 제약은 없다.The definition of Py 1 in the formulas (1-11) to (1-14) is as described above. The definition of R in the above-mentioned formula (2 '), (3') or (4 ') is as described above. s is an integer of 1 to 4, preferably 1 or 2, more preferably 1. The position of the pyridyl substituted by R is not particularly limited.

또한, 식 (1)로 표시되는 화합물은, 보다 구체적으로는 하기 식 (1-15) 또는 (1-16)으로 표시되는 화합물이다.More specifically, the compound represented by the formula (1) is a compound represented by the following formula (1-15) or (1-16).

Figure 112013039443236-pct00029
Figure 112013039443236-pct00029

식 (1-15) 및 (1-16)에 있어서의 Py 및 R의 정의는 전술한 바와 같다. t는 1∼4의 정수이며, 1 또는 2인 것이 바람직하고, 1인 것이 보다 바람직하다. R이 치환되는 페닐렌의 위치에 제약은 없지만, 합성의 용이함을 고려하면, 1,4-페닐렌의 경우에는 안트라센에 연결되어 있는 탄소를 기준으로 하여 3번 위치인 것이 바람직하다. 1,3-페닐렌의 경우에는, 안트라센에 연결되어 있는 탄소를 기준으로 하여 4번 위치인 것이 바람직하다.The definitions of Py and R in the formulas (1-15) and (1-16) are as described above. t is an integer of 1 to 4, preferably 1 or 2, more preferably 1. There is no restriction on the position of phenylene in which R is substituted, but in consideration of easiness of synthesis, in the case of 1,4-phenylene, it is preferable that the position is 3 times with respect to carbon connected to anthracene. In the case of 1,3-phenylene, it is preferably the 4-position based on the carbon connected to the anthracene.

상기와 같이 식 (1)로 표시되는 화합물은, 구체적으로는 식 (1-7)∼(1-16)으로 표시되는 화합물로 대별된다. 이들 중에서 바람직한 구조는, 식 (1-7), 식 (1-9)∼(1-11) 및 식 (1-13)∼(1-16)이며, 보다 바람직한 구조는 식 (1-7)이다.As described above, the compounds represented by the formula (1) are specifically classified into the compounds represented by the formulas (1-7) to (1-16). Among them, preferred structures are the formulas (1-7), (1-9) to (1-11) and (1-13) to (1-16) to be.

<화합물의 구체예><Specific Example of Compound>

본 발명의 화합물의 구체예는 이하에서 열거하는 식으로 나타내지만, 본 발명은 이들 구체적인 구조의 개시에 의해 한정되지 않는다.Specific examples of the compound of the present invention are shown below in the formulas listed below, but the present invention is not limited by the disclosure of these specific structures.

<식 (1-7)로 표시되는 화합물의 구체예>Specific examples of the compound represented by the formula (1-7)

식 (1-7)로 표시되는 화합물의 구체예는 하기 식 (1-7-1)∼(1-7-144)로 나타낸다. 이들 중에서 바람직한 화합물은 식 (1-7-1)∼(1-7-6), 식 (1-7-10)∼(1-7-12), 식 (1-7-16)∼(1-7-30), 식 (1-7-34)∼(1-7-36), 식 (1-7-40)∼(1-7-48), 식 (1-7-73)∼(1-7-78), 식 (1-7-82)∼(1-7-84), 식 (1-7-88)∼(1-7-102), 식 (1-7-106)∼(1-7-108) 및 식 (1-7-112)∼(1-7-120)이다.Specific examples of the compound represented by the formula (1-7) are represented by the following formulas (1-7-1) to (1-7-144). Among these compounds, preferable compounds are the compounds represented by formulas (1-7-1) to (1-7-6), (1-7-10) to (1-7-12), (1-7-16) (1-7-34) to (1-7-36), (1-7-40) to (1-7-48), (1-7-73) to 1-7-78), equations 1-7-82 to 1-7-84, equations 1-7-88 to 1-7-102, equations 1-7-106- (1-7-108) and equations (1-7-112) to (1-7-120).

Figure 112013039443236-pct00030
Figure 112013039443236-pct00030

Figure 112013039443236-pct00031
Figure 112013039443236-pct00031

Figure 112013039443236-pct00032
Figure 112013039443236-pct00032

Figure 112013039443236-pct00033
Figure 112013039443236-pct00033

Figure 112013039443236-pct00034
Figure 112013039443236-pct00034

Figure 112013039443236-pct00035
Figure 112013039443236-pct00035

Figure 112013039443236-pct00036
Figure 112013039443236-pct00036

Figure 112013039443236-pct00037
Figure 112013039443236-pct00037

Figure 112013039443236-pct00038
Figure 112013039443236-pct00038

Figure 112013039443236-pct00039
Figure 112013039443236-pct00039

Figure 112013039443236-pct00040
Figure 112013039443236-pct00040

Figure 112013039443236-pct00041
Figure 112013039443236-pct00041

Figure 112013039443236-pct00042
Figure 112013039443236-pct00042

Figure 112013039443236-pct00043
Figure 112013039443236-pct00043

Figure 112013039443236-pct00044
Figure 112013039443236-pct00044

Figure 112013039443236-pct00045
Figure 112013039443236-pct00045

Figure 112013039443236-pct00046
Figure 112013039443236-pct00046

Figure 112013039443236-pct00047
Figure 112013039443236-pct00047

<식 (1-8)로 표시되는 화합물의 구체예>Specific examples of the compound represented by the formula (1-8)

식 (1-8)로 표시되는 화합물의 구체예는 하기 식 (1-8-1)∼(1-8-105)로 나타낸다.Specific examples of the compound represented by the formula (1-8) are represented by the following formulas (1-8-1) to (1-8-105).

Figure 112013039443236-pct00048
Figure 112013039443236-pct00048

Figure 112013039443236-pct00049
Figure 112013039443236-pct00049

Figure 112013039443236-pct00050
Figure 112013039443236-pct00050

Figure 112013039443236-pct00051
Figure 112013039443236-pct00051

Figure 112013039443236-pct00052
Figure 112013039443236-pct00052

Figure 112013039443236-pct00053
Figure 112013039443236-pct00053

Figure 112013039443236-pct00054
Figure 112013039443236-pct00054

Figure 112013039443236-pct00055
Figure 112013039443236-pct00055

Figure 112013039443236-pct00056
Figure 112013039443236-pct00056

Figure 112013039443236-pct00057
Figure 112013039443236-pct00057

<식 (1-9)로 표시되는 화합물의 구체예><Specific examples of the compound represented by formula (1-9)

식 (1-9)로 표시되는 화합물의 구체예는 하기 식 (1-9-1)∼(1-9-48)로 나타낸다. 이들 중에서 바람직한 화합물은 식 (1-9-10)∼(1-9-12), (1-9-16)∼(1-9-18), 식 (1-9-34)∼(1-9-36) 및 식 (1-9-40)∼(1-9-42)이다.Specific examples of the compound represented by the formula (1-9) are represented by the following formulas (1-9-1) to (1-9-48). Among them, preferred compounds are the compounds represented by formulas (1-9-10) to (1-9-12), (1-9-16) to (1-9-18), (1-9-34) 9-36) and (1-9-40) to (1-9-42).

Figure 112013039443236-pct00058
Figure 112013039443236-pct00058

Figure 112013039443236-pct00059
Figure 112013039443236-pct00059

Figure 112013039443236-pct00060
Figure 112013039443236-pct00060

Figure 112013039443236-pct00061
Figure 112013039443236-pct00061

<식 (1-10)으로 표시되는 화합물의 구체예><Specific examples of the compound represented by formula (1-10)

식 (1-10)으로 표시되는 화합물의 구체예는 하기 식 (1-10-1)∼(1-10-48)로 나타낸다. 이들 중에서 바람직한 화합물은 식 (1-10-1)∼(1-10-6), (1-10-10)∼(1-10-12) 및 (1-10-16)∼(1-10-21)이다.Specific examples of the compound represented by the formula (1-10) are represented by the following formulas (1-10-1) to (1-10-48). Among them, preferable compounds are compounds represented by formulas (1-10-1) to (1-10-6), (1-10-10) to (1-10-12) and (1-10-16) -21).

Figure 112013039443236-pct00062
Figure 112013039443236-pct00062

Figure 112013039443236-pct00063
Figure 112013039443236-pct00063

Figure 112013039443236-pct00064
Figure 112013039443236-pct00064

Figure 112013039443236-pct00065
Figure 112013039443236-pct00065

<식 (1-11)로 표시되는 화합물의 구체예>Specific examples of the compound represented by the formula (1-11)

식 (1-11)로 표시되는 화합물의 구체예는 하기 식 (1-11-1)∼(1-11-60)으로 나타낸다. 이들 중에서 바람직한 화합물은 식 (1-11-3)∼(1-11-10), (1-11-25)∼(1-11-28) 및 (1-11-51)∼(1-11-60)이다.Specific examples of the compound represented by the formula (1-11) are represented by the following formulas (1-11-1) to (1-11-60). Among them, preferred compounds are the compounds represented by formulas (1-11-3) to (1-11-10), (1-11-25) to (1-11-28), (1-11-51) -60).

Figure 112013039443236-pct00066
Figure 112013039443236-pct00066

Figure 112013039443236-pct00067
Figure 112013039443236-pct00067

Figure 112013039443236-pct00068
Figure 112013039443236-pct00068

Figure 112013039443236-pct00069
Figure 112013039443236-pct00069

Figure 112013039443236-pct00070
Figure 112013039443236-pct00070

<식 (1-12)로 표시되는 화합물의 구체예><Specific examples of the compound represented by formula (1-12)

식 (1-12)로 표시되는 화합물의 구체예는 하기 식 (1-12-1)∼(1-12-60)로 나타낸다.Specific examples of the compound represented by the formula (1-12) are represented by the following formulas (1-12-1) to (1-12-60).

Figure 112013039443236-pct00071
Figure 112013039443236-pct00071

Figure 112013039443236-pct00072
Figure 112013039443236-pct00072

Figure 112013039443236-pct00073
Figure 112013039443236-pct00073

Figure 112013039443236-pct00074
Figure 112013039443236-pct00074

Figure 112013039443236-pct00075
Figure 112013039443236-pct00075

<식 (1-13)으로 표시되는 화합물의 구체예><Specific examples of the compound represented by formula (1-13)

식 (1-13)으로 표시되는 화합물의 구체예는 하기 식 (1-13-1)∼(1-13-60)으로 나타낸다. 이들 중에서 바람직한 화합물은 식 (1-13-21)∼(1-13-28) 및 식 (1-13-31)∼(1-31-40)이다.Specific examples of the compound represented by the formula (1-13) are represented by the following formulas (1-13-1) to (1-13-60). Among them, preferable compounds are the formulas (1-13-21) to (1-13-28) and the formulas (1-13-31) to (1-31-40).

Figure 112013039443236-pct00076
Figure 112013039443236-pct00076

Figure 112013039443236-pct00077
Figure 112013039443236-pct00077

Figure 112013039443236-pct00078
Figure 112013039443236-pct00078

Figure 112013039443236-pct00079
Figure 112013039443236-pct00079

Figure 112013039443236-pct00080
Figure 112013039443236-pct00080

<식 (1-14)로 표시되는 화합물의 구체예>Specific examples of the compound represented by the formula (1-14)

식 (1-14)로 표시되는 화합물의 구체예는 하기 식 (1-14-1)∼(1-14-60)으로 나타낸다. 이들 중에서 바람직한 화합물은 식 (1-14-1)∼(1-14-18)이다.Specific examples of the compound represented by the formula (1-14) are represented by the following formulas (1-14-1) to (1-14-60). Among them, preferable compounds are the formulas (1-14-1) to (1-14-18).

Figure 112013039443236-pct00081
Figure 112013039443236-pct00081

Figure 112013039443236-pct00082
Figure 112013039443236-pct00082

Figure 112013039443236-pct00083
Figure 112013039443236-pct00083

Figure 112013039443236-pct00084
Figure 112013039443236-pct00084

Figure 112013039443236-pct00085
Figure 112013039443236-pct00085

<식 (1-15)로 표시되는 화합물의 구체예>Specific examples of the compound represented by the formula (1-15)

식 (1-15)로 표시되는 화합물의 구체예는 하기 식 (1-15-1)∼(1-15-48)로 나타낸다. 이들 중에서 바람직한 화합물은 식 (1-15-10)∼(1-15-12), (1-15-16)∼(1-15-18), 식 (1-15-34)∼(1-15-36) 및 (1-15-40)∼(1-15-42)이다.Specific examples of the compound represented by the formula (1-15) are represented by the following formulas (1-15-1) to (1-15-48). Among them, preferred compounds are the compounds represented by formulas (1-15-10) to (1-15-12), (1-15-16) to (1-15-18), (1-15-34) 15-36) and (1-15-40) to (1-15-42).

Figure 112013039443236-pct00086
Figure 112013039443236-pct00086

Figure 112013039443236-pct00087
Figure 112013039443236-pct00087

Figure 112013039443236-pct00088
Figure 112013039443236-pct00088

Figure 112013039443236-pct00089
Figure 112013039443236-pct00089

<식 (1-16)으로 표시되는 화합물의 구체예>Specific examples of the compound represented by the formula (1-16)

식 (1-16)으로 표시되는 화합물의 구체예는 하기 식 (1-16-1)∼(1-16-24)로 나타낸다. 이들 중에서 바람직한 화합물은 식 (1-16-1)∼(1-16-5)이다.Specific examples of the compound represented by the formula (1-16) are represented by the following formulas (1-16-1) to (1-16-24). Among them, preferred compounds are the formulas (1-16-1) to (1-16-5).

Figure 112013039443236-pct00090
Figure 112013039443236-pct00090

Figure 112013039443236-pct00091
Figure 112013039443236-pct00091

<화합물의 합성법>&Lt; Synthesis method of compound &

이하에서 본 발명의 화합물의 합성법에 대하여 설명한다. 본 발명의 화합물은, 범용되는 기존의 합성법을 적절하게 조합하여 이용함으로써 합성할 수 있다.Hereinafter, the synthesis method of the compound of the present invention will be described. The compounds of the present invention can be synthesized by appropriately combining conventional synthetic methods which are generally used.

<식 (1-7-1)∼식 (1-7-144)로 표시되는 화합물의 합성법><Synthesis method of the compound represented by formula (1-7-1) to formula (1-7-144)> [

Figure 112013039443236-pct00092
Figure 112013039443236-pct00092

R: 탄소수 1∼6의 알킬 또는 탄소수 1∼6의 시클로알킬R is an alkyl having 1 to 6 carbon atoms or a cycloalkyl having 1 to 6 carbon atoms

m: 1 내지 5의 정수m: integer of 1 to 5

먼저, 반응 1에서 페닐이 알킬기(시클로알킬기)로 치환된 9-페닐안트라센을 합성한다. 알킬 치환된 브로모벤젠을 THF 중 금속 마그네슘과 반응시켜 그리냐르 시약으로 만들고, 여기에 촉매의 존재 하에서 9-브로모안트라센을 반응시켜 페닐이 알킬기(시클로알킬기)로 치환된 9-페닐안트라센으로 만든다. 벤젠환과 안트라센환을 커플링하기 위해서는 상기 방법으로 한정되지 않고, 예를 들면, 아연 착체를 사용한 네기시 커플링 반응, 붕소산 또는 붕소산에스테르를 사용한 스즈키 커플링 반응 등에 의해서도 가능하며, 상황에 따라 이들 통상적인 법을 적절하게 사용할 수 있다.First, 9-phenylanthracene in which phenyl is substituted with an alkyl group (cycloalkyl group) in Reaction 1 is synthesized. Alkyl substituted bromobenzene is reacted with metal magnesium in THF to give a Grignard reagent which is then reacted with 9-bromoanthracene in the presence of a catalyst to give 9-phenylanthracene in which the phenyl is substituted with an alkyl group (cycloalkyl group) . The coupling of the benzene ring and the anthracene ring is not limited to the above method. For example, a coupling reaction using a zinc complex, a Suzuki coupling reaction using a boronic acid or a boronic acid ester, and the like can be used. Conventional methods can be suitably used.

Figure 112013039443236-pct00093
Figure 112013039443236-pct00093

반응 2에서는 N-브로모숙신이미드를 사용하여 페닐이 알킬기(시클로알킬기)로 치환된 9-페닐안트라센의 10번 위치를 브롬화한다. 여기에서도 N-브로모숙신이미드 이외의 통상적으로 사용되는 브롬화제를 사용할 수 있다.In reaction 2, N-bromosuccinimide is used to brominate the 10-position of 9-phenylanthracene in which phenyl is substituted with an alkyl group (cycloalkyl group). Here, conventionally used brominating agents other than N-bromosuccinimide can also be used.

Figure 112013039443236-pct00094
Figure 112013039443236-pct00094

반응 3에서는 안트라센환과 나프탈렌환을 커플링한다. 먼저 2-브로모-6-메톡시나프탈렌을 통상적인 방법에 따라 그리냐르 시약으로 만들고, 여기에 촉매의 존재 하에서 반응 2에서 합성한 9-브로모안트라센 유도체를 반응시켜 9-(6-메톡시나프탈렌-2-일)-10-페닐안트라센 유도체를 합성한다. 반응 1과 마찬가지로, 벤젠환과 안트라센환을 커플링하기 위해서는 상기 방법으로 한정되지 않고, 예를 들면, 아연 착체를 사용한 네기시 커플링 반응, 붕소산 또는 붕소산에스테르를 사용한 스즈키 커플링 반응 등에 의해서도 가능하며, 상황에 따라 이들 통상적인 방법을 적절하게 사용할 수 있다.In reaction 3, anthracene ring and naphthalene ring are coupled. First, 2-bromo-6-methoxynaphthalene is converted into Grignard reagent according to a conventional method, and 9-bromoanthracene derivative synthesized in Reaction 2 is reacted with 9- (6-methoxy Naphthalen-2-yl) -10-phenylanthracene derivative is synthesized. In the same manner as in Reaction 1, coupling of a benzene ring and an anthracene ring is not limited to the above method. For example, a Negishi coupling reaction using a zinc complex, a Suzuki coupling reaction using a boronic acid or a boronic ester , These conventional methods can be suitably used depending on the situation.

Figure 112013039443236-pct00095
Figure 112013039443236-pct00095

반응 4에서는 9-(6-메톡시나프탈렌-2-일)-10-페닐안트라센 유도체의 메톡시기를 탈메틸화하여 나프톨로 만든다. 여기에서도 탈메틸화 반응에 통상적으로 사용되는 시약을 적절하게 사용할 수 있다.In reaction 4, the methoxy group of the 9- (6-methoxynaphthalen-2-yl) -10-phenylanthracene derivative is demethylated to naphthol. Here too, reagents conventionally used for the demethylation reaction can be suitably used.

Figure 112013039443236-pct00096
Figure 112013039443236-pct00096

반응 5에서 나프톨의 -OH를 트리플루오로메틸술포네이트[트리플레이트(triflate)]로 한다. 반응식 중의 -OTf는- OSO2CF3의 약칭이다.In reaction 5, -OH of naphthol is referred to as trifluoromethylsulfonate (triflate). -OTf in the reaction scheme is - an abbreviation of OSO 2 CF 3.

Figure 112013039443236-pct00097
Figure 112013039443236-pct00097

반응 6에서 네기시 커플링 반응에 의해 나프탈렌환에 피리딘환을 결합시킨다. 먼저 4-브로모피리딘을 그리냐르 시약으로 만든다. 여기서는 원료에 안정적인 4-브로모피리딘 염산염을 사용하고 있으므로 이소프로필 마그네슘 염화물을 2배몰 사용하고 있지만, 염산염을 사용할 필요가 없는 원료에 대해서는 등 몰로 사용해도 무방하다. 그리냐르 시약에 염화 아연 테트라메틸에틸렌디아민 착체를 가하여 피리딘의 염화 아연 착체를 합성하고, 여기에 팔라듐 촉매의 존재 하에서 반응 5에서 얻은 트리플레이트를 반응시켜 목적물을 합성한다.In the reaction 6, a pyridine ring is bonded to the naphthalene ring by a negative coupling reaction. First, 4-bromopyridine is made into a Grignard reagent. In this case, since stable 4-bromopyridine hydrochloride is used as a raw material, isopropylmagnesium chloride is used at a ratio of 2 times, but it may be used as a molar for a raw material which does not need to use a hydrochloride. A zinc chloride complex of pyridine is synthesized by adding zinc chloride tetramethylethylenediamine complex to a Grignard reagent, and the triflate obtained in the reaction 5 is reacted in the presence of a palladium catalyst to synthesize a target product.

반응 6에서는 네기시 커플링 반응 이외에도, 스즈키 커플링 반응 등 통상적으로 사용되는 커플링 반응을 적절하게 사용할 수 있다. 스즈키 커플링 반응을 사용한 경우에는 목적물에 따라 최적인 붕소산 또는 붕소산 에스테르를 준비 하면 되고, 예를 들면, 하기 반응 7에 나타낸 바와 같은 붕소산 에스테르를 사용하여 목적물을 얻을 수 있다.In Reaction 6, besides the Negishi coupling reaction, a commonly used coupling reaction such as a Suzuki coupling reaction can be suitably used. When a Suzuki coupling reaction is used, an optimum boronic acid or boric acid ester may be prepared according to the target product. For example, a target compound can be obtained using a boronic acid ester as shown in the following reaction 7.

Figure 112013039443236-pct00098
Figure 112013039443236-pct00098

커플링 반응에 사용되는 팔라듐 촉매의 구체예로서는, Pd(PPh3)4, PdCl2(PPh3)2, Pd(OAc)2, 트리스(디벤질리덴아세톤)2팔라듐(0), 트리스(디벤질리덴아세톤)2팔라듐(0) 클로로포름 착체, 비스(디벤질리덴아세톤)팔라듐(0), 비스(트리tert-부틸포스피노)팔라듐(0), 또는 (1,1'-비스(디페닐포스피노)페로센)디클로로팔라듐(II)를 들 수 있다.Specific examples of the palladium catalyst used in the coupling reaction include Pd (PPh 3 ) 4 , PdCl 2 (PPh 3 ) 2 , Pd (OAc) 2 , tris (dibenzylideneacetone) 2 palladium (Dibenzylideneacetone) palladium (0), bis (tri tert-butylphosphino) palladium (0), or (1,1'-bis (diphenylphosphino) ) Ferrocene) dichloropalladium (II).

또한, 반응을 촉진시키기 위해, 경우에 따라 이들 팔라듐 화합물에 포스핀 화합물을 가해도 된다. 이러한 포스핀 화합물의 구체예로서는, 트리(tert-부틸)포스핀, 트리시클로헥실포스핀, 1-(N,N-디메틸아미노 메틸)-2-(디tert-부틸포스피노)페로센, 1-(N,N-디부틸아미노메틸)-2-(디tert-부틸포스피노)페로센, 1-(메톡시메틸)-2-(디tert-부틸포스피노)페로센, 1,1'-비스(디tert-부틸포스피노)페로센, 2,2'-비스(디tert-부틸포스피노)-1,1'-비나프틸, 2-메톡시-2'-(디tert-부틸포스피노)-1,1'-비나프틸, 또는 2-디시클로헥실포스피노-2',6'-디메톡시비페닐을 들 수 있다.In order to promote the reaction, a phosphine compound may be added to these palladium compounds, as the case may be. Specific examples of such phosphine compounds include tri (tert-butyl) phosphine, tricyclohexylphosphine, 1- (N, N-dimethylaminomethyl) -2- (ditert- butylphosphino) N, N-dibutylaminomethyl) -2- (ditert-butylphosphino) ferrocene, 1- (methoxymethyl) -2- (ditert- butylphosphino) ferrocene, 1,1'- (ditert-butylphosphino) -1,1'-binaphthyl, 2-methoxy-2 '- (ditert-butylphosphino) , 1'-binaphthyl, or 2-dicyclohexylphosphino-2 ', 6'-dimethoxybiphenyl.

반응에 사용되는 염기의 구체예로서는, 탄산 나트륨, 탄산 칼륨, 탄산 세슘, 탄산수소 나트륨, 수산화 나트륨, 수산화 칼륨, 수산화 바륨, 나트륨에톡시드, 나트륨 tert-부톡시드, 아세트산 나트륨, 인산 3칼륨, 또는 불화 칼륨을 들 수 있다.Specific examples of the base used in the reaction include sodium carbonate, potassium carbonate, cesium carbonate, sodium hydrogencarbonate, sodium hydroxide, potassium hydroxide, barium hydroxide, sodium ethoxide, sodium tert-butoxide, sodium acetate, And potassium fluoride.

또한, 반응에 사용되는 용매의 구체예로서는, 벤젠, 톨루엔, 크실렌, 1,2,4-트리메틸벤젠, N,N-디메틸포름아미드, 테트라하이드로퓨란, 디에틸에테르, tert-부틸메틸에테르, 1,4-디옥산, 메탄올, 에탄올, 시클로펜틸메틸에테르 또는 이소프로필알코올을 들 수 있다. 이들 용매는 적절하게 선택할 수 있고, 단독으로 사용할 수도 있고, 혼합 용매로서 사용할 수도 있다.Specific examples of the solvent used in the reaction include benzene, toluene, xylene, 1,2,4-trimethylbenzene, N, N-dimethylformamide, tetrahydrofuran, diethylether, tert- 4-dioxane, methanol, ethanol, cyclopentyl methyl ether or isopropyl alcohol. These solvents may be appropriately selected and used singly or as a mixed solvent.

<식 (1-8-1)∼식 (1-8-105)로 표시되는 화합물의 합성법>&Lt; Synthesis method of compound represented by formulas (1-8-1) to (1-8-105) &gt;

전술한 반응 3에 있어서, 2-브로모-6-메톡시나프탈렌 대신 2-브로모-7-메톡시나프탈렌을 사용해도, 마찬가지로 합성할 수 있다.In the above-described reaction 3, 2-bromo-7-methoxynaphthalene may be used in place of 2-bromo-6-methoxynaphthalene to similarly synthesize.

<식 (1-9-1)∼식 (1-9-48) 및 식 (1-10-1)∼식 (1-10-48)로 표시되는 화합물의 합성법><Synthesis of Compound Represented by Formula (1-9-1) to Formula (1-9-48) and Formula (1-10-1) to Formula (1-10-48)

전술한 반응 1∼3에 있어서 사용한 원료 대신, 이들의 벤젠 골격과 나프탈렌 골격을 치환하여 원료를 사용함으로써, 상기와 마찬가지로 합성할 수 있다. 즉, 2-브로모안트라센의 그리냐르 시약과 9-브로모안트라센을 커플링하고, 반응 2에 준하여 안트라센의 10번 위치를 브롬화하고, 이어서, 이 브롬화물을 파라메톡시브로모벤젠 또는 메타메톡시브로모벤젠의 그리냐르 시약과 반응시켜 9-(4- 또는 3-메톡시페닐)-10-(2-나프틸)안트라센을 얻는다. 이 화합물에 대하여 메톡시기의 탈메틸화 반응 이후의 스텝은 상기에 준하여 행하면 된다. 또한, 구체적으로 예시한 화합물 이외에 대해서도, 목적물에 맞추어 원료를 적절하게 사용함으로써, 상기한 합성법에 준하여 합성할 수 있는 것은 물론이다.Instead of the raw materials used in the above-described reactions 1 to 3, the benzene skeleton and the naphthalene skeleton can be substituted and the raw materials can be used to synthesize them as described above. That is, coupling of Grignard reagent of 2-bromoanthracene with 9-bromoanthracene, bromination of position 10 of anthracene according to Reaction 2, and subsequent bromination of this bromide with paramethoxybenzene or metamethoxybenzene (4- or 3-methoxyphenyl) -10- (2-naphthyl) anthracene is obtained by reacting with Grignard reagent of benzyl benzene. The step after the demethylation of the methoxy group with respect to this compound may be carried out in the same manner as described above. It goes without saying that, besides the specifically exemplified compounds, the compounds can also be synthesized in accordance with the above-described synthesis method by appropriately using the starting materials in accordance with the desired products.

<식 (1-11-1)∼식 (1-11-60), 식 (1-12-1)∼식 (1-12-60), 식 (1-13-1)∼식 (1-13-60) 및 식 (1-14-1)∼식 (1-14-60)으로 표시되는 화합물의 합성법>Expressions (1-11-1) to (1-11-60), Expressions (1-12-1) to (1-12-60), Expressions (1-13-1) to (1- 13-60) and the synthesis methods of the compounds represented by the formulas (1-14-1) to (1-14-60)

전술한 반응 6 또는 7에 있어서 사용한 원료의 피리딘 유도체 대신, 알킬기 또는 시클로알킬기로 치환된 피리딘 유도체를 원료에 사용함으로써, 상기와 마찬가지로 합성할 수 있다.The pyridine derivative substituted with an alkyl group or a cycloalkyl group can be used instead of the pyridine derivative of the raw material used in the reaction 6 or 7 described above to prepare a raw material.

알킬기 또는 시클로알킬기로 치환된 피리딘 유도체는 하기 반응 8∼9에 나타낸 바와 같이 합성할 수 있다. 여기서는 식 (1-11-11), 식 (1-12-11), 식 (1-13-11) 및 식 (1-14-11)로 표시되는 화합물에 있어서의 피리딘 부위의 합성법을 예시했지만, 원료를 적절하게 변경함으로써, 각종 알킬기 또는 시클로알킬기로 치환된 피리딘 유도체를 합성할 수 있다.Pyridine derivatives substituted with an alkyl group or a cycloalkyl group can be synthesized as shown in the following reactions 8 to 9. Here, the synthesis method of the pyridine moiety in the compound represented by the formula (1-11-11), the formula (1-12-11), the formula (1-13-11) and the formula (1-14-11) , A pyridine derivative substituted with various alkyl groups or cycloalkyl groups can be synthesized by appropriately changing the raw materials.

Figure 112013039443236-pct00099
Figure 112013039443236-pct00099

<식 (1-15-1)∼식 (1-15-48) 및 식 (1-16-1)∼식 (1-16-24)로 표시되는 화합물의 합성법><Synthesis of Compound Represented by Formula (1-15-1) to Formula (1-15-48) and Formula (1-16-1) to Formula (1-16-24)

전술한 "식 (1-9-1)∼식 (1-9-48) 및 식 (1-10-1)∼식 (1-10-48)로 표시되는 화합물의 합성법"에 있어서의 페닐기의 도입 공정 시에, 알킬기 또는 시클로알킬기로 치환된 페닐기를 이용하면 된다. 예를 들면, 하기 반응 10으로 표시되는 합성법을 이용할 수 있다.In the synthesis method of the compound represented by the above-mentioned "Formulas (1-9-1) to (1-9-48) and Formulas (1-10-1) to (1-10-48)" At the introduction step, a phenyl group substituted with an alkyl group or a cycloalkyl group may be used. For example, a synthesis method represented by the following reaction 10 can be used.

Figure 112013039443236-pct00100
Figure 112013039443236-pct00100

식 중의 R의 정의는 전술한 바와 같다. o는 1∼4의 정수이다. R은 목적으로 하는 화합물에 따라 벤젠환의 임의의 위치에, 원하는 수만큼 연결하면 된다.The definition of R in the formula is as described above. o is an integer of 1 to 4; R may be linked to any desired position of the benzene ring depending on the desired compound, as many as desired.

본 발명의 화합물을, 유기 EL 소자에 있어서의, 전자 주입층 또는 전자 수송층에 사용한 경우, 전계 인가 시에 있어서 안정적이 된다. 이는, 본 발명의 화합물이, 전계 발광형 소자의 전자 주입 재료, 또는 전자 수송 재료로서 우수한 것을 나타낸다. 여기서 말하는 전자 주입층은 음극으로부터 유기층에 전자를 받아들이는 층이며, 전자 수송층은 주입된 전자를 발광층에 수송하기 위한 층이다. 또한, 전자 수송층이 전자 주입층을 겸하는 것도 가능하다. 각각의 층에 사용하는 재료를, 전자 주입 재료 및 전자 수송 재료라고 한다.When the compound of the present invention is used for an electron injection layer or an electron transporting layer in an organic EL device, it becomes stable when an electric field is applied. This indicates that the compound of the present invention is excellent as an electron injecting material or an electron transporting material of an electroluminescent device. The electron injecting layer referred to herein is a layer for receiving electrons from the cathode to the organic layer, and the electron transporting layer is for transporting injected electrons to the light emitting layer. Further, the electron transporting layer may also serve as an electron injecting layer. The materials used for each layer are referred to as an electron injecting material and an electron transporting material.

<유기 EL 소자의 설명><Description of Organic EL Device>

본원의 제2 발명은, 전자 주입층, 또는 전자 수송층에, 본 발명의 식 (1)로 표시되는 화합물을 함유하는 유기 EL 소자이다. 본 발명의 유기 EL 소자는, 구동 전압이 낮고, 구동 시의 내구성이 높다.The second invention of the present application is an organic EL device containing the compound represented by the formula (1) of the present invention in the electron injection layer or electron transport layer. The organic EL device of the present invention has low driving voltage and high durability during driving.

본 발명의 유기 EL 소자의 구조는 각종 태양이 있지만, 기본적으로는 양극과 음극과의 사이에 적어도 정공 수송층, 발광층, 전자 수송층을 협지한 다층 구조이다. 소자의 구체적인 구성의 예는, (1) 양극/정공 수송층/발광층/전자 수송층/음극, (2) 양극/정공 주입층/정공 수송층/발광층/전자 수송층/음극, (3) 양극/정공 주입층/정공 수송층/발광층/전자 수송층/전자 주입층/음극 등이 있다.Although the structure of the organic EL device of the present invention is various, it is basically a multilayer structure sandwiching at least a hole transporting layer, a light emitting layer and an electron transporting layer between the anode and the cathode. Examples of specific configurations of the device include (1) anode / hole transporting layer / light emitting layer / electron transporting layer / cathode, (2) anode / hole injecting layer / hole transporting layer / light emitting layer / electron transporting layer / cathode, (3) anode / / Hole transporting layer / light emitting layer / electron transporting layer / electron injecting layer / cathode.

본 발명의 화합물은, 높은 전자 주입성 및 전자 수송성을 가지고 있으므로, 단체(單體)로 또는 다른 재료와 병용하여 전자 주입층, 또는 전자 수송층에 사용할 수 있다. 본 발명의 유기 EL 소자는, 본 발명의 전자 수송 재료에 다른 재료를 사용한 정공 주입층, 정공 수송층, 발광층 등을 조합함으로써, 청색, 녹색, 적색이나 백색의 발광을 얻을 수도 있다.Since the compound of the present invention has a high electron injecting property and an electron transporting property, it can be used alone or in combination with other materials for an electron injecting layer or an electron transporting layer. In the organic EL device of the present invention, light emission of blue, green, red or white may be obtained by combining a hole injection layer, a hole transporting layer, a light emitting layer, or the like using another material for the electron transporting material of the present invention.

본 발명의 유기 EL 소자에 사용할 수 있는 발광 재료 또는 발광성 도펀트은, 일본 고분자학회편, 고분자 기능 재료 시리즈“광기능 재료”, 교도 출판(1991), P236에 기재되어 있는 바와 같은 주광(晝光, daylight) 형광 재료, 형광 증백제, 레이저 색소, 유기 신틸레이터, 각종 형광 분석 시약 등의 발광 재료, 기도 준지(城戶 淳二) 감수, “유기 EL 재료와 디스플레이”시엠시사 출판(2001) P155∼156에 기재되어 있는 도펀트 재료, P170∼172에 기재되어 있는 바와 같은 3중항 재료의 발광 재료 등이다.The light emitting material or luminescent dopant usable in the organic EL device of the present invention is a light emitting material or a light emitting dopant which can be used in daylight as described in Polymer Functional Materials Series, &quot; Functional Materials &quot;, Kyodo Publications (1991) Emitting materials such as fluorescent materials, fluorescent whitening agents, laser pigments, organic scintillators, and various fluorescence analysis reagents, supervised by Junji Kuno, "Organic EL materials and displays", published by Siemens Publishing Co. (2001) P155 to 156 A luminescent material of a triplet material as described in P170 to 172, and the like.

발광 재료 또는 발광성 도펀트로서 사용할 수 있는 화합물은, 다환 방향족 화합물, 헤테로 방향족 화합물, 유기 금속 착체, 색소, 고분자계 발광 재료, 스티릴 유도체, 방향족 아민 유도체, 쿠마린 유도체, 보란 유도체, 옥사진 유도체, 스피로환을 가지는 화합물, 옥사디아졸 유도체, 플루오렌 유도체 등이다. 다환 방향족 화합물의 예는, 안트라센 유도체, 페난트렌 유도체, 나프타센 유도체, 피렌 유도체, 크리센 유도체, 페릴렌 유도체, 코로넨 유도체, 루브렌 유도체 등이다. 헤테로 방향족 화합물의 예는, 디알킬아미노기 또는 디아릴아미노기를 가지는 옥사디아졸 유도체, 피라졸로퀴놀린 유도체, 피리딘 유도체, 피란 유도체, 페난트롤린 유도체, 시로 유도체, 트리페닐아미노기를 가지는 티오펜 유도체, 퀴나크리돈 유도체 등이다. 유기 금속 착체의 예는, 아연, 알루미늄, 베릴륨, 유로퓸, 테르븀, 디스프로슘, 이리듐, 백금, 오스뮴, 금 등과, 퀴놀리놀 유도체, 벤즈옥사졸 유도체, 벤조티아졸 유도체, 옥사디아졸 유도체, 티아디아졸 유도체, 벤조이미다졸 유도체, 피롤 유도체, 피리딘 유도체, 페난트롤린 유도체 등과의 착체이다. 색소의 예는, 크산텐 유도체, 폴리메틴 유도체, 포르피린 유도체, 쿠마린 유도체, 디시아노메틸렌피란 유도체, 디시아노메틸렌티오피란 유도체, 옥소벤즈안트라센 유도체, 카르보스티릴 유도체, 페릴렌 유도체, 벤즈옥사졸 유도체, 벤조티아졸 유도체, 벤조이미다졸 유도체 등의 색소를 들 수 있다. 고분자계 발광 재료의 예는, 폴리파라페닐비니렌 유도체, 폴리티오펜 유도체, 폴리비닐카르바졸 유도체, 폴리실란 유도체, 폴리플루오렌 유도체, 폴리파라페니렌 유도체 등이다. 스티릴 유도체의 예는, 아민 함유 스티릴 유도체, 스티릴아릴렌 유도체 등이다.The compound which can be used as a light emitting material or a luminescent dopant includes a polycyclic aromatic compound, a heteroaromatic compound, an organic metal complex, a dye, a polymer light emitting material, a styryl derivative, an aromatic amine derivative, a coumarin derivative, a borane derivative, Compounds having a ring, oxadiazole derivatives, and fluorene derivatives. Examples of the polycyclic aromatic compound include anthracene derivatives, phenanthrene derivatives, naphthacene derivatives, pyrene derivatives, chrysene derivatives, perylene derivatives, coronene derivatives, and rubrene derivatives. Examples of the heteroaromatic compound include oxadiazole derivatives having a dialkylamino group or diarylamino group, pyrazoloquinoline derivatives, pyridine derivatives, pyran derivatives, phenanthroline derivatives, siroo derivatives, thiophene derivatives having triphenylamino groups, And the like. Examples of the organometallic complexes include metal complexes such as zinc, aluminum, beryllium, europium, terbium, dysprosium, iridium, platinum, osmium, gold and the like, quinolinol derivatives, benzoxazole derivatives, benzothiazole derivatives, oxadiazole derivatives, A benzoimidazole derivative, a pyrrole derivative, a pyridine derivative, a phenanthroline derivative and the like. Examples of the coloring matter are oxetane derivatives, polymethine derivatives, porphyrin derivatives, coumarin derivatives, dicyanomethylenepyran derivatives, dicyanomethylenethiopyran derivatives, oxobenzanthracene derivatives, carbostyryl derivatives, perylene derivatives, benzoxazole derivatives , Benzothiazole derivatives, benzoimidazole derivatives, and the like. Examples of the polymer light emitting material include polyparaphenylenevinylene derivatives, polythiophene derivatives, polyvinylcarbazole derivatives, polysilane derivatives, polyfluorene derivatives, and polyparaphenylene derivatives. Examples of the styryl derivatives include amine-containing styryl derivatives, styrylarylene derivatives and the like.

본 발명의 유기 EL 소자에 사용되는 다른 전자 수송 재료는, 광도전 재료에 있어서 전자 전달 화합물로서 사용할 수 있는 화합물, 유기 EL 소자의 전자 수송층 및 전자 주입층에 사용할 수 있는 화합물 중에서 임의로 선택하여 사용할 수 있다.Other electron transporting materials used in the organic EL device of the present invention can be arbitrarily selected from compounds usable as an electron transporting compound in a photoconductive material, an electron transporting layer of an organic EL device, and a compound usable in an electron injecting layer have.

이와 같은 전자 수송 재료의 구체예는, 퀴놀리놀계 금속 착체, 2,2'-비피리딜 유도체, 페난트롤린 유도체, 디페닐퀴논 유도체, 페릴렌 유도체, 옥사디아졸 유도체, 티오펜 유도체, 트리아졸 유도체, 티아디아졸 유도체, 옥신 유도체의 금속 착체, 퀴녹살린 유도체, 퀴녹살린 유도체의 폴리머, 벤자졸류 화합물, 갈륨 착체, 피라졸 유도체, 퍼플루오로화 페닐렌 유도체, 트리아진 유도체, 피라진 유도체, 벤조퀴놀린 유도체, 이미다조피리딘 유도체, 보란 유도체 등이다.Specific examples of such electron transporting materials include quinolinol-based metal complexes, 2,2'-bipyridyl derivatives, phenanthroline derivatives, diphenylquinone derivatives, perylene derivatives, oxadiazole derivatives, thiophene derivatives, A thiadiazole derivative, a metal complex of an oxine derivative, a quinoxaline derivative, a polymer of a quinoxaline derivative, a benzazole compound, a gallium complex, a pyrazole derivative, a perfluorinated phenylene derivative, a triazine derivative, a pyrazine derivative, Benzoquinoline derivatives, imidazopyridine derivatives, borane derivatives, and the like.

본 발명의 유기 EL 소자에 사용되는 정공 주입 재료 및 정공 수송 재료에 대해서는, 광도전 재료에 있어서, 정공의 전하 수송 재료로서 종래부터 관용되고 있는 화합물이나, 유기 EL 소자의 정공 주입층 및 정공 수송층에 사용되고 있는 공지의 것 중에서 임의의 것을 선택하여 사용할 수 있다. 이들의 구체예는, 카르바졸 유도체, 트릴아릴아민 유도체, 프탈로시아닌 유도체 등이다.As for the hole injecting material and the hole transporting material used in the organic EL device of the present invention, it is preferable to use a compound conventionally used as a charge transporting material of a hole in a photoconductive material, a hole injecting layer and a hole transporting layer of an organic EL device Any of the well-known known ones may be selected and used. Specific examples thereof include carbazole derivatives, trilaurylamine derivatives, phthalocyanine derivatives and the like.

본 발명의 유기 EL 소자를 구성하는 각 층은, 각 층을 구성할 재료를 증착법, 스핀코트법 또는 캐스트법 등의 방법으로 박막화함으로써, 형성할 수 있다. 이와 같이 하여 형성된 각 층의 막 두께에 대해서는 특별히 한정은 없으며, 재료의 성질에 따라 적절하게 설정할 수 있지만, 통상 2 nm∼5000 nm의 범위이다. 그리고, 발광 재료를 박막화하는 방법은, 균질한 막을 얻기 쉽고, 또한 핀홀이 생성되기 어려운 등의 점에서 증착법을 채용하는 것이 바람직하다. 증착법을 이용하여 박막화하는 경우, 그 증착 조건은, 본 발명의 발광 재료의 종류에 따라 상이하다. 증착 조건은 일반적으로, 보트 가열 온도 50∼400 ℃, 진공도 10-6∼10-3 Pa, 증착 속도 0.01∼50 nm/초, 기판 온도 -150∼+300 ℃, 막 두께 5 nm∼5㎛의 범위에서 적절하게 설정하는 것이 바람직하다.Each layer constituting the organic EL device of the present invention can be formed by thinning a material constituting each layer by a vapor deposition method, a spin coating method, a casting method, or the like. The film thickness of each layer thus formed is not particularly limited and may be appropriately set according to the properties of the material, but is usually in the range of 2 nm to 5000 nm. The thin film forming method of the light emitting material is preferably a vapor deposition method in that a homogeneous film is easily obtained and pinholes are difficult to be generated. In the case of thinning using a vapor deposition method, the deposition conditions differ depending on the kind of the light emitting material of the present invention. The deposition conditions are generally in the range of boat heating temperature 50 to 400 占 폚, vacuum degree 10-6 to 10-3 Pa, deposition rate 0.01 to 50 nm / sec, substrate temperature 150 to 300 占 폚 and film thickness 5 nm to 5 占 퐉 As shown in Fig.

본 발명의 유기 EL 소자는, 전술한 어떤 구조에서도, 기판에 지지되어 있는 것이 바람직하다. 기판은 기계적 강도, 열안정성 및 투명성을 가지는 것이면 되며, 유리, 투명 플라스틱 필름 등을 사용할 수 있다. 양극 물질은 4 eV보다 큰 일함수(work function)를 가지는 금속, 합금, 전기 전도성 화합물 및 이들의 혼합물을 사용할 수 있다. 그 구체예는, Au 등의 금속, CuI, 인듐주석옥사이드(이하, ITO로 약기 함), SnO2, ZnO 등이다.The organic EL device of the present invention is preferably supported on the substrate in any of the above-described structures. The substrate is not particularly limited as long as it has mechanical strength, thermal stability and transparency, and glass, transparent plastic film and the like can be used. The anode material may be a metal, alloy, electrically conductive compound and mixtures thereof having a work function greater than 4 eV. Specific examples thereof include metals such as Au, CuI, indium tin oxide (hereinafter abbreviated as ITO), SnO 2 , and ZnO.

음극 물질은 4 eV보다 작은 일함수의 금속, 합금, 전기 전도성 화합물, 및 이들의 혼합물을 사용할 수 있다. 그 구체예는, 알루미늄, 칼슘, 마그네슘, 리튬, 마그네슘 합금, 알루미늄 합금 등이다. 합금의 구체예는, 알루미늄/불화 리튬, 알루미늄/리튬, 마그네슘/은, 마그네슘/인듐 등이다. 유기 EL 소자의 발광을 효율적으로 얻기 위하여, 전극 중 적어도 한쪽은 광투과율을 10% 이상으로 하는 것이 바람직하다. 전극으로서의 시트 저항은 수백 Ω/□ 이하로 하는 것이 바람직하다. 그리고, 막 두께는 전극 재료의 성질에 따라 다르지만, 통상 10nm∼1㎛, 바람직하게는 10∼400 nm의 범위로 설정된다. 이와 같은 전극은, 전술한 전극 물질을 사용하여, 증착이나 스퍼터링 등의 방법으로 박막을 형성함으로써 제조할 수 있다.The cathode material may use a work function metal, alloy, electroconductive compound, and mixtures thereof less than 4 eV. Specific examples thereof include aluminum, calcium, magnesium, lithium, a magnesium alloy, an aluminum alloy, and the like. Specific examples of the alloy include aluminum / lithium fluoride, aluminum / lithium, magnesium / silver, magnesium / indium and the like. In order to efficiently obtain luminescence of the organic EL device, it is preferable that at least one of the electrodes has a light transmittance of 10% or more. It is preferable that the sheet resistance as the electrode is several hundreds? /? Or less. The film thickness varies depending on the properties of the electrode material, but is usually set in the range of 10 nm to 1 占 퐉, preferably 10 to 400 nm. Such an electrode can be produced by forming a thin film by a method such as vapor deposition or sputtering using the electrode material described above.

다음으로, 본 발명의 발광 재료를 사용하여 유기 EL 소자를 제조하는 방법의 일례로서, 전술한 양극/정공 주입층/정공 수송층/발광층/본 발명의 전자 수송 재료/음극으로 이루어지는 유기 EL 소자의 제조법에 대하여 설명한다. 적절한 기판 상에, 양극 재료의 박막을 증착법에 의해 형성하여 양극을 제조한 후, 이 양극 상에 정공 주입층 및 정공 수송층의 박막을 형성한다. 그 위에 발광층의 박막을 형성한다. 이 발광층 상에 본 발명의 전자 수송 재료를 진공 증착하고, 박막을 형성시켜, 전자 수송층으로 한다. 또한, 음극용 물질로 이루어지는 박막을 증착법에 의해 형성하여 음극으로 함으로써, 목적으로 하는 유기 EL 소자를 얻을 수 있다. 그리고, 전술한 유기 EL 소자의 제조에 있어서는, 제조 순서를 반대로 하여, 음극, 전자 수송층, 발광층, 정공 수송층, 정공 주입층, 양극의 차례로 제조할 수도 있다.Next, as an example of a method for producing an organic EL device using the light emitting material of the present invention, a method for producing an organic EL device comprising the anode / hole injection layer / hole transporting layer / light emitting layer / electron transporting material / cathode of the present invention Will be described. A thin film of a cathode material is formed on a suitable substrate by a vapor deposition method to produce a cathode, and a thin film of a hole injection layer and a hole transport layer is formed on the anode. And a thin film of the light emitting layer is formed thereon. The electron transporting material of the present invention is vacuum-deposited on the light-emitting layer to form a thin film to form an electron transporting layer. Further, a target organic EL device can be obtained by forming a thin film made of a material for a negative electrode by vapor deposition to form a negative electrode. In the above-described production of the organic EL device, the cathode, the electron transporting layer, the light emitting layer, the hole transporting layer, the hole injecting layer, and the anode may be prepared in this order.

이와 같이 하여 얻어진 유기 EL 소자에 직류 전압을 인가하는 경우에는, 양극을 +, 음극 -의 극성으로 하여 인가하면 되며, 전압 2∼40 V 정도를 인가하면, 투명 또는 반투명의 전극측(양극 또는 음극, 및 양쪽)으로부터 발광을 관측할 수 있다. 또한, 이 유기 EL 소자는, 교류 전압을 인가한 경우에도 발광한다. 그리고, 인가하는 교류의 파형은 임의로 할 수 있다.When a direct current voltage is applied to the organic EL device thus obtained, the positive electrode may be applied with the polarity of + or -. When a voltage of about 2 to 40 V is applied, the transparent or semitransparent electrode side , And both) can be observed. Further, this organic EL element emits light even when an AC voltage is applied. The waveform of the applied alternating current can be arbitrarily set.

[실시예][Example]

이하에서, 본 발명을 실시예에 따라, 보다 상세하게 설명한다. 먼저, 실시예에서 사용한 화합물의 합성예에 대하여, 이하에서 설명한다.Hereinafter, the present invention will be described in more detail with reference to examples. First, synthesis examples of the compounds used in the examples will be described below.

[합성예 1] 화합물 (1-7-74)의 합성[Synthesis Example 1] Synthesis of Compound (1-7-74)

<9-(4-tert-부틸페닐)안트라센의 합성>&Lt; Synthesis of 9- (4-tert-butylphenyl) anthracene &gt;

질소 분위기 하에서, 9-브로모안트라센 31 g, 4-tert-부틸페닐 붕소산 25 g, Pd(PPh3)4 1.3 g, 인산 칼륨 51 g 및 1,2,4-트리메틸벤젠 150 ml가 들어간 플라스크를 환류 온도에서 21시간 교반했다. 반응액을 실온까지 냉각시킨 후, 물 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거함으로써 석출되는 고체를 흡인 여과에 의해 채취하고, 메탄올에 이어서 아세트산 에틸로 세정하여, 9-(4-tert-부틸페닐)안트라센 28 g을 얻었다.Under nitrogen atmosphere, 9-bromo-anthracene 31 g, 4-tert- butyl-phenyl boronic acid 25 g, Pd (PPh 3) 4 1.3 g, potassium phosphate, and 51 g of 1,2,4-trimethyl benzene, 150 ml flask containing a Were stirred at reflux temperature for 21 hours. After the reaction solution was cooled to room temperature, water and toluene were added thereto to separate the solution. The solvent was distilled off under reduced pressure, and the precipitated solid was collected by suction filtration, washed with methanol and then with ethyl acetate to obtain 28 g of 9- (4-tert-butylphenyl) anthracene.

<9-브로모-10-(4-tert-부틸페닐)안트라센의 합성><Synthesis of 9-bromo-10- (4-tert-butylphenyl) anthracene>

9-(4-tert-부틸페닐)안트라센 27 g, 옥소 0.1 g 및 THF 300ml가 들어간 플라스크에, 질소 분위기 하에서, N-브로모숙신이미드 19 g을 가하였다. 실온에서 18시간 교반하고, 티오황산 나트륨 수용액을 가하고, 반응을 정지시켰다. 이 용액을 분액 로트로 옮겨, 클로로포름으로 추출했다. 용매를 감압 증류 제거함으로써 석출되는 고체를 흡인 여과에 의해 채취하고, 그 다음으로, 클로로벤젠으로부터 재결정하여, 9-브로모-10-(4-tert-부틸페닐)안트라센 29 g을 얻었다.In a flask containing 27 g of 9- (4-tert-butylphenyl) anthracene, 0.1 g of oxo and 300 ml of THF, 19 g of N-bromosuccinimide was added under nitrogen atmosphere. The mixture was stirred at room temperature for 18 hours, and an aqueous solution of sodium thiosulfate was added to terminate the reaction. The solution was transferred to a separatory funnel and extracted with chloroform. The solvent was distilled off under reduced pressure to precipitate a solid. The solid was collected by suction filtration and then recrystallized from chlorobenzene to obtain 29 g of 9-bromo-10- (4-tert-butylphenyl) anthracene.

<3-(6-브로모나프탈렌-2-일)피리딘의 합성><Synthesis of 3- (6-bromonaphthalen-2-yl) pyridine>

3-브로모피리딘 10 g 및 THF 60ml를 넣은 플라스크를 빙욕(氷浴)에서 냉각시키고, 질소 분위기 하에서, 2 M의 이소프로필마그네슘 염화물 THF 용액 35 ml를 교반하면서 적하하였다. 적하 종료 후 일단 실온까지 승온한 후, 얼음 물로 냉각시키고, 염화 아연 테트라메틸에틸렌디아민 착체 17 g을 교반하면서 가하였다. 그 후 실온에서 1시간 교반한 후, 6-브로모나프탈렌-2-일트리플루오로메탄술포네이트 18 g 및 PdCl2(dppp) 1.6 g을 가하여, 환류 온도에서 3시간 교반했다. 반응액을 실온까지 냉각시킨 후, 촉매의 금속 이온을 제거하기 위해, 목적으로 하는 화합물에 대하여 대략 3배몰에 상당하는 에틸렌디아민4아세트산·4나트륨염 이수화물을 적정량의 물에 용해시킨 용액(이후, EDTA·4 Na 수용액으로 약기함) 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거한 후, 실리카겔 컬럼 크로마토그래피[톨루엔/아세트산 에틸=7/3(용적비)]로 정제하여, 3-(6-브로모나프탈렌-2-일)피리딘 12 g을 얻었다.10 g of 3-bromopyridine and 60 ml of THF was cooled in an ice bath and 35 ml of a 2 M solution of isopropylmagnesium chloride in THF was added dropwise with stirring under a nitrogen atmosphere. After completion of the dropwise addition, the temperature was once increased to room temperature, then cooled with ice water, and 17 g of zinc tetramethylethylenediamine chloride complex was added with stirring. Thereafter, the mixture was stirred at room temperature for 1 hour, 18 g of 6-bromonaphthalene-2-yl trifluoromethanesulfonate and 1.6 g of PdCl 2 (dppp) were added, and the mixture was stirred at reflux temperature for 3 hours. After cooling the reaction solution to room temperature, a solution in which an ethylenediamine tetraacetic acid · tetrasodium salt dihydrate equivalent to approximately 3 times the molar amount of the aimed compound is dissolved in an appropriate amount of water (hereinafter referred to as &quot; , Abbreviated as EDTA · 4 Na aqueous solution) and toluene were added to the solution. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography [toluene / ethyl acetate = 7/3 (volume ratio)] to obtain 12 g of 3- (6-bromonaphthalen-2-yl) pyridine.

<화합물 (1-7-74)의 합성>&Lt; Synthesis of Compound (1-7-74) &gt;

3-(6-브로모나프탈렌-2-일)피리딘 6.2 g, 비스피나콜레이토디보론 5.9 g, 비스(디벤질리덴아세톤)팔라듐(0) 0.4 g, 트리시클로헥실포스핀 0.5 g, 아세트산 칼륨 3.9 g 및 디메톡시에탄 50 ml를 넣은 플라스크를 질소 분위기 하에서, 환류 온도에서 4시간 교반했다. 이 용액에 9-브로모-10-(4-tert-부틸페닐)안트라센 8.6 g, 인산 칼륨 9.3 g 및 1,2,4-트리메틸벤젠 50 ml를 가하고, 디메톡시에탄을 딘스타크(Dean-Stark)관을 사용하여, 상온에서 가열 증류 제거했다. tert-부틸알코올 5 ml, 물 5 ml, 비스(디벤질리덴아세톤)팔라듐(0) 0.4 g 및 트리시클로헥실포스핀 0.5 g을 가하여, 환류 온도에서 5시간 더 교반했다. 반응액을 실온까지 냉각시키고, 수세하여 염을 용해시킨 후, 흡인 여과에 의해 고체를 채취했다. 얻어진 고체를 메탄올에 이어서 아세트산 에틸로 세정한 후, 실리카겔 컬럼 크로마토그래피[톨루엔/아세트산 에틸=9/1(용적비)]로 정제하여, 화합물 (1-7-74):3-(6-(10-(4-tert-부틸)페닐)안트라센-9-일)나프탈렌-2-일)피리딘 1.0 g을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.6.2 g of 3- (6-bromonaphthalen-2-yl) pyridine, 5.9 g of bispinolol acetone, 0.4 g of bis (dibenzylideneacetone) palladium (0), 0.5 g of tricyclohexylphosphine, g and 50 ml of dimethoxyethane was stirred in a nitrogen atmosphere at a reflux temperature for 4 hours. 8.6 g of 9-bromo-10- (4-tert-butylphenyl) anthracene, 9.3 g of potassium phosphate and 50 ml of 1,2,4-trimethylbenzene were added to this solution, and dimethoxyethane was added dropwise to a solution of Dean- ) Tube, and the mixture was heated and distilled off at room temperature. 5 ml of tert-butyl alcohol, 5 ml of water, 0.4 g of bis (dibenzylideneacetone) palladium (0) and 0.5 g of tricyclohexylphosphine were added, and the mixture was further stirred at a reflux temperature for 5 hours. The reaction solution was cooled to room temperature, washed with water to dissolve the salt, and then the solid was collected by suction filtration. The resulting solid was washed with methanol followed by ethyl acetate and then purified by silica gel column chromatography [toluene / ethyl acetate = 9/1 (volume ratio)] to obtain the compound (1-7-74) - (4-tert-butyl) phenyl) anthracene-9-yl) naphthalen-2-yl) pyridine. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=9.07(m, 1H), 8.68(dd, 1H), 8.23(m, 1H), 8.15(d, 1H), 8.08(m, 1H), 8.03(m, 2H), 7.83(dd, 1H), 7.78(d, 2H), 7.72(d, 2H), 7.68(dd, 1H), 7.63(d, 2H), 7.42-7.48(m, 3H), 7.30-7.38(m, 4H), 1.49(s, 9H). 1 H-NMR (CDCl 3) : δ = 9.07 (m, 1H), 8.68 (dd, 1H), 8.23 (m, 1H), 8.15 (d, 1H), 8.08 (m, 1H), 8.03 (m, (M, 3H), 7.30 (d, 2H), 7.83 (d, (m, 4 H), 1.49 (s, 9 H).

[합성예 2] 화합물 (1-7-26)의 합성Synthesis Example 2 Synthesis of Compound (1-7-26)

<9-(3-톨릴)안트라센의 합성>&Lt; Synthesis of 9- (3-tolyl) anthracene &gt;

질소 분위기 하에서, 9-브로모안트라센 36 g, 3-메틸페닐 붕소산 21 g, Pd(PPh3)4 1.4 g, 인산 칼륨 59 g 및 1,2,4-트리메틸벤젠 150 ml가 들어간 플라스크를 환류 온도에서 2.5시간 교반했다. 반응액을 실온까지 냉각시킨 후, 물 및 톨루엔을 가하여 분액했다. 얻어진 톨루엔 용액을 실리카겔 쇼트 컬럼에 의해 정제한 후, 용매를 감압 증류 제거했다. 얻어진 오일에 헵탄을 가하여, 석출되는 고체를 흡인 여과에 의해 채취하여, 9-(3-톨릴)안트라센 31 g을 얻었다.Under nitrogen atmosphere, 9-bromo-anthracene 36 g, 3- methylphenyl boronic acid 21 g, Pd (PPh 3) 4 1.4 g, potassium phosphate, and 59 g of 1,2,4-trimethyl benzene, 150 ml is into a reflux flask Lt; / RTI &gt; for 2.5 hours. After the reaction solution was cooled to room temperature, water and toluene were added thereto to separate the solution. The obtained toluene solution was purified by a silica gel short column, and then the solvent was distilled off under reduced pressure. Heptane was added to the obtained oil, and the precipitated solid was collected by suction filtration to obtain 31 g of 9- (3-tolyl) anthracene.

<9-브로모-10-(3-톨릴)안트라센의 합성><Synthesis of 9-bromo-10- (3-tolyl) anthracene>

9-(3-톨릴)안트라센 30 g 및 THF 200ml가 들어간 플라스크에, 질소 분위기 하에서 빙욕에서 냉각시키고, N-브로모숙신이미드 20 g 및 옥소 0.1 g을 가하였다. 실온에서 15시간 교반하고, 티오 황산 나트륨 수용액을 가하여, 반응을 정지시켰다. 이 용액을 분액 로트로 옮겨, 톨루엔으로 추출한 후, 실리카겔 쇼트 컬럼에 의해 정제를 행하였다. 용매를 감압 증류 제거하여, 얻어진 용액에 헵탄을 가하여 석출된 고체를 흡인 여과에 의해 채취하여, 9-브로모-10-(3-톨릴)안트라센 30 g을 얻었다.30 g of 9- (3-tolyl) anthracene and 200 ml of THF was cooled in an ice bath under a nitrogen atmosphere, 20 g of N-bromosuccinimide and 0.1 g of oxo were added. The mixture was stirred at room temperature for 15 hours, and an aqueous solution of sodium thiosulfate was added to stop the reaction. The solution was transferred to a separatory funnel, extracted with toluene, and then purified with a silica gel short column. The solvent was distilled off under reduced pressure, heptane was added to the resulting solution, and the precipitated solid was collected by suction filtration to obtain 30 g of 9-bromo-10- (3-tolyl) anthracene.

<4,4,5,5-테트라메틸-2-(10-(3-톨릴)안트라센-9-일)-1,3,2-디옥사보롤란의 합성>Synthesis of <4,4,5,5-tetramethyl-2- (10- (3-tolyl) anthracen-9-yl) -1,3,2-dioxaborolane>

9-브로모-10-(3-톨릴)안트라센 30 g, 비스피나콜레이토디보론 26 g, 비스(디벤질리덴아세톤)팔라듐(0) 1.5 g, 트리시클로헥실포스핀 1.4 g, 아세트산 칼륨 15 g, 탄산 칼륨 12 g 및 시클로펜틸메틸에테르 100 ml를 넣은 플라스크를 질소 분위기 하에서, 환류 온도에서 16시간 교반했다. 반응액을 실온까지 냉각시킨 후, 물 및 톨루엔을 가하여 분액하고, 얻어진 톨루엔 용액을 실리카겔 쇼트 컬럼으로 정제했다. 용매를 감압 증류 제거하고, 얻어진 오일에 헵탄을 가하여 석출된 고체를 흡인 여과에 의해 채취하여, 4,4,5,5-테트라메틸-2-(10-(3-톨릴)안트라센-9-일)-1,3,2-디옥사보롤란 24 g을 얻었다.30 g of 9-bromo-10- (3-tolyl) anthracene, 26 g of bispinolacetodiboron, 1.5 g of bis (dibenzylideneacetone) palladium (0), 1.4 g of tricyclohexylphosphine, , 12 g of potassium carbonate and 100 ml of cyclopentyl methyl ether was stirred in a nitrogen atmosphere at a reflux temperature for 16 hours. After the reaction solution was cooled to room temperature, water and toluene were added thereto for liquid separation, and the resulting toluene solution was purified by a silica gel short column. The solvent was distilled off under reduced pressure, heptane was added to the obtained oil, and the precipitated solid was collected by suction filtration to obtain 4,4,5,5-tetramethyl-2- (10- (3-tolyl) anthracene- ) -1,3,2-dioxaborolane (24 g).

<화합물 (1-7-26)의 합성>&Lt; Synthesis of Compound (1-7-26) &gt;

4,4,5,5-테트라메틸-2-(10-(3-톨릴)안트라센-9-일)-1,3,2-디옥사보롤란 12 g, 3-(6-브로모나프탈렌-2-일)피리딘 10 g, Pd(PPh3)4 1.0 g, 인산 칼륨 13 g, 1,2,4-트리메틸벤젠 50 ml, tert-부틸알코올 10 ml 및 물 10 ml가 들어간 플라스크를 환류 온도에서 1시간 교반했다. 반응액을 실온까지 냉각시킨 후, 물 및 톨루엔을 가하여 분액하고, 용매를 감압 증류 제거했다. 얻어진 조체를 실리카겔 컬럼 크로마토그래피[톨루엔/아세트산 에틸=20/1(용적비)]에 의해 정제한 후, 톨루엔/헵탄 혼합 용액으로부터 재결정하여, 화합물 (1-7-26):3-(6-(10-(3-톨릴)안트라센-9-일)나프탈렌-2-일)피리딘 7.1 g을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.12 g of 4,4,5,5-tetramethyl-2- (10- (3-tolyl) anthracene-9-yl) -1,3,2-dioxaborolane, 3- (6-bromonaphthalene- 2- yl) pyridine 10 g, Pd (PPh 3) 4 1.0 g, potassium phosphate, 13 g, 1,2,4- trimethyl benzene, 50 ml, tert- butyl alcohol and 10 ml of water containing 10 ml of the flask at reflux And stirred for 1 hour. After the reaction solution was cooled to room temperature, water and toluene were added thereto for liquid separation, and the solvent was distilled off under reduced pressure. The obtained crude product was purified by silica gel column chromatography [toluene / ethyl acetate = 20/1 (volume ratio)] and then recrystallized from toluene / heptane mixed solution to obtain the compound (1-7-26) (3-tolyl) anthracen-9-yl) naphthalen-2-yl) pyridine. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=9.06(m, 1H), 8.67(dd, 1H), 8.22(m, 1H), 8.14(d, 1H), 8.06(m, 1H), 8.02(m, 2H), 7.81(m, 1H), 7.75(d, 2H), 7.72(d, 2H), 7.66(dd, 1H), 7.50(t, 1H), 7.45(m, 1H), 7.27-7.39(m, 7H), 2.50(s, 3H). 1 H-NMR (CDCl 3) : δ = 9.06 (m, 1H), 8.67 (dd, 1H), 8.22 (m, 1H), 8.14 (d, 1H), 8.06 (m, 1H), 8.02 (m, 1H), 7.45 (m, 1H), 7.27-7.39 (m, 2H), 7.81 (d, , &Lt; / RTI &gt; 7H), 2.50 (s, 3H).

[합성예 3] 화합물 (1-7-98)의 합성[Synthesis Example 3] Synthesis of Compound (1-7-98)

<9-(3-tert-부틸페닐)안트라센의 합성><Synthesis of 9- (3-tert-butylphenyl) anthracene>

질소 분위기 하에서, 9-브로모안트라센 23 g, 2-(3-tert-부틸페닐)-4,4,5,5-테트라메틸-1,3,2-디옥사보롤란 25 g, Pd(PPh3)4 3.1 g, 인산 칼륨 37 g, 1,2,4-트리메틸벤젠 250 ml, tert-부틸알코올 50 ml 및 물 30 ml가 들어간 플라스크를 환류 온도에서 21시간 교반했다. 반응액을 실온까지 냉각시킨 후, 물 및 톨루엔을 가하여 분액했다. 얻어진 톨루엔 용액을 실리카겔 쇼트 컬럼으로 정제하고, 용매를 감압 증류 제거하고, 메탄올을 가함으로써 석출되는 고체를 흡인 여과에 의해 채취하여, 9-(3-tert-부틸페닐)안트라센 24 g을 얻었다.In a nitrogen atmosphere, 23 g of 9-bromoanthracene, 25 g of 2- (3-tert-butylphenyl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 3 ) 4 , 37 g of potassium phosphate, 250 ml of 1,2,4-trimethylbenzene, 50 ml of tert-butyl alcohol and 30 ml of water were stirred at a reflux temperature for 21 hours. After the reaction solution was cooled to room temperature, water and toluene were added thereto to separate the solution. The obtained toluene solution was purified by silica gel short column, and the solvent was distilled off under reduced pressure. The solid precipitated by adding methanol was collected by suction filtration to obtain 24 g of 9- (3-tert-butylphenyl) anthracene.

<9-브로모-10-(3-tert-부틸페닐)안트라센의 합성>Synthesis of <9-bromo-10- (3-tert-butylphenyl) anthracene>

9-(3-tert-부틸페닐)안트라센 23 g, 옥소 0.1 g 및 THF 100ml가 들어간 플라스크에, 질소 분위기 하에서, N-브로모숙신이미드 13 g을 가하였다. 실온에서 1시간 교반하고, 티오 황산 나트륨 수용액을 가하여, 반응을 정지시켰다. 이 용액을 분액 로트로 옮겨, 톨루엔으로 추출했다. 얻어진 톨루엔 용액을 실리카겔 쇼트 컬럼으로 정제하고, 용매를 감압 증류 제거한 후, 톨루엔/메탄올 재침전을 행하여, 9-브로모-10-(3-tert-부틸페닐)안트라센 23 g을 얻었다.13 g of N-bromosuccinimide was added to a flask containing 23 g of 9- (3-tert-butylphenyl) anthracene, 0.1 g of oxo and 100 ml of THF in a nitrogen atmosphere. The mixture was stirred at room temperature for 1 hour, and an aqueous solution of sodium thiosulfate was added to stop the reaction. The solution was transferred to a separatory funnel and extracted with toluene. The obtained toluene solution was purified by silica gel short column, and the solvent was distilled off under reduced pressure, followed by re-precipitation with toluene / methanol to obtain 23 g of 9-bromo-10- (3-tert-butylphenyl) anthracene.

<화합물 (1-7-98)의 합성>&Lt; Synthesis of Compound (1-7-98) &gt;

3-(6-브로모나프탈렌-2-일)피리딘 6.2 g, 비스피나콜레이토디보론 5.9 g, 비스(디벤질리덴아세톤)팔라듐(0) 0.4 g, 트리시클로헥실포스핀 0.5 g, 아세트산 칼륨 3.9 g 및 디메톡시에탄 50 ml를 넣은 플라스크를 질소 분위기 하에서, 환류 온도에서 4시간 교반했다. 이 용액에 9-브로모-10-(3-tert-부틸페닐)안트라센 8.6 g, 인산 칼륨 9.3 g 및 1,2,4-트리메틸벤젠 50 ml를 더하여, 디메톡시에탄을 딘스타크관을 사용하여, 상온에서 가열 증류 제거했다. tert-부틸알코올 5 ml, 물 5 ml, 비스(디벤질리덴아세톤)팔라듐(0) 0.4 g 및 트리시클로헥실포스핀 0.5 g을 가하여, 환류 온도에서 2시간 더 교반했다. 반응액을 실온까지 냉각시키고, 수세하여 염을 용해시킨 후, 흡인 여과에 의해 고체를 채취했다. 얻어진 고체를 실리카겔 컬럼 크로마토그래피[톨루엔/아세트산 에틸=9/1(용적비)]로 정제한 후, 톨루엔으로부터 재결정하여, 화합물 (1-7-98):3-(6-(10-(3-tert-부틸페닐)안트라센-9-일)나프탈렌-2-일)피리딘 1.5 g을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.6.2 g of 3- (6-bromonaphthalen-2-yl) pyridine, 5.9 g of bispinolol acetone, 0.4 g of bis (dibenzylideneacetone) palladium (0), 0.5 g of tricyclohexylphosphine, g and 50 ml of dimethoxyethane was stirred in a nitrogen atmosphere at a reflux temperature for 4 hours. To this solution, 8.6 g of 9-bromo-10- (3-tert-butylphenyl) anthracene, 9.3 g of potassium phosphate and 50 ml of 1,2,4-trimethylbenzene were added and dimethoxyethane was added , And the mixture was heated and distilled off at room temperature. 5 ml of tert-butyl alcohol, 5 ml of water, 0.4 g of bis (dibenzylideneacetone) palladium (0) and 0.5 g of tricyclohexylphosphine were added, and the mixture was further stirred at a reflux temperature for 2 hours. The reaction solution was cooled to room temperature, washed with water to dissolve the salt, and then the solid was collected by suction filtration. The resulting solid was purified by silica gel column chromatography [toluene / ethyl acetate = 9/1 (volume ratio)] and then recrystallized from toluene to obtain 3- (6- (10- (3- 9-yl) naphthalen-2-yl) pyridine (1.5 g) was obtained. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=9.07(m, 1H), 8.68(dd, 1H), 8.23(s, 1H), 8.16(d, 1H), 8.08(m, 1H), 8.03(m, 2H), 7.83(m, 1H), 7.75(d, 2H), 7.72(d, 2H), 7.68(m, 1H), 7.52-7.61(m, 3H), 7.46(m, 1H), 7.30-7.38(m, 5H), 1.41(s, 9H). 1 H-NMR (CDCl 3) : δ = 9.07 (m, 1H), 8.68 (dd, 1H), 8.23 (s, 1H), 8.16 (d, 1H), 8.08 (m, 1H), 8.03 (m, (M, 2H), 7.83 (m, 1H), 7.75 (d, 2H), 7.72 (m, 5 H), 1.41 (s, 9 H).

[합성예 4] 화합물 (1-7-96)의 합성[Synthesis Example 4] Synthesis of Compound (1-7-96)

<2-(10-(4-tert-부틸페닐)안트라센-9-일)-4,4,5,5-테트라메틸-1,3,2-디옥사보롤란의 합성>Synthesis of 2- (10- (4-tert-butylphenyl) anthracen-9-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane [

9-브로모-10-(4-tert-부틸페닐)안트라센 7.8 g, 비스피나콜레이트디보론 6.1 g, 비스(디벤질리덴아세톤)팔라듐(0) 0.3 g, 트리시클로헥실포스핀 0.3 g, 아세트산 칼륨 3.9 g, 탄산 칼륨 2.8 g, 및 시클로펜틸메틸에테르 40 ml를 넣은 플라스크를 질소 분위기 하에서, 환류 온도에서 6시간 반 교반했다. 반응액을 실온까지 냉각시킨 후, 물 및 톨루엔을 가하여 분액하고, 용매를 감압 증류 제거했다. 얻어진 오일에 헵탄을 가하여 석출된 고체를 흡인 여과에 의해 채취하여, 2-(10-(4-tert-부틸페닐)안트라센-9-일)-4,4,5,5-테트라메틸-1,3,2-디옥사보롤란 6.9 g을 얻었다.7.8 g of 9-bromo-10- (4-tert-butylphenyl) anthracene, 6.1 g of bispinolate diboron, 0.3 g of bis (dibenzylideneacetone) palladium (0), 0.3 g of tricyclohexylphosphine, 3.9 g of potassium, 2.8 g of potassium carbonate, and 40 ml of cyclopentyl methyl ether was stirred in a nitrogen atmosphere at a reflux temperature for 6 hours and a half. After the reaction solution was cooled to room temperature, water and toluene were added thereto for liquid separation, and the solvent was distilled off under reduced pressure. Heptane was added to the obtained oil, and the precipitated solid was collected by suction filtration to obtain 2- (10- (4-tert-butylphenyl) anthracen-9-yl) -4,4,5,5- To obtain 6.9 g of 3,2-dioxaborolane.

<4-(3-(6-브로모나프탈렌-2-일)페닐)피리딘의 합성><Synthesis of 4- (3- (6-bromonaphthalen-2-yl) phenyl) pyridine>

질소 분위기 하에서, 4-(3-브로모페닐)피리딘 9.8 g 및 THF 20ml가 들어간 플라스크를 드라이아이스/메탄올 욕에서 -70℃ 이하로 냉각시키고, 2.6 M 노말 부틸리튬 17 ml를 천천히 적하시켰다. 적하 종료 후, 동일한 온도에서 0.5시간 교반하고, 염화 아연 테트라메틸에틸렌디아민 착체 12 g을 가하였다. 그 후, 실온에서 0.5시간 교반한 후, 6-브로모나프탈렌-2-일트리플루오로메탄술포네이트 15 g, 비스(디벤질리덴아세톤)팔라듐(0) 및 1,2-비스(디페닐포스피노) 프로판 0.5 g을 가하여, 환류 온도에서 1시간 교반했다. 반응 종료 후, EDTA·4 Na 수용액, 아세트산 에틸을 가하여 분액하고, 용매를 감압 증류 제거한 후, 활성 알루미나 컬럼 크로마토그래피[톨루엔/아세트산 에틸=9/1(용적비)]로 정제했다. 그 다음으로, 메탄올로 세정하고, 아세트산 에틸/메탄올 혼합 용매로부터 재결정하여, 4-(3-(6-브로모나프탈렌-2-일)페닐)피리딘 5.3 g을 얻었다.9.8 g of 4- (3-bromophenyl) pyridine and 20 ml of THF were cooled in a dry ice / methanol bath to -70 ° C or lower, and 17 ml of 2.6 M normal butyl lithium was slowly dropped in a nitrogen atmosphere. After completion of the dropwise addition, the mixture was stirred at the same temperature for 0.5 hours, and 12 g of zinc chloride tetramethylethylenediamine complex was added. Thereafter, the mixture was stirred at room temperature for 0.5 hours, 15 g of 6-bromonaphthalene-2-yl trifluoromethanesulfonate, 5 g of bis (dibenzylideneacetone) palladium (0) and 1,2- Propano) was added, and the mixture was stirred at a reflux temperature for 1 hour. After completion of the reaction, an aqueous EDTA · 4 Na solution and ethyl acetate were added and the liquid was separated. The solvent was distilled off under reduced pressure, and the residue was purified by activated alumina column chromatography [toluene / ethyl acetate = 9/1 (volume ratio)]. Subsequently, this was washed with methanol and recrystallized from an ethyl acetate / methanol mixed solvent to obtain 5.3 g of 4- (3- (6-bromonaphthalen-2-yl) phenyl) pyridine.

<화합물 (1-7-96)의 합성>&Lt; Synthesis of Compound (1-7-96) &gt;

2-(10-(4-tert-부틸페닐)안트라센-9-일)-4,4,5,5-테트라메틸-1,3,2-디옥사보롤란 6.1 g, 4-(3-(6-브로모나프탈렌-2-일)페닐)피리딘 5.0 g, Pd(PPh3)4 0.5 g, 인산 칼륨 3.0 g, 1,2,4-트리메틸벤젠 25 ml, tert-부틸알코올 5 ml 및 물 5 ml가 들어간 플라스크를 환류 온도에서 6시간 교반했다. 반응액을 실온까지 냉각시킨 후, EDTA·4Na 수용액 및 톨루엔을 가하여 분액하고, 용매를 감압 증류 제거했다. 얻어진 조체(粗體)를 활성 알루미나 컬럼 크로마토그래피[톨루엔/아세트산 에틸=9/1(용적비)]에 의해 정제했다. 용매를 감압 증류 제거하여 얻어진 고체를 아세트산 에틸로 세정한 후, 톨루엔으로부터 재결정하여, 화합물 (1-7-96):4(3-(6-(10-(4-tert-부틸페닐)안트라센-9-일)나프탈렌-2-일)페닐)피리딘 3.3 g을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.6.1 g of 4- (3- ((4-tert-butylphenyl) anthracene-9-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 6-bromo-naphthalene-2-yl) phenyl) pyridine 5.0 g, Pd (PPh 3) 4 0.5 g, potassium phosphate 3.0 g, 1,2,4- trimethyl benzene, 25 ml, tert- butyl alcohol and 5 ml water 5 ml was stirred at reflux temperature for 6 hours. After the reaction solution was cooled to room temperature, an aqueous EDTA · 4Na solution and toluene were added to the reaction solution, and the solvent was distilled off under reduced pressure. The resulting crude product was purified by activated alumina column chromatography [toluene / ethyl acetate = 9/1 (volume ratio)]. The solvent was distilled off under reduced pressure and the obtained solid was washed with ethyl acetate and then recrystallized from toluene to obtain the compound (1-7-96): 4 (3- (6- (10- (4-tert- butylphenyl) anthracene- Yl) naphthalen-2-yl) phenyl) pyridine (3.3 g). The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):8.73(dd, 2H), 8.27(m, 1H), 8.15(d, 1H), 8.03(m, 3H), 7.99(m, 2H), 7.78(d, 2H), 7.73(d, 2H), 7.61∼7.70(m, 7H), 7.44(m, 2H), 7.30∼7.38(m, 4H), 1.49(s, 9H). 1 H-NMR (CDCl 3) : 8.73 (dd, 2H), 8.27 (m, 1H), 8.15 (d, 1H), 8.03 (m, 3H), 7.99 (m, 2H), 7.78 (d, 2H) , 7.73 (d, 2H), 7.61-7.70 (m, 7H), 7.44 (m, 2H), 7.30-7.38 (m, 4H), 1.49 (s, 9H).

[합성예 5] 화합물 (1-14-14)의 합성[Synthesis Example 5] Synthesis of the compound (1-14-14)

<9-(3-에톡시페닐)-10-(나프탈렌-2-일)안트라센의 합성>Synthesis of <9- (3-ethoxyphenyl) -10- (naphthalen-2-yl) anthracene>

플라스크에 1-브로모-3-에톡시벤젠 72.4 g, (10-(나프탈렌-2-일)안트라센-9-일)붕소산 104.5 g, Pd(PPh3)4 10.4 g, 인산 칼륨 127.4 g, 1,2,4-트리메틸벤젠 600 ml, 2-프로판올 120 ml, 및 물 120 ml를 넣고, 질소 분위기 하에서, 환류 온도에서 6시간 교반했다. 반응액을 실온까지 냉각시킨 후, 액 중의 고체를 흡인 여과에 의해 채취하고, 메탄올로 세정하여, 9-(3-에톡시페닐)-10-(나프탈렌-2-일)안트라센 82 g을 얻었다.For 1-bromo-3-ethoxy benzene in a flask 72.4 g, (10- (naphthalene-2-yl) anthracene-9-yl) boronic acid 104.5 g, Pd (PPh 3) 4 10.4 g, 127.4 g potassium phosphate, 600 ml of 1,2,4-trimethylbenzene, 120 ml of 2-propanol and 120 ml of water were placed, and the mixture was stirred at a reflux temperature for 6 hours under a nitrogen atmosphere. After the reaction solution was cooled to room temperature, the solid in the liquid was collected by suction filtration and washed with methanol to obtain 82 g of 9- (3-ethoxyphenyl) -10- (naphthalene-2-yl) anthracene.

<3-(10-(나프탈렌-2-일)안트라센-9-일)페놀의 합성>Synthesis of <3- (10- (naphthalen-2-yl) anthracene-9-yl) phenol>

플라스크에 9-(3-에톡시페닐)-10-(나프탈렌-2-일)안트라센 82 g 및 피리딘 염산염 446.0 g을 넣어, 질소 분위기 하에서, 환류 온도에서 8시간 교반했다. 반응액을 실온까지 냉각시킨 후, 물을 가하여 석출된 고체를 흡인 여과에 의해 채취하고, 메탄올에 이어서 톨루엔으로 세정하여, 3-(10-(나프탈렌-2-일)안트라센-9-일)페놀 76.0 g을 얻었다.82 g of 9- (3-ethoxyphenyl) -10- (naphthalen-2-yl) anthracene and 446.0 g of pyridine hydrochloride were placed in a flask and stirred at a reflux temperature for 8 hours. The reaction solution was cooled to room temperature and then water was added thereto. The precipitated solid was collected by suction filtration, washed with methanol and then with toluene to obtain 3- (10- (naphthalen-2-yl) anthracene- 76.0 g was obtained.

<3-(10-(나프탈렌-2-일)안트라센-9-일)페닐트리플루오로메탄술포네이트의 합성>Synthesis of <3- (10- (naphthalen-2-yl) anthracene-9-yl) phenyltrifluoromethanesulfonate>

3-(10-(나프탈렌-2-일)안트라센-9-일)페놀(76.0 g) 및 피리딘(1 L)이 들어간 플라스크를 빙욕에서 냉각시키고, 여기에 질소 분위기 하에서, 트리플루오로메탄술폰산 무수물 65.0 g을 적하시켰다. 적하 종료 후, 또한 실온에서 15시간 교반하고, 물을 가하여 석출된 고체를 흡인 여과에 의해 채취했다. 이 고체를 메탄올로 세정하여, 3-(10-(나프탈렌-2-일)안트라센-9-일)페닐트리플루오로메탄술포네이트 90.3 g을 얻었다.A flask containing 3- (10- (naphthalen-2-yl) anthracene-9-yl) phenol (76.0 g) and pyridine (1 L) was cooled in an ice bath and trifluoromethanesulfonic anhydride 65.0 g was added dropwise. After completion of the dropwise addition, the mixture was further stirred at room temperature for 15 hours, and water was added thereto, and the precipitated solid was collected by suction filtration. This solid was washed with methanol to obtain 90.3 g of 3- (10- (naphthalen-2-yl) anthracen-9-yl) phenyltrifluoromethanesulfonate.

<4,4,5,5-테트라메틸-2-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-1,3,2-디옥사보롤란의 합성>Synthesis of 4,4,5,5-tetramethyl-2- (3- (10- (naphthalen-2-yl) anthracen-9-yl) phenyl) -1,3,2-dioxaborolane [

플라스크에 3-(10-(나프탈렌-2-일)안트라센-9-일)페닐트리플루오로메탄술포네이트 90.3 g, 비스피나콜레이트디보론 52.1 g, 비스(디벤질리덴아세톤)팔라듐(0) 7.4 g, 트리시클로헥실포스핀 7.2 g, 아세트산 칼륨 33.6 g, 탄산 칼륨 23.6 g, 및 아니솔 500 ml를 넣어, 환류 온도에서 5시간 교반했다. 반응액을 실온까지 냉각시킨 후, 셀라이트를 깐 기리야마 로토(Kiriyama-rhoto) 깔대기로 흡인 여과하여 불용물을 제거하고, 여과액을 EDTA·4Na 수용액으로 세정하였다. 여과액의 용매를 감압 증류 제거하여 얻은 고체를 헵탄으로 세정하여, 4,4,5,5-테트라메틸-2-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-1,3,2-디옥사보롤란(52.0 g)을 얻었다.The flask was charged with 90.3 g of 3- (10- (naphthalen-2-yl) anthracen-9-yl) phenyltrifluoromethanesulfonate, 52.1 g of bispinolate diboron, 7.4 g of bis (dibenzylideneacetone) palladium 7.2 g of tricyclohexylphosphine, 33.6 g of potassium acetate, 23.6 g of potassium carbonate and 500 ml of anisole were placed and stirred at a reflux temperature for 5 hours. After the reaction solution was cooled to room temperature, the celite was suction filtered through a Kiriyama-rhoto funnel to remove insolubles, and the filtrate was washed with an aqueous EDTA · 4Na solution. The solvent of the filtrate was distilled off under reduced pressure, and the resulting solid was washed with heptane to obtain 4,4,5,5-tetramethyl-2- (3- (10- (naphthalen-2-yl) anthracene- ) -1,3,2-dioxaborolane (52.0 g).

<화합물 (1-14-14)의 합성>&Lt; Synthesis of compound (1-14-14) &gt;

플라스크에 4,4,5,5-테트라메틸-2-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-1,3,2-디옥사보롤란 8.6 g, 일본 특허출원 공개번호 2009-124114에 기재되어 있는 방법으로 합성한 5'-브로모-3-메틸-2,2'-비피리딘 5.1 g, Pd(PPh3)4 0.6 g, 인산 칼륨 7.2 g, 1,2,4-트리메틸벤젠 25 ml, tert-부틸알코올 5 ml, 및 물 1 ml를 넣어, 환류 온도에서 2.5시간 교반했다. 반응액을 실온까지 냉각시킨 후, 물을 가한 후, 액 중의 고체를 흡인 여과에 의해 채취하고, 메탄올로 세정하였다. 이 고체를 실리카겔 컬럼 크로마토그래피[톨루엔/아세트산 에틸=9/1(용적비)]에 의해 정제하고, 그 다음으로, 활성탄 컬럼 크로마토그래피에 의해 더 정제했다. 용액을 농축하고, 클로로벤젠으로부터 재결정하여, 화합물 (1-14-14):3-메틸-5'-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,2'-비피리딘 2.3 g을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.8.6 g of 4,4,5,5-tetramethyl-2- (3- (10- (naphthalen-2-yl) anthracen-9-yl) phenyl) -1,3,2-dioxaborolane, Japanese Patent Application a 5'-bromo synthesized by the method described in Publication No. 2009-124114 Mo-3-methyl-2,2'-bipyridine 5.1 g, Pd (PPh 3) 4 0.6 g, potassium phosphate 7.2 g, 25 ml of 1,2,4-trimethylbenzene, 5 ml of tert-butyl alcohol, and 1 ml of water, and the mixture was stirred at a reflux temperature for 2.5 hours. After the reaction solution was cooled to room temperature, water was added, and the solid in the solution was collected by suction filtration and washed with methanol. This solid was purified by silica gel column chromatography [toluene / ethyl acetate = 9/1 (volume ratio)] and then further purified by activated carbon column chromatography. The solution was concentrated and recrystallized from chlorobenzene to obtain the compound (1-14-14): 3-Methyl-5'- (3- (10- (naphthalen- And 2.3 g of 2'-bipyridine. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=9.05(m, 1H), 8.55(d, 1H), 8.11(dd, 1H), 8.09(d, 1H), 8.02(m, 1H), 8.00(s, 1H), 7.73-7.95(m, 9H), 7.60(m, 5H), 7.30-7.40(m, 4H), 7.23(m, 1H), 2.56(s, 3H). 1 H-NMR (CDCl 3) : δ = 9.05 (m, 1H), 8.55 (d, 1H), 8.11 (dd, 1H), 8.09 (d, 1H), 8.02 (m, 1H), 8.00 (s, 1H), 7.73-7.95 (m, 9H), 7.60 (m, 5H), 7.30-7.40 (m, 4H), 7.23 (m,

[합성예 6] 화합물 (1-11-1)의 합성[Synthesis Example 6] Synthesis of the compound (1-11-1)

<2-메틸-4-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘의 합성>Synthesis of 2-methyl-4- (6- (10-phenylanthracen-9-yl) naphthalen-2-yl)

4,4,5,5-테트라메틸-2-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)-1,3,2-디옥사보롤란(2.0 g), 4-브로모-2-메틸피리딘(0.8 g), Pd(PPh3)4(0.3 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠(20 ml), tert-부틸알코올(5 ml) 및 물(1 ml)을 플라스크에 넣어, 질소 분위기 하에서 환류 온도에서 7시간 반 교반했다. 가열 종료 후, 반응액을 실온까지 냉각시키고, 물 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거하고, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=95/5)로 정제했다. 그 다음으로, 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 얻어진 여과액을 감압 증류 제거하고 있는 도중에 석출된 결정을 채취하여, (1-11-1)로 표시되는 화합물 2-메틸-4-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘(0.7 g)를 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.(2.0 g), 4,4,5,5-tetramethyl-2- (6- (10-phenylanthracen-9-yl) bromo-2-methylpyridine (0.8 g), Pd (PPh 3) 4 (0.3 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene (20 ml), tert- butyl alcohol (5 ml ) And water (1 ml) were placed in a flask, and stirred at reflux temperature for 7 hours and 30 minutes under a nitrogen atmosphere. After completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added to separate the layers. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 95/5). Next, the obtained eluate was passed through an activated carbon short column to remove the colored component. The precipitated crystals were collected while distilling off the filtrate under reduced pressure to obtain the compound 2-methyl-4- (6- (10-phenylanthracene-9-yl) naphthalene-2 Yl) pyridine (0.7 g). The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=8.66(d, 1H), 8.30(s, 1H), 8.17(d, 1H), 8.03(m, 2H), 7.87(d, 1H), 7.72-7.78(m, 4H), 7.70(d, 1H), 7.65(m, 2H), 7.58(m, 2H), 7.56(m, 3H), 7.31-7.39(m, 4H), 2.73(s, 3H). 1 H-NMR (CDCl 3) : δ = 8.66 (d, 1H), 8.30 (s, 1H), 8.17 (d, 1H), 8.03 (m, 2H), 7.87 (d, 1H), 7.72-7.78 ( (m, 4H), 7.70 (d, 1H), 7.65 (m, 2H), 7.58 (m, 2H), 7.56 (m, 3H), 7.31-7.

[합성예 7] 화합물 (1-11-2)의 합성[Synthesis Example 7] Synthesis of compound (1-11-2)

<3-메틸-4-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘의 합성>Synthesis of 3-methyl-4- (6- (10-phenylanthracen-9-yl) naphthalen-2-yl)

4,4,5,5-테트라메틸-2-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)-1,3,2-디옥사보롤란(2.0 g), 4-브로모-3-메틸피리딘 염산염(1.0 g), Pd(PPh3)4(0.3 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠(20 ml), tert-부틸알코올(5 ml) 및 물(1 ml)을 플라스크에 넣어, 질소 분위기 하에서 환류 온도에서 24시간 반 교반했다. 가열 종료 후, 반응액을 실온까지 냉각시키고, 물 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거하고, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=95/5)로 정제했다. 그 다음으로, 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 얻어진 여과액을 감압 증류 제거하고 있는 도중에 석출된 결정을 채취하고, 또한 톨루엔으로부터 재결정하여, (1-11-2)로 표시되는 화합물 3-메틸-4-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘(0.5 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.(2.0 g), 4,4,5,5-tetramethyl-2- (6- (10-phenylanthracen-9-yl) bromo-3-methyl-pyridine hydrochloride (1.0 g), Pd (PPh 3) 4 (0.3 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene (20 ml), tert- butyl alcohol (5 ml) and water (1 ml) were placed in a flask, and stirred at a reflux temperature for 24 hours under a nitrogen atmosphere. After completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added to separate the layers. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 95/5). Next, the obtained eluate was passed through an activated carbon short column to remove the colored component. The precipitated crystals were collected while distilling off the filtrate under reduced pressure and recrystallized from toluene to obtain the compound 3-methyl-4- (6- (10-phenylanthracene-9 Yl) naphthalen-2-yl) pyridine (0.5 g). The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=8.62(s, 1H), 8.58(d, 1H), 8.13(d, 1H), 8.06(s, 1H), 8.02(d, 1H), 7.99(s, 1H), 7.75(d, 4H), 7.70(dd, 1H), 7.65(t, 2H), 7.59(t, 2H), 7.53(m, 2H), 7.33-7.39(m, 5H), 2.44(s, 3H). 1 H-NMR (CDCl 3) : δ = 8.62 (s, 1H), 8.58 (d, 1H), 8.13 (d, 1H), 8.06 (s, 1H), 8.02 (d, 1H), 7.99 (s, 2H), 7.53 (m, 2H), 7.33-7.39 (m, 5H), 2.44 (s, 2H) , 3H).

[합성예 8] 화합물 (1-11-3)의 합성[Synthesis Example 8] Synthesis of the compound (1-11-3)

<2-메틸-5-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘의 합성>Synthesis of 2-methyl-5- (6- (10-phenylanthracen-9-yl) naphthalen-2-yl)

4,4,5,5-테트라메틸-2-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)-1,3,2-디옥사보롤란(2.0 g), 5-브로모-2-메틸피리딘(0.8 g), Pd(PPh3)4(0.15 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠(20 ml), tert-부탄올(5 ml) 및 물(1 ml)을 플라스크에 넣어, 질소 분위기 하에서 환류 온도에서 5시간 교반했다. 가열 종료 후, 반응액을 실온까지 냉각시키고, 물 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거하고, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=95/5)로 정제했다. 용매를 감압 증류 제거하여 얻어진 고체를 톨루엔으로부터 재결정하여, (1-11-3)으로 표시되는 화합물 2-메틸-5-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘(1.2 g)를 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) -1,3,2-dioxaborolane (2.0 g), 5- (4-fluorophenyl) Pd (PPh 3 ) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4-trimethylbenzene (20 ml) and tert-butanol (5 ml) And water (1 ml) were placed in a flask, and stirred at reflux temperature for 5 hours under a nitrogen atmosphere. After completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added to separate the layers. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 95/5). The solvent was distilled off under reduced pressure, and the resulting solid was recrystallized from toluene to obtain the compound 2-methyl-5- (6- (10-phenylanthracene-9-yl) naphthalen- Pyridine (1.2 g). The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=8.95(m, 1H), 8.20(s, 1H), 8.14(d, 1H), 8.01(m, 2H), 7.96(dd, 1H), 7.81(dd, 1H), 7.74(m, 4H), 7.67(dd, 1H), 7.63(t, 2H), 7.57(t, 1H), 7.52(m, 2H), 7.30-7.37(m, 5H), 2.67(s, 3H). 1 H-NMR (CDCl 3) : δ = 8.95 (m, 1H), 8.20 (s, 1H), 8.14 (d, 1H), 8.01 (m, 2H), 7.96 (dd, 1H), 7.81 (dd, 2H), 7.57 (m, 2H), 7.30-7.37 (m, 5H), 2.67 (s, , 3H).

[합성예 9] 화합물 (1-11-4)의 합성[Synthesis Example 9] Synthesis of the compound (1-11-4)

<3-메틸-5-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘의 합성>Synthesis of 3-methyl-5- (6- (10-phenylanthracen-9-yl) naphthalen-2-yl)

4,4,5,5-테트라메틸-2-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)-1,3,2-디옥사보롤란(2.0 g), 3-브로모-5-메틸피리딘(0.8 g), Pd(PPh3)4(0.3 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠(20 ml), tert-부탄올(5 ml) 및 물(1 ml)을 플라스크에 넣어, 질소 분위기 하에서 환류 온도에서 7시간 반 교반했다. 가열 종료 후, 반응액을 실온까지 냉각시키고, 물 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거하고, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=95/5)로 정제했다. 그 다음으로, 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 헵탄을 가하여 재침전시켜, (1-11-4)로 표시되는 화합물 3-메틸-5-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘(1.3 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) -1,3,2-dioxaborolane (2.0 g), 3- (4-fluoropyrimidin- Pd (PPh 3 ) 4 (0.3 g), potassium phosphate (1.7 g), 1,2,4-trimethylbenzene (20 ml) and tert-butanol (5 ml) And water (1 ml) were put in a flask, and stirred at a reflux temperature for 7 hours and a half under a nitrogen atmosphere. After completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added to separate the layers. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 95/5). Next, the obtained eluate was passed through an activated carbon short column to remove the colored component. The solvent was distilled off under reduced pressure, and heptane was added to re-precipitate to obtain the compound 3-methyl-5- (6- (10-phenylanthracene-9-yl) naphthalen- Pyridine (1.3 g). The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3): 1 H-NMR (CDCl 3) :

δ=8.87(m, 1H), 8.51(m, 1H), 8.22(s, 1H), 8.15(d, 1H), 8.03(m, 2H), 7.89(m, 1H), 7.83(dd, 1H), 7.73(m, 4H), 7.67(dd, 1H), 7.63(m, 2H), 7.57(t, 1H), 7.52(m, 2H), 7.30-7.37(m, 4H), 2.49(s, 3H).2H), 7.89 (m, IH), 7.83 (dd, IH), 8.13 (d, , 7.73 (m, 4H), 7.67 (d, 1H), 7.63 (m, 2H), 7.57 (m, 2H) ).

[합성예 10] 화합물 (1-11-5)의 합성[Synthesis Example 10] Synthesis of the compound (1-11-5)

<4-메틸-3-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘의 합성>Synthesis of 4-methyl-3- (6- (10-phenylanthracen-9-yl) naphthalen-2-yl)

4,4,5,5-테트라메틸-2-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)-1,3,2-디옥사보롤란(2.0 g), 3-브로모-4-메틸피리딘 염산염(1.0 g), Pd(PPh3)4(0.3 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠(20 ml), tert-부틸알코올(5 ml) 및 물(1 ml)을 플라스크에 넣어, 질소 분위기 하에서 환류 온도에서 7시간 교반했다. 가열 종료 후, 반응액을 실온까지 냉각시키고, 물 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거하고, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=95/5)로 정제했다. 그 다음으로, 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 얻어진 고체를 톨루엔으로부터 재결정하여, (1-11-5)로 표시되는 화합물 4-메틸-3-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘(0.6 g)를 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) -1,3,2-dioxaborolane (2.0 g), 3- (4-fluoropyrimidin- bromo-4-methyl-pyridine hydrochloride (1.0 g), Pd (PPh 3) 4 (0.3 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene (20 ml), tert- butyl alcohol (5 ml) and water (1 ml) were placed in a flask, and the mixture was stirred at a reflux temperature for 7 hours under a nitrogen atmosphere. After completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added to separate the layers. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 95/5). Next, the obtained eluate was passed through an activated carbon short column to remove the colored component. The solvent was distilled off under reduced pressure, and the resulting solid was recrystallized from toluene to obtain the compound 4-methyl-3- (6- (10-phenylanthracene-9-yl) naphthalen- ) Pyridine (0.6 g) was obtained. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=8.64(s, 1H), 8.55(d, 1H), 8.14(d, 1H), 8.06(s, 1H), 8.02(d, 1H), 7.99(s, 1H), 7.76(m, 4H), 7.70(dd, 1H), 7.63(m, 2H), 7.59(t, 2H), 7.53(m, 2H), 7.32-7.39(m, 4H), 7.30(d, 1H), 2.45(s, 3H). 1 H-NMR (CDCl 3) : δ = 8.64 (s, 1H), 8.55 (d, 1H), 8.14 (d, 1H), 8.06 (s, 1H), 8.02 (d, 1H), 7.99 (s, 2H), 7.53 (m, 2H), 7.32-7.39 (m, 4H), 7.30 (d, , &Lt; / RTI &gt; 1H), 2.45 (s, 3H).

[합성예 11] 화합물 (1-11-6)의 합성[Synthesis Example 11] Synthesis of Compound (1-11-6)

<2-메틸-3-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘의 합성>Synthesis of 2-methyl-3- (6- (10-phenylanthracen-9-yl) naphthalen-2-yl)

4,4,5,5-테트라메틸-2-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)-1,3,2-디옥사보롤란(2.0 g), 3-브로모-2-메틸피리딘(0.8 g), Pd(PPh3)4(0.15 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠(20 ml), tert-부틸알코올(5 ml) 및 물(1 ml)을 플라스크에 넣어, 질소 분위기 하에서 환류 온도에서 4시간 교반했다. 가열 종료 후, 반응액을 실온까지 냉각시키고, 물 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거하고, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=95/5)로 정제했다. 그 다음으로, 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 헵탄을 가하여 재침전시켜, (1-11-6)으로 표시되는 화합물 2-메틸-3-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘(1.1 g)를 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) -1,3,2-dioxaborolane (2.0 g), 3- (4-fluoropyrimidin- bromo-2-methylpyridine (0.8 g), Pd (PPh 3) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene (20 ml), tert- butyl alcohol (5 ml ) And water (1 ml) were placed in a flask, and stirred at a reflux temperature for 4 hours under a nitrogen atmosphere. After completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added to separate the layers. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 95/5). Next, the obtained eluate was passed through an activated carbon short column to remove the colored component. The solvent was distilled off under reduced pressure, and heptane was added to re-precipitate to obtain the compound 2-methyl-3- (6- (10-phenylanthracene-9-yl) naphthalen- Pyridine (1.1 g). The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=8.60(m, 1H), 8.11(d, 1H), 8.05(s, 1H), 8.00(d, 1H), 7.96(s, 1H), 7.74(m, 4H), 7.69(m, 2H), 7.63(m, 2H), 7.57(m, 2H), 7.52(m, 2H), 7.30-7.37(m, 4H), 7.28(m, 1H), 2.66(s, 3H). 1 H-NMR (CDCl 3) : δ = 8.60 (m, 1H), 8.11 (d, 1H), 8.05 (s, 1H), 8.00 (d, 1H), 7.96 (s, 1H), 7.74 (m, 2H), 7.56 (m, 2H), 7.30-7.37 (m, 4H), 7.28 (m, 1H), 2.66 , 3H).

[합성예 12] 화합물 (1-11-8)의 합성Synthesis Example 12 Synthesis of Compound (1-11-8)

<5-메틸-2-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘의 합성>Synthesis of 5-methyl-2- (6- (10-phenylanthracen-9-yl) naphthalen-2-yl)

4,4,5,5-테트라메틸-2-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)-1,3,2-디옥사보롤란(2.5 g), 3-브로모-2-메틸피리딘(1.0 g), Pd(PPh3)4(0.15 g), 인산 칼륨(2.1 g), 1,2,4-트리메틸벤젠(20 ml), tert-부틸알코올(5 ml) 및 물(1 ml)을 플라스크에 넣어, 질소 분위기 하에서 환류 온도에서 18시간 교반했다. 가열 종료 후, 반응액을 실온까지 냉각시키고, 석출된 고체를 흡인 여과에 의해 채취했다. 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔)로 정제했다. 그 다음으로, 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 아세트산 에틸을 가하여 재침전시켜, (1-11-8)로 표시되는 화합물 5-메틸-2-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘(1.5 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) -1,3,2-dioxaborolane (2.5 g), 3- (4-fluorophenyl) bromo-2-methylpyridine (1.0 g), Pd (PPh 3) 4 (0.15 g), potassium phosphate (2.1 g), 1,2,4- trimethyl benzene (20 ml), tert- butyl alcohol (5 ml ) And water (1 ml) were placed in a flask, and stirred at a reflux temperature for 18 hours under a nitrogen atmosphere. After completion of the heating, the reaction solution was cooled to room temperature, and the precipitated solid was collected by suction filtration. The resulting solid was purified by silica gel column chromatography (eluent: toluene). Next, the obtained eluate was passed through an activated carbon short column to remove the colored component. The solvent was distilled off under reduced pressure, and ethyl acetate was added to re-precipitate to obtain the compound 5-methyl-2- (6- (10-phenylanthracene-9-yl) naphthalen- ) Pyridine (1.5 g). The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=8.63(m, 2H), 8.23(dd, 1H), 8.16(d, 1H), 8.00(m, 2H), 7.86(d, 1H), 7.73(m, 4H), 7.60-7.67(m, 4H), 7.56(t, 1H), 7.51(m, 2H), 7.30-7.36(m, 4H), 2.44(s, 3H). 1 H-NMR (CDCl 3) : δ = 8.63 (m, 2H), 8.23 (dd, 1H), 8.16 (d, 1H), 8.00 (m, 2H), 7.86 (d, 1H), 7.73 (m, (M, 4H), 7.60-7.67 (m, 4H), 7.56 (t, 1H), 7.51 (m, 2H), 7.30-7.36 (m, 4H), 2.44

[합성예 13] 화합물 (1-11-39)의 합성[Synthesis Example 13] Synthesis of the compound (1-11-39)

<5-브로모-2'-메틸-3,4'-비피리딘의 합성>Synthesis of <5-bromo-2'-methyl-3,4'-bipyridine>

4-브로모-2-메틸피리딘(13.8 g) 및 톨루엔(150 ml)이 들어간 플라스크를 아세톤/드라이아이스 욕에서 냉각시켰다. 이 용액에 1.6 M의 노말 부틸리튬헥산 용액(55 ml)을 적하시켰다. 적하 종료 후, 아세톤/드라이아이스 욕에서 냉각하면서 1시간 교반하고, 염화 아연 테트라메틸에틸렌디아민(29.3 g) 및 THF(45 ml)를 가하여, 아세톤/드라이아이스 욕을 제거하여 승온하였다. 실온까지 승온한 후, 톨루엔(20 ml), 3,5-디브로모피리딘(19.0 g) 및 Pd(PPh3)4(2.8 g)를 가하여, 환류 온도에서 2시간 교반했다. 반응액을 실온까지 냉각시킨 후, EDTA·4Na 수용액 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거한 후, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸)로 정제했다. 이 때, "유기 화학 실험의 가이드(1)-물질 취급법과 분리 정제법-" 가부시키가이샤 화학 동인 출판, 94 페이지에 기재된 방법을 참고하여, 전개액 중의 아세트산 에틸의 비율을 서서히 증가시켜 목적물을 용출시켰다. 그 다음으로, 용매를 감압 증류 제거하고, 얻어진 고체를 헵탄으로부터 재결정하여, 5-브로모-2'-메틸-3,4'-비피리딘(5.3 g)를 얻었다.A flask containing 4-bromo-2-methylpyridine (13.8 g) and toluene (150 ml) was cooled in an acetone / dry ice bath. A 1.6 M normal butyl lithium hexane solution (55 ml) was added dropwise to this solution. After completion of the dropwise addition, the mixture was stirred for 1 hour while cooling in an acetone / dry ice bath, zinc chloride tetramethylethylenediamine (29.3 g) and THF (45 ml) were added, and the acetone / dry ice bath was removed and the temperature was raised. After the temperature was raised to room temperature, toluene (20 ml), 3,5-dibromopyridine (19.0 g) and Pd (PPh 3 ) 4 (2.8 g) were added and the mixture was stirred at reflux temperature for 2 hours. After the reaction solution was cooled to room temperature, an aqueous solution of EDTA · 4Na and toluene were added to separate the solution. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate). At this time, referring to the method described in "Organic Chemistry Experiment Guide (1) -Material Handling Method and Separation and Refinement Method" published by Kagaku Dojin Publishing Co., Ltd., page 94, the ratio of ethyl acetate in the developing solution was gradually increased, Lt; / RTI &gt; Subsequently, the solvent was distilled off under reduced pressure, and the obtained solid was recrystallized from heptane to obtain 5-bromo-2'-methyl-3,4'-bipyridine (5.3 g).

<2'-메틸-5-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)3,4'-비피리딘의 합성>Synthesis of 2'-methyl-5- (6- (10-phenylanthracene-9-yl) naphthalen-2-yl)

4,4,5,5-테트라메틸-2-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)-1,3,2-디옥사보롤란(2.5 g), 5-브로모-2'-메틸-3,4'-비피리딘(1.1 g), Pd(PPh3)4(0.15 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠(20 ml), tert-부틸알코올(5 ml) 및 물(1 ml)을 플라스크에 넣어, 질소 분위기 하에서 환류 온도에서 3시간 교반했다. 가열 종료 후, 반응액을 실온까지 냉각시키고, 물 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거하고, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=1/1)로 정제했다. 용매를 감압 증류 제거하고, 얻어진 고체를 톨루엔으로부터 재결정하여, (1-11-39)로 표시되는 화합물 2'-메틸-5-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)3,4'-비피리딘(0.3 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) -1,3,2-dioxaborolane (2.5 g), 5- (4-fluoropyridin- bromo-2'-methyl-3,4'-bipyridine (1.1 g), Pd (PPh 3) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene (20 ml) , tert-butyl alcohol (5 ml) and water (1 ml) were put in a flask and stirred at a reflux temperature for 3 hours under a nitrogen atmosphere. After completion of the heating, the reaction solution was cooled to room temperature, and water and toluene were added to separate the layers. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 1/1). The solvent was distilled off under reduced pressure, and the obtained solid was recrystallized from toluene to obtain the compound 2'-methyl-5- (6- (10-phenylanthracene-9-yl) naphthalene- Yl) 3,4'-bipyridine (0.3 g) was obtained. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=9.11(m, 1H), 8.92(m, 1H), 8.65(d, 1H), 8.28(m, 2H), 8.17(d, 1H), 8.05(m, 2H), 7.87(d, 1H), 7.68-7.75(m, 5H), 7.61(m, 2H), 7.56(t, 1H), 7.51(m, 3H), 7.45(m, 1H), 7.30-7.37(m, 4H), 2.70(s, 3H). 1 H-NMR (CDCl 3) : δ = 9.11 (m, 1H), 8.92 (m, 1H), 8.65 (d, 1H), 8.28 (m, 2H), 8.17 (d, 1H), 8.05 (m, 2H), 7.87 (d, 1H), 7.68-7.75 (m, 5H), 7.61 (m, 2H), 7.56 (t, (m, 4 H), 2.70 (s, 3 H).

[합성예 14] 화합물 (1-14-2)의 합성[Synthesis Example 14] Synthesis of compound (1-14-2)

<3-메틸-4-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)피리딘의 합성>Synthesis of 3-methyl-4- (3- (10- (naphthalen-2-yl) anthracen-9-yl)

4,4,5,5-테트라메틸-2-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-1,3,2-디옥사보롤란(2.5 g), 4-브로모-3-메틸피리딘 염산염(1.3 g), Pd(PPh3)4(0.35 g), 인산 칼륨(3.2 g), 1,2,4-트리메틸벤젠 20 ml, tert-부틸알코올 5 ml, 및 물 1 ml를 넣어, 환류 온도에서 11시간 반 교반했다. 반응액을 실온까지 냉각시킨 후, 톨루엔 및 물을 가하여, 분액했다. 용매를 감압 증류 제거하고, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=95/5)에 의해 정제했다. 그 다음으로, 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 헵탄을 가하여 재침전시켜, (1-14-2)로 표시되는 화합물 3-메틸-4-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)피리딘(1.4 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.Yl) phenyl) -1,3,2-dioxaborolane (2.5 g), 4,4,5,5-tetramethyl-2- (3- (10- (naphthalen- 4-bromo-3-methyl-pyridine hydrochloride (1.3 g), Pd (PPh 3) 4 (0.35 g), potassium phosphate (3.2 g), 1,2,4- trimethyl benzene, 20 ml, tert- butyl alcohol, 5 ml , And water (1 ml), and the mixture was stirred at a reflux temperature for 11 hours and a half. After the reaction solution was cooled to room temperature, toluene and water were added to the solution, and the solution was separated. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 95/5). Next, the obtained eluate was passed through an activated carbon short column to remove the colored component. The solvent was distilled off under reduced pressure, and heptane was added to re-precipitate to obtain the compound 3-methyl-4- (3- (10- (naphthalen-2-yl) anthracene- Phenyl) pyridine (1.4 g) was obtained. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3): 1 H-NMR (CDCl 3) :

δ=8.53(s, 1H), 8.50(d, 1H), 8.08(dd, 1H), 8.02(m, 1H), 7.97(d, 1H), 7.92(m, 1H), 7.70-7.78(m, 5H), 7.48-7.63(m, 6H), 7.35-7.39(m, 2H), 7.29-7.34(m, 3H), 2.41(s, 3H).1H), 7.70-7.78 (m, 1H), 8.02 (d, 1H), 8.02 (d, 5H), 7.48-7.63 (m, 6H), 7.35-7.39 (m, 2H), 7.29-7.34 (m, 3H), 2.41 (s, 3H).

[합성예 15] 화합물 (1-14-3)의 합성[Synthesis Example 15] Synthesis of the compound (1-14-3)

<2-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)피리딘의 합성>Synthesis of 2-methyl-5- (3- (10- (naphthalen-2-yl) anthracen-9-yl)

4,4,5,5-테트라메틸-2-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-1,3,2-디옥사보롤란(2.5 g), 5-브로모-2-메틸피리딘(1.0 g), Pd(PPh3)4(0.35 g), 인산 칼륨(3.2 g), 1,2,4-트리메틸벤젠 20 ml, tert-부틸알코올 5 ml, 및 물 1 ml를 넣어, 환류 온도에서 8시간 반 교반했다. 반응액을 실온까지 냉각시킨 후, 석출된 고체를 흡인 여과에 의해 채취했다. 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=95/5)에 의해 정제했다. 그 다음으로, 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 얻어진 고체를 아세트산 에틸로 세정하여, (1-14-3)으로 표시되는 화합물 2-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)피리딘(1.5 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.Yl) phenyl) -1,3,2-dioxaborolane (2.5 g), 4,4,5,5-tetramethyl-2- (3- (10- (naphthalen- 5-bromo-2-methylpyridine (1.0 g), Pd (PPh 3) 4 (0.35 g), potassium phosphate (3.2 g), 20 ml 1,2,4- trimethylbenzene, tert- butyl alcohol, 5 ml, And 1 ml of water, and the mixture was stirred at a reflux temperature for 8 hours and a half. The reaction solution was cooled to room temperature, and the precipitated solid was collected by suction filtration. The resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 95/5). Next, the obtained eluate was passed through an activated carbon short column to remove the colored component. The solvent was distilled off under reduced pressure, and the resulting solid was washed with ethyl acetate to obtain the compound 2-methyl-5- (3- (10- (naphthalen-2-yl) anthracene- Yl) phenyl) pyridine (1.5 g) was obtained. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=8.45(m, 1H), 8.08(d, 1H), 8.03(m, 1H), 7.99(s, 1H), 7.93(m, 1H), 7.87(dd, 1H), 7.70-7.81(m, 7H), 7.57-7.63(m, 3H), 7.54(m, 1H), 7.30-7.40(m, 4H), 7.23(d, 1H), 2.61(s, 3H). 1 H-NMR (CDCl 3) : δ = 8.45 (m, 1H), 8.08 (d, 1H), 8.03 (m, 1H), 7.99 (s, 1H), 7.93 (m, 1H), 7.87 (dd, (S, 3H), 7.30-7.40 (m, 4H), 7.30-7.81 (m, 7H), 7.57-7.63 .

[합성예 16] 화합물 (1-14-11)의 합성[Synthesis Example 16] Synthesis of the compound (1-14-11)

<5-브로모-6'-메틸-2,2'-비피리딘의 합성>Synthesis of <5-bromo-6'-methyl-2,2'-bipyridine>

2-브로모-6-메틸피리딘(5.2 g) 및 시클로펜틸메틸에테르(30 ml)가 들어간 플라스크를 메탄올/드라이아이스 욕에서 냉각시켰다. 이 용액에 1.6 M의 노말 부틸리튬헥산 용액(22 ml)을 적하시켰다. 적하 종료 후, 메탄올/드라이아이스 욕에서 냉각하면서 2시간 교반하고, 염화 아연 테트라메틸에틸렌디아민(8.3 g)을 가하고, 메탄올/드라이아이스 욕을 제거하고 승온하였다. 실온까지 승온한 후, 2,5-디브로모피리딘(7.1 g) 및 Pd(PPh3)4(1.0 g)를 가하여, 환류 온도에서 3시간 반 교반했다. 반응액을 실온까지 냉각시킨 후, EDTA·4 Na 수용액 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거한 후, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸)로 정제했다. 이 때, 전개액 중의 아세트산 에틸의 비율을 서서히 증가시켜 목적물을 용출시켰다. 그 다음으로, 용매를 감압 증류 제거하고, 얻어진 고체를 헵탄으로부터 재결정하여, 5-브로모-6'-메틸-2,2'-비피리딘(1.4 g)을 얻었다.A flask containing 2-bromo-6-methylpyridine (5.2 g) and cyclopentyl methyl ether (30 ml) was cooled in a methanol / dry ice bath. To this solution was added dropwise a 1.6 M normal butyl lithium hexane solution (22 ml). After completion of the dropwise addition, the mixture was stirred for 2 hours while cooling in a methanol / dry ice bath, zinc tetramethylethylenediamine chloride (8.3 g) was added, the methanol / dry ice bath was removed and the temperature was raised. After the temperature was raised to room temperature, 2,5-dibromopyridine (7.1 g) and Pd (PPh 3 ) 4 (1.0 g) were added and stirred at reflux temperature for 3 hours and a half. The reaction solution was cooled to room temperature, and then an aqueous EDTA · 4 Na solution and toluene were added to the reaction mixture. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate). At this time, the ratio of ethyl acetate in the developing solution was gradually increased to elute the target product. Subsequently, the solvent was distilled off under reduced pressure, and the obtained solid was recrystallized from heptane to obtain 5-bromo-6'-methyl-2,2'-bipyridine (1.4 g).

<6'-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,2'-비피리딘의 합성>Synthesis of 6'-methyl-5- (3- (10- (naphthalen-2-yl) anthracen-9-yl) phenyl) -2,2'-

4,4,5,5-테트라메틸-2-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-1,3,2-디옥사보롤란(2.0 g), 5-브로모-6'-메틸-2,2'-비피리딘(1.0 g), Pd(PPh3)4(0.15 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠 20 ml, tert-부틸알코올 5 ml, 및 물 1 ml를 넣어, 환류 온도에서 7시간 반 교반했다. 반응액을 실온까지 냉각시킨 후, 석출된 고체를 흡인 여과에 의해 채취했다. 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=95/5)에 의해 정제하고, 얻어진 용출액을 그대로 활성탄을 깐 기리야마 로트 깔대기를 이용하여 흡인 여과하여, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 아세트산 에틸을 가하여 재침전시켜, (1-14-11)로 표시되는 화합물 6'-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,2'-비피리딘(1.2 g)를 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) anthracene-9-yl) phenyl) -1,3,2-dioxaborolane (2.0 g), 4,4,5,5-tetramethyl- 5-bromo-6'-methyl-2,2'-bipyridine (1.0 g), Pd (PPh 3) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene, 20 ml , 5 ml of tert-butyl alcohol and 1 ml of water, and the mixture was stirred at a reflux temperature for 7 hours and a half. The reaction solution was cooled to room temperature, and the precipitated solid was collected by suction filtration. The obtained solid was purified by silica gel column chromatography (developing solution: toluene / ethyl acetate = 95/5), and the obtained eluate was directly subjected to suction filtration using an activated charcoal using a Kankiriamarut funnel to remove the colored component. The solvent was distilled off under reduced pressure, and ethyl acetate was added to re-precipitate to obtain the compound 6'-methyl-5- (3- (10- (naphthalen-2-yl) anthracene- Yl) phenyl) -2,2'-bipyridine (1.2 g) was obtained. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=9.03(m, 1H), 8.49(dd, 1H), 8.22(d, 1H), 8.09(m, 2H), 8.03(m, 1H), 8.00(s, 1H), 7.93(m, 1H), 7.87(d, 1H), 7.68-7.83(m, 7H), 7.55-7.64(m, 4H), 7.30-7.40(m, 4H), 7.17(d, 1H), 2.65(s, 3H). 1 H-NMR (CDCl 3) : δ = 9.03 (m, 1H), 8.49 (dd, 1H), 8.22 (d, 1H), 8.09 (m, 2H), 8.03 (m, 1H), 8.00 (s, 1H), 7.93 (m, 1H), 7.87 (d, 1H), 7.68-7.83 (m, 7H), 7.55-7.64 (m, 4H), 7.30-7.40 , &Lt; / RTI &gt; 2.65 (s, 3H).

[합성예 17] 화합물 (1-14-12)의 합성[Synthesis Example 17] Synthesis of the compound (1-14-12)

<5-브로모-5'-메틸-2,2'-비피리딘의 합성>Synthesis of <5-bromo-5'-methyl-2,2'-bipyridine>

2-브로모-5-메틸피리딘(1.7 g) 및 THF(5 ml)가 들어간 플라스크를 빙욕에서 냉각시키고, 이 용액에 2 M의 이소프로필마그네슘 염화물 THF 용액(5.5 ml)을 적하시켰다. 적하 종료 후, 빙욕을 제거하고 실온에서 3시간 반 교반한 후, 다시 빙욕에서 냉각시키고, 염화 아연 테트라메틸에틸렌디아민(2.8 g)을 가하였다. 빙욕을 제거하고 실온까지 승온한 후, 2,5-디브로모피리딘(2.4 g) 및 Pd(PPh3)4(0.35 g)를 가하여, 환류 온도에서 1시간 반 교반했다. 반응액을 실온까지 냉각시킨 후, EDTA·4 Na 수용액 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거한 후, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=9/1)로 정제했다. 용매를 감압 증류 제거하고, 헵탄을 가하여 재침전시켜, 5-브로모-5'-메틸-2,2'-비피리딘(1.5 g)을 얻었다.A flask containing 2-bromo-5-methylpyridine (1.7 g) and THF (5 ml) was cooled in an ice bath and 2 M isopropyl magnesium chloride THF solution (5.5 ml) was added dropwise to this solution. After completion of the dropwise addition, the ice bath was removed, and the mixture was stirred at room temperature for 3 hours and 30 minutes, cooled again in an ice bath, and zinc tetramethylethylenediamine chloride (2.8 g) was added thereto. After the ice bath was removed and the temperature was raised to room temperature, 2,5-dibromopyridine (2.4 g) and Pd (PPh 3 ) 4 (0.35 g) were added and stirred at a reflux temperature for 1 hour and a half. The reaction solution was cooled to room temperature, and then an aqueous EDTA · 4 Na solution and toluene were added to the reaction mixture. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 9/1). The solvent was distilled off under reduced pressure, and heptane was added to re-precipitate to obtain 5-bromo-5'-methyl-2,2'-bipyridine (1.5 g).

<5-메틸-5'-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,2'-비피리딘의 합성>Synthesis of 5-methyl-5 '- (3- (10- (naphthalen-2-yl) anthracen-9-yl) phenyl) -2,2'-

4,4,5,5-테트라메틸-2-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-1,3,2-디옥사보롤란(2.0 g), 5-브로모-5'-메틸-2,2'-비피리딘(1.2 g), Pd(PPh3)4(0.15 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠 20 ml, tert-부틸알코올 5 ml, 및 물 1 ml를 넣어, 환류 온도에서 6시간 교반했다. 반응액을 실온까지 냉각시킨 후, 톨루엔 및 물을 가하여 분액했다. 용매를 감압 증류 제거하고, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=95/5)에 의해 정제하고, 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 아세트산 에틸을 가하여 재침전시켜, 또한 얻어진 고체를 톨루엔으로부터 재결정하여, (1-14-12)로 표시되는 화합물 5-메틸-5'-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,2'-비피리딘(1.2 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) anthracene-9-yl) phenyl) -1,3,2-dioxaborolane (2.0 g), 4,4,5,5-tetramethyl- 5-bromo-5'-methyl-2,2'-bipyridine (1.2 g), Pd (PPh 3) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene, 20 ml , 5 ml of tert-butyl alcohol, and 1 ml of water were placed, and the mixture was stirred at reflux temperature for 6 hours. After the reaction solution was cooled to room temperature, toluene and water were added to separate the layers. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 95/5) and the obtained eluate was passed through an activated carbon short column to remove the colored component. The solvent was distilled off under reduced pressure, ethyl acetate was added to re-precipitate the product, and the obtained solid was recrystallized from toluene to obtain the compound 5-methyl-5'- (3- (10- (naphthalene Yl) anthracene-9-yl) phenyl) -2,2'-bipyridine (1.2 g). The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=9.03(m, 1H), 8.52(s, 1H), 8.44(dd, 1H), 8.33(d, 1H), 8.09(m, 1H), 8.03(m, 1H), 8.00(s, 2H), 7.93(m, 1H), 7.87(m, 1H), 7.73-7.83(m, 6H), 7.56-7.66(m, 5H), 7.31-7.39(m, 4H), 2.41(s, 3H). 1 H-NMR (CDCl 3) : δ = 9.03 (m, 1H), 8.52 (s, 1H), 8.44 (dd, 1H), 8.33 (d, 1H), 8.09 (m, 1H), 8.03 (m, 2H), 7.93 (m, 1H), 7.87-7.83 (m, 6H), 7.56-7.66 (m, 5H), 7.31-7.39 , &Lt; / RTI &gt; 2.41 (s, 3H).

[합성예 18] 화합물 (1-14-13)의 합성[Synthesis Example 18] Synthesis of the compound (1-14-13)

<5'-브로모-4-메틸-2,2'-비피리딘의 합성>Synthesis of <5'-bromo-4-methyl-2,2'-bipyridine>

2-브로모-4-메틸피리딘(6.9 g) 및 THF(20 ml)가 들어간 플라스크를 빙욕에서 냉각시키고, 이 용액에 2 M의 이소프로필마그네슘 염화물 THF 용액(24 ml)을 적하시켰다. 적하 종료 후, 빙욕을 제거하고 실온에서 1시간 교반한 후, 다시 빙욕에서 냉각시키고, 염화 아연 테트라메틸에틸렌디아민(12.1 g)을 가하였다. 빙욕을 제거하고 실온까지 승온한 후, 2,5-디브로모피리딘(9.5 g) 및 Pd(PPh3)4(1.4 g)를 가하여, 환류 온도에서 2시간 반 교반했다. 반응액을 실온까지 냉각시킨 후, EDTA·4 Na 수용액 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거한 후, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=9/1)로 정제했다. 용매를 감압 증류 제거하고, 얻어진 고체를 헵탄으로부터 재결정하여, 5'-브로모-4-메틸-2,2'-비피리딘(5.5 g)을 얻었다.A flask containing 2-bromo-4-methylpyridine (6.9 g) and THF (20 ml) was cooled in an ice bath and 2 M isopropyl magnesium chloride THF solution (24 ml) was added dropwise to this solution. After completion of the dropwise addition, the ice bath was removed, and the mixture was stirred at room temperature for 1 hour, then cooled in an ice bath, and zinc tetramethylethylenediamine chloride (12.1 g) was added. After the ice bath was removed and the temperature was raised to room temperature, 2,5-dibromopyridine (9.5 g) and Pd (PPh 3 ) 4 (1.4 g) were added and stirred at a reflux temperature for 2 hours and a half. The reaction solution was cooled to room temperature, and then an aqueous EDTA · 4 Na solution and toluene were added to the reaction mixture. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 9/1). The solvent was distilled off under reduced pressure, and the obtained solid was recrystallized from heptane to obtain 5'-bromo-4-methyl-2,2'-bipyridine (5.5 g).

<4-메틸-5'-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,2'-비피리딘의 합성>Synthesis of 4-methyl-5 '- (3- (10- (naphthalen-2-yl) anthracen-9-yl) phenyl) -2,2'-

4,4,5,5-테트라메틸-2-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-1,3,2-디옥사보롤란(2.0 g), 5'-브로모-4-메틸-2,2'-비피리딘(1.2 g), Pd(PPh3)4(0.15 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠 20 ml, tert-부틸알코올 5 ml, 및 물 1 ml를 넣어, 환류 온도에서 16시간 교반했다. 반응액을 실온까지 냉각시킨 후, 톨루엔 및 물을 가하여 분액했다. 용매를 감압 증류 제거하고, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=95/5)에 의해 정제하고, 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 헵탄으로 세정함으로써, (1-14-13)으로 표시되는 화합물 4-메틸-5'-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,2'-비피리딘(1.4 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) anthracene-9-yl) phenyl) -1,3,2-dioxaborolane (2.0 g), 4,4,5,5-tetramethyl- 5'-bromo-4-methyl-2,2'-bipyridine (1.2 g), Pd (PPh 3) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene, 20 ml , 5 ml of tert-butyl alcohol, and 1 ml of water, and the mixture was stirred at a reflux temperature for 16 hours. After the reaction solution was cooled to room temperature, toluene and water were added to separate the layers. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 95/5) and the obtained eluate was passed through an activated carbon short column to remove the colored component. The solvent was distilled off under reduced pressure and the residue was washed with heptane to obtain the compound 4-methyl-5'- (3- (10- (naphthalen-2-yl) anthracene- ) -2,2'-bipyridine (1.4 g) was obtained. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3): 1 H-NMR (CDCl 3) :

δ=9.04(m, 1H), 8.55(d, 1H), 8.47(dd, 1H), 8.28(s, 1H), 8.11(dd, 1H), 8.09(d, 1H), 8.03(m, 1H), 8.00(s, 1H), 7.93(m, 1H), 7.88(d, 1H), 7.73-7.83(m, 6H), 7.57-7.63(m, 4H), 7.30-7.40(m, 4H), 7.14(d, 1H), 2.45(s, 3H).1H), 8.03 (d, IH), 8.05 (d, IH), 8.05 (d, (M, 4H), 7.30-7.40 (m, 4H), 7.14 (m, IH) (d, 1 H), 2.45 (s, 3 H).

[합성예 19] 화합물 (1-14-15)의 합성[Synthesis Example 19] Synthesis of Compound (1-14-15)

<5-브로모-6'-메틸-2,3'-비피리딘의 합성>Synthesis of <5-bromo-6'-methyl-2,3'-bipyridine>

5-브로모-2-메틸피리딘(3.4 g) 및 THF(10 ml)가 들어간 플라스크를 빙욕에서 냉각시키고, 이 용액에 2 M의 이소프로필마그네슘 염화물 THF 용액(11 ml)을 적하시켰다. 적하 종료 후, 빙욕을 제거하고 실온에서 3시간 교반한 후, 다시 빙욕에서 냉각시키고, 염화 아연 테트라메틸에틸렌디아민(5.5 g)을 가하였다. 빙욕을 제거하고 실온까지 승온한 후, 2,5-디브로모피리딘(4.7 g) 및 Pd(PPh3)4(0.7 g)를 가하여, 환류 온도에서 5시간 교반했다. 반응액을 실온까지 냉각시킨 후, EDTA·4Na 수용액 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거한 후, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=7/3)로 정제하여, 5-브로모-6'-메틸-2,3'-비피리딘(1.5 g)을 얻었다.A flask containing 5-bromo-2-methylpyridine (3.4 g) and THF (10 ml) was cooled in an ice bath, and a 2 M solution of isopropylmagnesium chloride in THF (11 ml) was added dropwise. After completion of the dropwise addition, the ice bath was removed, and the mixture was stirred at room temperature for 3 hours, cooled again in an ice bath, and zinc tetramethylethylenediamine chloride (5.5 g) was added. After the ice bath was removed and the temperature was raised to room temperature, 2,5-dibromopyridine (4.7 g) and Pd (PPh 3 ) 4 (0.7 g) were added and the mixture was stirred at reflux temperature for 5 hours. After the reaction solution was cooled to room temperature, an aqueous solution of EDTA · 4Na and toluene were added to separate the solution. The solvent was distilled off under reduced pressure, and the obtained solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 7/3) to obtain 5-bromo- g).

<6'-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,3'-비피리딘의 합성>Synthesis of 6'-methyl-5- (3- (10- (naphthalen-2-yl) anthracen-9-yl) phenyl) -2,3'-

4,4,5,5-테트라메틸-2-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-1,3,2-디옥사보롤란(2.0 g), 5-브로모-6'-메틸-2,3'-비피리딘(1.2 g), Pd(PPh3)4(0.15 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠 25 ml, tert-부틸알코올 5 ml, 및 물 1 ml를 넣어, 환류 온도에서 5시간 교반했다. 반응액을 실온까지 냉각시킨 후, 석출된 고체를 흡인 여과에 의해 채취하고, 메탄올에 이어서 아세트산 에틸로 세정하였다. 그 다음으로, 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=4/1)에 의해 정제하고, 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 얻어진 고체를 또한, 클로로벤젠으로부터 재결정하여, (1-14-15)로 표시되는 화합물 6'-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,3'-비피리딘(1.3 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) anthracene-9-yl) phenyl) -1,3,2-dioxaborolane (2.0 g), 4,4,5,5-tetramethyl- 5-bromo-6'-methyl -2,3'- bipyridine (1.2 g), Pd (PPh 3) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene, 25 ml , 5 ml of tert-butyl alcohol and 1 ml of water, and the mixture was stirred at reflux temperature for 5 hours. After the reaction solution was cooled to room temperature, the precipitated solid was collected by suction filtration, washed with methanol and then with ethyl acetate. Then, the solution was purified by silica gel column chromatography (developing solution: toluene / ethyl acetate = 4/1), and the obtained eluate was passed through an activated carbon short column to remove the colored component. The solvent was distilled off under reduced pressure, and the obtained solid was further recrystallized from chlorobenzene to obtain the compound 6'-methyl-5- (3- (10- (naphthalen-2-yl) anthracene Yl) phenyl) -2,3'-bipyridine (1.3 g) was obtained. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3): 1 H-NMR (CDCl 3) :

δ=9.13(m, 1H), 9.07(m, 1H), 8.28(dd, 1H), 8.01-8.11(m, 3H), 8.00(s, 1H), 7.93(m, 1H), 7.86(m, 1H), 7.73-7.83(m, 7H), 7.57-7.64(m, 4H), 7.31-7.39(m, 4H), 7.28(d, 1H), 2.63(s, 3H).1H), 7.93 (m, 1H), 7.86 (m, 1H), 8.07 (m, 1H), 7.73-7.83 (m, 7H), 7.57-7.64 (m, 4H), 7.31-7.39 (m, 4H), 7.28 (d,

[합성예 20] 화합물 (1-14-16)의 합성[Synthesis Example 20] Synthesis of compound (1-14-16)

<5-브로모-5'-메틸-2,3'-비피리딘의 합성>Synthesis of <5-bromo-5'-methyl-2,3'-bipyridine>

3-브로모-5-메틸피리딘(3.4 g) 및 THF(10 ml)가 들어간 플라스크를 빙욕에서 냉각시키고, 이 용액에 2 M의 이소프로필마그네슘 염화물 THF 용액(11 ml)을 적하시켰다. 적하 종료 후, 빙욕을 제거하고 실온에서 1시간 반 교반한 후, 다시 빙욕에서 냉각시키고, 염화 아연 테트라메틸에틸렌디아민(5.5 g)을 가하였다. 빙욕을 제거하고 실온까지 승온한 후, 2,5-디브로모피리딘(4.7 g) 및 Pd(PPh3)4(0.7 g)를 가하여, 환류 온도에서 5시간 교반했다. 반응액을 실온까지 냉각시킨 후, EDTA·4 Na 수용액 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거한 후, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=7/3)로 정제하여, 5-브로모-5'-메틸-2,3'-비피리딘(1.4 g)를 얻었다.A flask containing 3-bromo-5-methylpyridine (3.4 g) and THF (10 ml) was cooled in an ice bath, and a 2 M solution of isopropylmagnesium chloride in THF (11 ml) was added dropwise. After completion of the dropwise addition, the ice bath was removed, and the mixture was stirred at room temperature for 1 hour and a half, then cooled in an ice bath, and zinc tetramethylethylenediamine chloride (5.5 g) was added thereto. After the ice bath was removed and the temperature was raised to room temperature, 2,5-dibromopyridine (4.7 g) and Pd (PPh 3 ) 4 (0.7 g) were added and the mixture was stirred at reflux temperature for 5 hours. The reaction solution was cooled to room temperature, and then an aqueous EDTA · 4 Na solution and toluene were added to the reaction mixture. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (developing solution: toluene / ethyl acetate = 7/3) to obtain 5-bromo-5'-methyl-2,3'-bipyridine g).

<5'-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,3'-비피리딘의 합성>Synthesis of 5'-methyl-5- (3- (10- (naphthalen-2-yl) anthracen-9-yl) phenyl) -2,3'-

4,4,5,5-테트라메틸-2-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-1,3,2-디옥사보롤란(2.0 g), 5-브로모-6'-메틸-2,3'-비피리딘(1.2 g), Pd(PPh3)4(0.15 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠 25 ml, tert-부틸알코올 5 ml, 및 물 1 ml를 넣어, 환류 온도에서 5시간 교반했다. 반응액을 실온까지 냉각시킨 후, 석출된 고체를 흡인 여과에 의해 채취하고, 메탄올에 이어서 아세트산 에틸로 세정하였다. 그 다음으로, 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=4/1)에 의해 정제하고, 거기서 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 또한 얻어진 고체를 클로로벤젠으로부터 재결정하여, (1-14-16)으로 표시되는 화합물 5'-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,3'-비피리딘(1.3 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) anthracene-9-yl) phenyl) -1,3,2-dioxaborolane (2.0 g), 4,4,5,5-tetramethyl- 5-bromo-6'-methyl -2,3'- bipyridine (1.2 g), Pd (PPh 3) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene, 25 ml , 5 ml of tert-butyl alcohol and 1 ml of water, and the mixture was stirred at reflux temperature for 5 hours. After the reaction solution was cooled to room temperature, the precipitated solid was collected by suction filtration, washed with methanol and then with ethyl acetate. Subsequently, the solution was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 4/1), and the eluted solution obtained was passed through an activated carbon short column to remove the colored component. The solvent was distilled off under reduced pressure, and the resulting solid was recrystallized from chlorobenzene to obtain the compound 5'-methyl-5- (3- (10- (naphthalen-2-yl) anthracene- Yl) phenyl) -2,3'-bipyridine (1.3 g) was obtained. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=9.08(m, 1H), 9.04(s, 1H), 8.50(s, 1H), 8.21(s, 1H), 8.09(m, 2H), 8.04(m, 1H), 8.00(s, 1H), 7.93(m, 1H), 7.73-7.88(m, 8H), 7.62(m, 4H), 7.31-7.40(m, 4H), 2.45(s, 3H). 1 H-NMR (CDCl 3) : δ = 9.08 (m, 1H), 9.04 (s, 1H), 8.50 (s, 1H), 8.21 (s, 1H), 8.09 (m, 2H), 8.04 (m, 1H), 8.00 (s, 1H), 7.93 (m, 1H), 7.73-7.88 (m, 8H), 7.62 (m, 4H), 7.31-7.40 (m, 4H), 2.45 (s,

[합성예 21] 화합물 (1-14-17)의 합성[Synthesis Example 21] Synthesis of compound (1-14-17)

<5-브로모-4'-메틸-2,3'-비피리딘의 합성>Synthesis of <5-bromo-4'-methyl-2,3'-bipyridine>

3-브로모-4-메틸피리딘(5.2 g) 및 THF(10 ml)가 들어간 플라스크를 빙욕에서 냉각시키고, 이 용액에 2 M의 이소프로필마그네슘 염화물 THF 용액(17 ml)을 적하시켰다. 적하 종료 후, 빙욕을 제거하고 실온에서 9시간 교반한 후, 다시 빙욕에서 냉각시키고, 염화 아연 테트라메틸에틸렌디아민(8.3 g)을 가하였다. 빙욕을 제거하고 실온까지 승온한 후, 2,5-디브로모피리딘(7.1 g), Pd-137(존슨·매티사)(0.4 g) 및 NMP(25 ml)를 가하여, 환류 온도에서 6시간 교반했다. 반응액을 실온까지 냉각시킨 후, EDTA·4 Na 수용액 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거한 후, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=7/3)로 정제했다. 용매를 감압 증류 제거하고, 얻어진 고체를 헵탄으로 세정하여, 5-브로모-4'-메틸-2,3'-비피리딘(2.4 g)를 얻었다.A flask containing 3-bromo-4-methylpyridine (5.2 g) and THF (10 ml) was cooled in an ice bath, and a 2 M solution of isopropylmagnesium chloride in THF (17 ml) was added dropwise. After completion of the dropwise addition, the ice bath was removed, and the mixture was stirred at room temperature for 9 hours, cooled again in an ice bath, and zinc chloride tetramethylethylenediamine (8.3 g) was added thereto. After the ice bath was removed and the temperature was raised to room temperature, 2.5 g of dibromopyridine (7.1 g), Pd-137 (Johnson Matthias) (0.4 g) and NMP (25 ml) Lt; / RTI &gt; The reaction solution was cooled to room temperature, and then an aqueous EDTA · 4 Na solution and toluene were added to the reaction mixture. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 7/3). The solvent was distilled off under reduced pressure, and the resulting solid was washed with heptane to obtain 5-bromo-4'-methyl-2,3'-bipyridine (2.4 g).

<4'-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,3'-비피리딘의 합성>Synthesis of 4'-methyl-5- (3- (10- (naphthalen-2-yl) anthracen-9-yl) phenyl) -2,3'-

4,4,5,5-테트라메틸-2-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-1,3,2-디옥사보롤란(2.0 g), 5-브로모-6'-메틸-2,3'-비피리딘(1.2 g), Pd(PPh3)4(0.15 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠 25 ml, tert-부틸알코올 5 ml, 및 물 1 ml를 넣어, 환류 온도에서 5시간 교반했다. 반응액을 실온까지 냉각시킨 후, 톨루엔 및 물을 가하여 분액했다. 용매를 감압 증류 제거하고, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=7/3)에 의해 정제하고, 거기서 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 또한 얻어진 고체를 톨루엔으로부터 재결정하여, (1-14-17)로 표시되는 화합물 4'-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,3'-비피리딘(0.7 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) anthracene-9-yl) phenyl) -1,3,2-dioxaborolane (2.0 g), 4,4,5,5-tetramethyl- 5-bromo-6'-methyl -2,3'- bipyridine (1.2 g), Pd (PPh 3) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene, 25 ml , 5 ml of tert-butyl alcohol and 1 ml of water, and the mixture was stirred at reflux temperature for 5 hours. After the reaction solution was cooled to room temperature, toluene and water were added to separate the layers. The solvent was distilled off under reduced pressure, and the resulting solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 7/3) and the obtained eluate was passed through an activated carbon short column to remove the colored component. The solvent was distilled off under reduced pressure, and the resulting solid was recrystallized from toluene to obtain the compound 4'-methyl-5- (3- (10- (naphthalen-2-yl) anthracene-9 Yl) phenyl) -2,3'-bipyridine (0.7 g) was obtained. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=9.09(s, 1H), 8.67(s, 1H), 8.51(d, 1H), 8.09(m, 2H), 8.03(m, 1H), 8.00(m, 1H), 7.93(m, 1H), 7.88(d, 1H), 7.73-7.84(m, 6H), 7.61(m, 4H), 7.52(d, 1H), 7.31-7.40(m, 4H), 7.23(d, 1H), 2.46(s, 3H). 1 H-NMR (CDCl 3) : δ = 9.09 (s, 1H), 8.67 (s, 1H), 8.51 (d, 1H), 8.09 (m, 2H), 8.03 (m, 1H), 8.00 (m, 1H), 7.93 (m, 4H), 7.93 (m, 1H) (d, 1 H), 2.46 (s, 3 H).

[합성예 22] 화합물 (1-14-18)의 합성[Synthesis Example 22] Synthesis of the compound (1-14-18)

<5-브로모-2'-메틸-2,3'-비피리딘의 합성>Synthesis of <5-bromo-2'-methyl-2,3'-bipyridine>

3-브로모-2-메틸피리딘(5.2 g) 및 THF(10 ml)가 들어간 플라스크를 빙욕에서 냉각시키고, 이 용액에 2 M의 이소프로필마그네슘 염화물 THF 용액(17 ml)을 적하시켰다. 적하 종료 후, 빙욕을 제거하고 실온에서 2시간 교반한 후, 다시 빙욕에서 냉각시키고, 염화 아연 테트라메틸에틸렌디아민(8.3 g)을 가하였다. 빙욕을 제거하고 실온까지 승온한 후, 2,5-디브로모피리딘(7.1 g), Pd(PPh3)4(1.0 g) 및 크실렌(10 ml)을 가하여, 환류 온도에서 7시간 교반했다. 반응액을 실온까지 냉각시킨 후, EDTA·4 Na 수용액 및 톨루엔을 가하여 분액했다. 용매를 감압 증류 제거한 후, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=4/1)로 정제하여, 5-브로모-2'-메틸-2,3'-비피리딘(1.3 g)을 얻었다.A flask containing 3-bromo-2-methylpyridine (5.2 g) and THF (10 ml) was cooled in an ice bath, and a 2 M solution of isopropylmagnesium chloride in THF (17 ml) was added dropwise. After completion of the dropwise addition, the ice bath was removed, and the mixture was stirred at room temperature for 2 hours, then cooled in an ice bath and zinc chloride tetramethylethylenediamine (8.3 g) was added. After the ice bath was removed and warmed to room temperature, was added 2,5-dibromo-pyridine (7.1 g), Pd (PPh 3) 4 (1.0 g) and xylene (10 ml), and the mixture was stirred for 7 hours at reflux temperature. The reaction solution was cooled to room temperature, and then an aqueous EDTA · 4 Na solution and toluene were added to the reaction mixture. After the solvent was distilled off under reduced pressure, the resulting solid was purified by silica gel column chromatography (developing solution: toluene / ethyl acetate = 4/1) to obtain 5-bromo-2'-methyl-2,3'-bipyridine g).

<2'-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,3'-비피리딘의 합성>Synthesis of 2'-methyl-5- (3- (10- (naphthalen-2-yl) anthracen-9-yl) phenyl) -2,3'-

4,4,5,5-테트라메틸-2-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-1,3,2-디옥사보롤란(2.0 g), 5-브로모-6'-메틸-2,3'-비피리딘(1.2 g), Pd(PPh3)4(0.15 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠 25 ml, tert-부틸알코올 5 ml, 및 물 1 ml를 넣어, 환류 온도에서 12시간 교반했다. 반응액을 실온까지 냉각시킨 후, 톨루엔 및 물을 가하여 분액했다. 용매를 감압 증류 제거하고, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=4/1)에 의해 정제하고, 거기서 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 석출된 고체를 흡인 여과에 의해 채취하여, (1-14-18)로 표시되는 화합물 2'-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,3'-비피리딘(0.8 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) anthracene-9-yl) phenyl) -1,3,2-dioxaborolane (2.0 g), 4,4,5,5-tetramethyl- 5-bromo-6'-methyl -2,3'- bipyridine (1.2 g), Pd (PPh 3) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene, 25 ml , 5 ml of tert-butyl alcohol, and 1 ml of water, and the mixture was stirred at a reflux temperature for 12 hours. After the reaction solution was cooled to room temperature, toluene and water were added to separate the layers. The solvent was distilled off under reduced pressure, and the obtained solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 4/1), and the obtained eluate was passed through an activated carbon short column to remove the colored component. The solvent was distilled off under reduced pressure, and the precipitated solid was collected by suction filtration to obtain the compound 2'-methyl-5- (3- (10- (naphthalen-2-yl) anthracene Yl) phenyl) -2,3'-bipyridine (0.8 g) was obtained. The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=9.08(m, 1H), 8.57(m, 1H), 7.99-8.10(m, 4H), 7.92(m, 1H), 7.88(d, 1H), 7.73-7.83(m, 7H), 7.61(m, 4H), 7.51(dd, 1H), 7.30-7.40(m, 4H), 7.25(m, 1H), 2.66(s, 3H). 1 H-NMR (CDCl 3 ):? = 9.08 (m, 1H), 8.57 (m, 1H), 7.99-8.10 (m, 4H), 7.92 (D, 1H), 7.30-7.40 (m, 4H), 7.25 (m, 1H), 2.66 (s, 3H).

[합성예 23] 화합물 (1-14-20)의 합성[Synthesis Example 23] Synthesis of the compound (1-14-20)

<5-브로모-3'-메틸-2,4'-비피리딘의 합성>Synthesis of <5-bromo-3'-methyl-2,4'-bipyridine>

4-브로모-3-메틸피리딘(5.0 g) 및 THF(30 ml)가 들어간 플라스크를 드라이아이스/메탄올 욕에서 냉각시키고, 이 용액에 2 M의 이소프로필마그네슘 염화물 THF 용액(16 ml)을 적하시켰다. 적하 종료 후, 냉각용 욕을 제거하고 실온에서 2시간 반 교반한 후, 빙욕에서 냉각시키고, 염화 아연 테트라메틸에틸렌디아민(8.0 g)을 가하였다. 빙욕을 제거하고 실온까지 승온한 후, 2,5-디브로모피리딘(7.6 g) 및 Pd(PPh3)4(1.0 g)를 가하여, 환류 온도에서 2시간 교반했다. 반응액을 실온까지 냉각시킨 후, EDTA·4 Na 수용액 및 아세트산 에틸을 가하여 분액했다. 용매를 감압 증류 제거한 후, 얻어진 고체를 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=5/1)로 정제하여, 5-브로모-3'-메틸-2,4'-비피리딘(5.6 g)을 얻었다.A flask containing 4-bromo-3-methylpyridine (5.0 g) and THF (30 ml) was cooled in a dry ice / methanol bath, and a 2 M solution of isopropylmagnesium chloride in THF (16 ml) . After completion of the dropwise addition, the cooling bath was removed, and the mixture was stirred at room temperature for 2 hours and a half, then cooled in an ice bath, and zinc tetramethylethylenediamine chloride (8.0 g) was added thereto. After the ice bath was removed and the temperature was raised to room temperature, 2,5-dibromopyridine (7.6 g) and Pd (PPh 3 ) 4 (1.0 g) were added and the mixture was stirred at reflux temperature for 2 hours. After the reaction solution was cooled to room temperature, an aqueous EDTA · 4 Na solution and ethyl acetate were added to the reaction mixture, and the mixture was separated. After the solvent was distilled off under reduced pressure, the obtained solid was purified by silica gel column chromatography (eluent: toluene / ethyl acetate = 5/1) to obtain 5-bromo-3'-methyl-2,4'-bipyridine g).

<3'-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,4'-비피리딘의 합성>Synthesis of 3'-methyl-5- (3- (10- (naphthalen-2-yl) anthracen-9-yl) phenyl) -2,4'-

4,4,5,5-테트라메틸-2-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-1,3,2-디옥사보롤란(2.0 g), 5-브로모-3'-메틸-2,4'-비피리딘(1.2 g), Pd(PPh3)4(0.15 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠 1 ml, tert-부틸알코올 1 ml, 및 물 1 ml를 넣어, 환류 온도에서 4시간 교반했다. 반응액을 실온까지 냉각시킨 후, 물을 가하여, 흡인 여과에 의해 석출물을 채취했다. 얻어진 고체를 물 및 메탄올로 세정한 후, NH 수식 실리카겔(DM1020:후지 실리시아 제조) 컬럼 크로마토그래피(전개액:톨루엔)에 의해 정제하여, (1-14-20)로 표시되는 화합물 3'-메틸-5-(3-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,4'-비피리딘(1.7 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) anthracene-9-yl) phenyl) -1,3,2-dioxaborolane (2.0 g), 4,4,5,5-tetramethyl- 5-bromo-3'-methyl -2,4'- bipyridine (1.2 g), Pd (PPh 3) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene 1 ml 1 ml of tert-butyl alcohol, and 1 ml of water were placed, and the mixture was stirred at a reflux temperature for 4 hours. After the reaction solution was cooled to room temperature, water was added, and the precipitate was collected by suction filtration. The obtained solid was washed with water and methanol, and then purified by column chromatography (eluent: toluene) with NH-modified silica gel (DM1020, manufactured by Fuji Silysia) to obtain the compound 3'- Methyl-5- (3- (10- (naphthalen-2-yl) anthracen-9-yl) phenyl) -2,4'-bipyridine (1.7 g). The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=9.09(m, 1H), 8.56(s, 1H), 8.55(d, 1H), 8.10(m, 2H), 8.03(m, 1H), 8.00(d, 1H), 7.93(d, 1H), 7.88(d, 1H), 7.73-7.83(m, 6H), 7.61(m, 4H), 7.53(d, 1H), 7.31-7.41(m, 5H), 2.44(s, 3H). 1 H-NMR (CDCl 3) : δ = 9.09 (m, 1H), 8.56 (s, 1H), 8.55 (d, 1H), 8.10 (m, 2H), 8.03 (m, 1H), 8.00 (d, 1H), 7.93 (d, 1H), 7.88 (d, 1H), 7.73-7.83 (m, 6H), 7.61 (m, 4H), 7.53 (s, 3 H).

[합성예 24] 화합물 (1-11-18)의 합성[Synthesis Example 24] Synthesis of the compound (1-11-18)

<2'-메틸-5-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)2,3'-비피리딘의 합성>Synthesis of 2'-methyl-5- (6- (10-phenylanthracen-9-yl) naphthalen-2-yl)

4,4,5,5-테트라메틸-2-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)-1,3,2-디옥사보롤란(2.0 g), 5-브로모-2'-메틸-2,3'-비피리딘(1.2 g), Pd(PPh3)4(0.15 g), 인산 칼륨(1.7 g), 1,2,4-트리메틸벤젠(20 ml), tert-부틸알코올(5 ml) 및 물(1 ml)을 플라스크에 넣어, 질소 분위기 하에서 환류 온도에서 8시간 교반했다. 가열 종료 후, 반응액을 실온까지 냉각시킨 후, 석출된 고체를 흡인 여과에 의해 채취하고, 메탄올에 이어서 아세트산 에틸로 세정하였다. 그 다음으로, 실리카겔 컬럼 크로마토그래피(전개액:톨루엔/아세트산 에틸=7/3)에 의해 정제하고, 거기서 얻어진 용출액을 활성탄 쇼트 컬럼에 통과시켜, 착색 성분을 제거하였다. 용매를 감압 증류 제거하고, 석출된 고체를 흡인 여과에 의해 채취하여, (1-11-18)로 표시되는 화합물 2'-메틸-5-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)2,3'-비피리딘(1.1 g)을 얻었다. NMR 측정에 의해 화합물의 구조를 확인하였다.2-yl) -1,3,2-dioxaborolane (2.0 g), 5- (4-fluorophenyl) bromo-2'-methyl -2,3'- bipyridine (1.2 g), Pd (PPh 3) 4 (0.15 g), potassium phosphate (1.7 g), 1,2,4- trimethyl benzene (20 ml) , tert-butyl alcohol (5 ml) and water (1 ml) were placed in a flask, and the mixture was stirred at a reflux temperature for 8 hours under a nitrogen atmosphere. After the completion of the heating, the reaction solution was cooled to room temperature, and the precipitated solid was collected by suction filtration, washed with methanol and then with ethyl acetate. Subsequently, purification was carried out by silica gel column chromatography (developing solution: toluene / ethyl acetate = 7/3), and the eluted solution obtained was passed through an activated carbon short column to remove coloring components. The solvent was distilled off under reduced pressure, and the precipitated solid was collected by suction filtration to obtain the compound 2'-methyl-5- (6- (10-phenylanthracene-9-yl) naphthalene -2-yl) 2,3'-bipyridine (1.1 g). The structure of the compound was confirmed by NMR measurement.

1H-NMR(CDCl3):δ=9.17(m, 1H), 8.60(dd, 1H), 8.230(s, 1H), 8.19(m, 2H), 8.06(m, 2H), 7.87(dd, 1H), 7.85(dd, 1H), 7.73(m, 4H), 7.69(dd, 1H), 7.55-7.65(m, 4H), 7.51(m, 2H), 7.26-7.37(m, 5H), 2.73(s, 3H). 1 H-NMR (CDCl 3) : δ = 9.17 (m, 1H), 8.60 (dd, 1H), 8.230 (s, 1H), 8.19 (m, 2H), 8.06 (m, 2H), 7.87 (dd, 2H), 7.26-7.37 (m, 5H), 2.73 (m, 2H), 7.85 (d, (s, 3 H).

원료의 화합물을 적절하게 변경함으로써, 전술한 합성예에 준한 방법으로, 본 발명의 다른 유도체 화합물을 합성할 수 있다.Other derivative compounds of the present invention can be synthesized by the method according to the above-mentioned synthesis example by suitably changing the compound of the starting material.

이하에서, 본 발명을 보다 상세하게 설명하기 위하여, 본 발명의 화합물을 사용한 유기 EL 소자의 실시예를 나타내지만, 본 발명은 이들로 한정되는 것은 아니다.Hereinafter, to describe the present invention in more detail, examples of the organic EL device using the compound of the present invention are shown, but the present invention is not limited thereto.

실시예 1 내지 4 및 비교예 1 내지 2에 따른 소자를 제조하고, 각각, 정전류 구동 시험에 있어서의 구동 개시 전압(V), 초기값의 90% 이상의 휘도를 유지하는 시간(hr)을 측정하였다. 이하, 실시예 및 비교예에 대하여 상세하게 설명한다.The devices according to Examples 1 to 4 and Comparative Examples 1 and 2 were manufactured and the driving start voltage (V) in the constant current driving test and the time (hr) in which the luminance was maintained at 90% or more of the initial value were measured . Examples and Comparative Examples are described below in detail.

제조한 실시예 1 내지 4 및 비교예 1 내지 2에 따른 소자에 있어서, 각 층의 재료 구성을 하기 표 1에 나타낸다.In the devices according to Examples 1 to 4 and Comparative Examples 1 and 2, the material composition of each layer is shown in Table 1 below.

[표 1][Table 1]

Figure 112013039443236-pct00101
Figure 112013039443236-pct00101

표 1에 있어서, "HI"는 N4, N4'-디페닐-N4, N4'-비스(9-페닐-9H-카르바졸-3-일)-[1,1'-비페닐]-4,4'-디아민, "NPD"는 N4, N4'-디(나프탈렌-1-일)-N4, N4'-디페닐-[1,1'-비페닐]-4,4'-디아민, 화합물 (A)는 9-페닐-10-(4-페닐나프탈렌-1-일)안트라센, 화합물 (B)는 N5, N5, N9, N9-7, 7-헥사페닐-7H-벤조[c]플루오렌-5,9-디아민, 화합물 (C)는 9,10-디([2,2'-비피리딘]-5-일)안트라센, 화합물 (D)는 9,10-비스(4-(피리딘-3-일)나프탈렌-1-일)안트라센이다. 전자 수송층과 음극의 중간에 형성되는 층에 사용한 "Liq"와 함께 이하에서 화학 구조를 나타낸다.In Table 1, "HI" refers to N 4 , N 4 ' -diphenyl -N 4 , N 4' -bis (9-phenyl-9H-carbazol- ] -4,4'-diamine, "NPD" is N 4, N 4 '- di (naphthalene-1-yl) -N 4, N 4' - diphenyl - [1,1'-biphenyl] -4 , 4'-diamine, the compound (A) is 9-phenyl-10- (4-phenyl-1-yl) anthracene, the compound (B) is N 5, N 5, N 9 , N 9 -7, 7- ([2,2'-bipyridine] -5-yl) anthracene, the compound (D) is a compound represented by the formula 9,10-bis (4- (pyridin-3-yl) naphthalen-1-yl) anthracene. Liq "used in the layer formed between the electron transporting layer and the cathode shows a chemical structure in the following.

Figure 112013039443236-pct00102
Figure 112013039443236-pct00102

[실시예 1][Example 1]

<화합물 (1-7-74)를 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-7-74) as electron transport layer &gt;

스퍼터링에 의해 180 nm의 두께로 제막한 ITO를 150 nm까지 연마한, 26 mm×28 mm×0.7 mm의 유리 기판[(주)옵토사이언스 제조]을 투명 지지 기판으로 했다. 이 투명 지지 기판을 시판중인 증착 장치[쇼와 진공(주) 제조]의 기판 홀더에 고정하고, HI를 넣은 몰리브덴제 증착용 보트, NPD를 넣은 몰리브덴제 증착용 보트, 화합물 (A)를 넣은 몰리브덴제 증착용 보트, 화합물 (B)를 넣은 몰리브덴제 증착용 보트, 화합물 (1-7-74)를 넣은 몰리브덴제 증착용 보트, Liq를 넣은 몰리브덴제 증착용 보트, 마그네슘을 넣은 몰리브덴 보트 및 은을 넣은 텅스텐제 증착용 보트를 장착하였다.A glass substrate of 26 mm x 28 mm x 0.7 mm (manufactured by Optoscience Co., Ltd.), in which ITO formed to a thickness of 180 nm by polishing was polished to 150 nm by sputtering was used as a transparent support substrate. This transparent support substrate was fixed to a substrate holder of a commercially available vapor deposition apparatus (manufactured by Showa Vacuum Co., Ltd.), and molybdenum-containing boats containing HI, molybdenum-containing boats containing NPD, molybdenum containing compound (A) Molybdenum boats with compounds (B), molybdenum boats with compounds (1-7-74), molybdenum boats with Liq, molybdenum boats with magnesium, and silver The tungsten boat was installed.

투명 지지 기판의 ITO막 상에 순차적으로, 하기의 각 층을 형성하였다. 진공조를 5×10-4 Pa까지 감압하고, 먼저, HI가 들어간 증착용 보트를 가열하여 막 두께 40 nm로 되도록 증착하여 정공 주입층을 형성하고, 그 다음으로, NPD가 들어간 증착용 보트를 가열하여 막 두께 30 nm가 되도록 증착하여 정공 수송층을 형성하였다. 다음으로, 화합물 (A)가 들어간 증착용 보트와 화합물 (B)가 들어간 증착용 보트를 동시에 가열하여 막 두께 35 nm로 되도록 증착하여 발광층을 형성하였다. 화합물 (A)와 화합물 (B)의 중량비가 대략 95 대 5가 되도록 증착 속도를 조절하였다. 다음으로, 화합물 (1-7-74)가 들어간 증착용 보트를 가열하여 막 두께 15 nm가 되도록 증착하여 전자 수송층을 형성하였다. 각 층의 증착 속도는 0.01∼1 nm/초였다.The following layers were sequentially formed on the ITO film of the transparent support substrate. The vacuum tank was evacuated to 5 x 10 &lt; -4 &gt; Pa. First, an evacuation boat containing HI was heated to form a hole injection layer to a film thickness of 40 nm. Next, Followed by evaporation to a thickness of 30 nm by heating to form a hole transport layer. Next, an evaporation boat containing the compound (A) and an evaporation booth containing the compound (B) were simultaneously heated to deposit a film having a film thickness of 35 nm to form a light emitting layer. The deposition rate was controlled so that the weight ratio of compound (A) to compound (B) was approximately 95: 5. Next, an evaporation boat containing the compound (1-7-74) was heated and evaporated to a film thickness of 15 nm to form an electron transport layer. The deposition rate of each layer was 0.01 to 1 nm / sec.

그 후, Liq가 들어간 증착용 보트를 가열하여 막 두께 1 nm로 되도록 0.01∼0.1 nm/초의 증착 속도로 증착하였다. 이어서, 마그네슘이 들어간 보트와 은이 들어간 보트를 동시에 가열하여 막 두께 100 nm로 되도록 증착하여 음극을 형성하였다. 이 때, 마그네슘과 은의 원자수비가 10 대 1이 되도록 증착 속도를 조절하고, 증착 속도가 0.1∼10 nm/초가 되도록 음극을 형성하여 유기 전계 발광 소자를 얻었다.Thereafter, the deposition boats containing Liq were heated to deposit at a deposition rate of 0.01 to 0.1 nm / sec so as to have a film thickness of 1 nm. Subsequently, a boat containing magnesium and a boat containing silver were heated at the same time to deposit a film having a thickness of 100 nm to form a negative electrode. At this time, the deposition rate was controlled so that the ratio of atomic ratio of magnesium and silver was 10: 1, and a cathode was formed so as to have a deposition rate of 0.1 to 10 nm / sec to obtain an organic electroluminescent device.

ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 직류 전압을 인가하면, 파장 약 460 nm의 청색 발광을 얻을 수 있었다. 또한, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시한 바, 구동 시험 개시 전압은 7.33 V이며, 초기값의 90%(1800 cd/m2) 이상의 휘도를 유지하는 시간은 45시간이었다.When a DC voltage was applied to the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode, blue light emission with a wavelength of about 460 nm was obtained. When the constant current driving test was carried out by the current density for obtaining the initial luminance of 2000 cd / m 2 , the driving test starting voltage was 7.33 V, and the luminance was maintained at 90% (1800 cd / m 2 ) or more of the initial value The time was 45 hours.

[실시예 2][Example 2]

<화합물 (1-7-26)을 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-7-26) as electron transport layer &gt;

화합물 (1-7-74)를 화합물 (1-7-26)으로 변경한 점 이외는 실시예 1에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 6.36 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 151시간이었다.An organic EL device was obtained in the same manner as in Example 1 except that the compound (1-7-74) was changed to the compound (1-7-26). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test starting voltage was 6.36 V, and the time for maintaining the luminance of 90% or more of the initial value was 151 hours.

[실시예 3][Example 3]

<화합물 (1-7-98)을 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-7-98) as electron transport layer &gt;

화합물 (1-7-74)를 화합물 (1-7-98)로 변경한 점 이외는 실시예 1에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 7.34 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 265시간이었다.An organic EL device was obtained in the same manner as in Example 1 except that the compound (1-7-74) was changed to the compound (1-7-98). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test starting voltage was 7.34 V, and the time for maintaining the luminance of 90% or more of the initial value was 265 hours.

[실시예 4][Example 4]

<화합물 (1-7-96)을 전자 수송층에 사용한 소자>&Lt; Device using compound (1-7-96) in electron transport layer &gt;

화합물 (1-7-74)를 화합물 (1-7-96)으로 변경한 점 이외는 실시예 1에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 5.33 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 103시간이었다.An organic EL device was obtained in the same manner as in Example 1 except that the compound (1-7-74) was changed to the compound (1-7-96). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test starting voltage was 5.33 V, and the time for maintaining the luminance of 90% or more of the initial value was 103 hours.

[비교예 1][Comparative Example 1]

화합물 (1-7-74)를 화합물 (C)로 변경한 점 이외는 실시예 1에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 그 결과, 구동 시험 개시 전압은 5.06 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 6시간이었다.An organic EL device was obtained in the same manner as in Example 1 except that the compound (1-7-74) was changed to the compound (C). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . As a result, the driving test starting voltage was 5.06 V, and the time for maintaining the luminance of 90% or more of the initial value was 6 hours.

[비교예 2][Comparative Example 2]

화합물 (1-7-74)를 화합물 (D)로 변경한 점 이외는 실시예 1에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 그 결과, 구동 시험 개시 전압은 5.05 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 10시간이었다.An organic EL device was obtained in the same manner as in Example 1 except that the compound (1-7-74) was changed to the compound (D). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . As a result, the driving test starting voltage was 5.05 V, and the time for maintaining the luminance of 90% or more of the initial value was 10 hours.

이상의 결과를 표 2에 정리하였다.Table 2 summarizes the above results.

[표 2][Table 2]

Figure 112013039443236-pct00103
Figure 112013039443236-pct00103

실시예 5 내지 20 및 비교예 3 내지 5에 따른 소자를 제조하고, 각각, 정전류 구동 시험에 있어서의 구동 개시 전압(V), 초기값의 90% 이상의 휘도를 유지하는 시간(hr)을 측정하였다. 이하에서, 실시예 및 비교예에 대하여 상세하게 설명한다.The devices according to Examples 5 to 20 and Comparative Examples 3 to 5 were manufactured and the driving start voltage (V) in the constant current driving test and the time (hr) for maintaining the luminance of 90% or more of the initial value were measured . Hereinafter, examples and comparative examples will be described in detail.

제조한 실시예 5 내지 20 및 비교예 3 내지 5에 따른 소자에 있어서, 각 층의 재료 구성을 하기 표 3에 나타낸다.In the devices according to the produced Examples 5 to 20 and Comparative Examples 3 to 5, the material composition of each layer is shown in Table 3 below.

[표 3][Table 3]

Figure 112013039443236-pct00104
Figure 112013039443236-pct00104

표 3에 있어서, HT는 N-([1,1'-비페닐]-4-일)-9,9-디메틸-N-(4-(9-페닐-9H-카르바졸-3-일)페닐)-9H-플루오렌-2-아민, 화합물 (E)는 9-(4-(나프탈렌-1-일)페닐)-10-페닐안트라센, 화합물 (F)는 4,4'-((7,7-디페닐-7H-벤조[c]플루오렌-5,9-디일)비스(페닐)아미노)디벤조니트릴, 화합물 (G)는 4'-(4-(10-(나프탈렌-2-일)안트라센-9-일)페닐)-2,2':6',2"-터피리딘, 화합물 (H)는 3-(6-(10-페닐안트라센-9-일)나프탈렌-2-일)피리딘, 화합물 (I)는 6-(4-(10-(나프탈렌-1-일)안트라센-9-일)페닐)-2,4'-비피리딘이다.In Table 3, HT is a mixture of N - ([1,1'-biphenyl] -4-yl) -9,9-dimethyl-N- (4- (9- Phenyl) -9H-fluorene-2-amine, compound (E) is 9- (4- (naphthalen- (4- (10- (naphthalene-2-yl) phenyl) amino) dibenzonitrile, compound (G) (10-phenylanthracene-9-yl) phenyl) -2,2 ': 6', 2 "-terpyridine and compound (H) ) Pyridine, and the compound (I) is 6- (4- (10- (naphthalen-1-yl) anthracen-9-yl) phenyl) -2,4'-bipyridine.

Figure 112013039443236-pct00105
Figure 112013039443236-pct00105

[실시예 5][Example 5]

<화합물 (1-11-1)을 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-11-1) as an electron transport layer &gt;

스퍼터링에 의해 180 nm의 두께로 제막한 ITO를 150 nm까지 연마한, 26 mm×28 mm×0.7 mm의 유리 기판[(주)옵토사이언스 제조]을 투명 지지 기판으로 했다. 이 투명 지지 기판을 시판중인 증착 장치[쇼와 진공(주) 제조]의 기판 홀더에 고정하고, HI를 넣은 몰리브덴제 증착용 보트, HT를 넣은 몰리브덴제 증착용 보트, 화합물 (E)을 넣은 몰리브덴제 증착용 보트, 화합물 (F)를 넣은 몰리브덴제 증착용 보트, 화합물 (1-11-1)을 넣은 몰리브덴제 증착용 보트, Liq를 넣은 몰리브덴제 증착용 보트, 마그네슘을 넣은 몰리브덴 보트 및 은을 넣은 텅스텐제 증착용 보트를 장착하였다.A glass substrate of 26 mm x 28 mm x 0.7 mm (manufactured by Optoscience Co., Ltd.), in which ITO formed to a thickness of 180 nm by polishing was polished to 150 nm by sputtering was used as a transparent support substrate. The transparent support substrate was fixed to a substrate holder of a commercially available vapor deposition apparatus (manufactured by Showa Vacuum Co., Ltd.), and molybdenum-containing boats containing HI, molybdenum-containing boats containing HT, molybdenum containing compound (E) Molybdenum boats with compound (F), molybdenum boats with compound (1-11-1), molybdenum boats with Liq, magnesium molybdenum boats and silver The tungsten boat was installed.

투명 지지 기판의 ITO막 상에 순차적으로,하기 각 층을 형성하였다. 진공조를 5×10-4 Pa까지 감압하고, 먼저, HI가 들어간 증착용 보트를 가열하여 막 두께 40 nm로 되도록 증착하여 정공 주입층을 형성하고, 그 다음으로, HT가 들어간 증착용 보트를 가열하여 막 두께 30 nm로 되도록 증착하여 정공 수송층을 형성하였다. 다음으로, 화합물 (E)가 들어간 증착용 보트와 화합물 (F)가 들어간 증착용 보트를 동시에 가열하여 막 두께 35 nm로 되도록 증착하여 발광층을 형성하였다. 화합물 (E)와 화합물 (F)의 중량비가 대략 95 대 5로 되도록 증착 속도를 조절하였다. 다음으로, 화합물 (1-11-1)이 들어간 증착용 보트와 Liq가 들어간 증착용 보트를 동시에 가열하여 막 두께 25 nm로 되도록 증착하여 전자 수송층을 형성하였다. 화합물 (1-11-1)과 Liq의 중량비가 대략 1:1로 되도록 증착 속도를 조절하였다. 각 층의 증착 속도는 0.01∼1 nm/초였다.The following layers were sequentially formed on the ITO film of the transparent support substrate. The vacuum tank was evacuated to 5 x 10 &lt; -4 &gt; Pa. First, an evacuation boat containing HI was heated to form a hole injection layer to a film thickness of 40 nm. Next, And the film was heated to a thickness of 30 nm to form a hole transport layer. Next, the evaporation boats containing the compound (E) and the evaporation boats containing the compound (F) were heated at the same time to deposit a film having a film thickness of 35 nm to form a light emitting layer. The deposition rate was controlled so that the weight ratio of compound (E) and compound (F) was approximately 95: 5. Next, an evaporation boat containing compound (1-11-1) and an evaporation booth containing Liq were simultaneously heated to deposit a film having a film thickness of 25 nm to form an electron transport layer. The deposition rate was controlled so that the weight ratio of the compound (1-11-1) and Liq was approximately 1: 1. The deposition rate of each layer was 0.01 to 1 nm / sec.

그 후, Liq가 들어간 증착용 보트를 가열하여 막 두께 1 nm로 되도록 0.01∼0.1 nm/초의 증착 속도로 증착하였다. 이어서, 마그네슘이 들어간 보트와 은이 들어간 보트를 동시에 가열하여 막 두께 100 nm로 되도록 증착하여 음극을 형성하였다. 이 때, 마그네슘과 은의 원자수비가 10 대 1로 되도록 증착 속도를 조절하고, 증착 속도가 0.1∼10 nm/초로 되도록 음극을 형성하여 유기 전계 발광 소자를 얻었다.Thereafter, the deposition boats containing Liq were heated to deposit at a deposition rate of 0.01 to 0.1 nm / sec so as to have a film thickness of 1 nm. Subsequently, a boat containing magnesium and a boat containing silver were heated at the same time to deposit a film having a thickness of 100 nm to form a negative electrode. At this time, the deposition rate was controlled so that the atomic ratio between magnesium and silver was 10: 1, and the cathode was formed so that the deposition rate was 0.1 to 10 nm / sec to obtain an organic electroluminescent device.

ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 직류 전압을 인가하면, 파장 약 450 nm의 청색 발광을 얻을 수 있었다. 또한, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시한 바, 구동 시험 개시 전압은 4.00 V이며, 초기값의 90%(1800 cd/m2) 이상의 휘도를 유지하는 시간은 87시간이었다.When a direct current voltage was applied to the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode, blue light emission with a wavelength of about 450 nm was obtained. Further, when the constant current driving test was performed by the current density for obtaining the initial luminance of 2000 cd / m 2 , the driving test starting voltage was 4.00 V, and the luminance was maintained at 90% (1800 cd / m 2 ) or more of the initial value The time was 87 hours.

[실시예 6][Example 6]

<화합물 (1-11-2)를 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-11-2) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-11-2)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 4.12 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 85시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-11-2). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test starting voltage was 4.12 V, and the time for maintaining the luminance of 90% or more of the initial value was 85 hours.

[실시예 7][Example 7]

<화합물 (1-11-3)을 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-11-3) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-11-3)으로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 3.78 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 97시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-11-3). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test start voltage was 3.78 V, and the time for maintaining the luminance of 90% or more of the initial value was 97 hours.

[실시예 8][Example 8]

<화합물 (1-11-4)를 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-11-4) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-11-4)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 3.95 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 83시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-11-4). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test start voltage was 3.95 V, and the time for maintaining the luminance of 90% or more of the initial value was 83 hours.

[실시예 9][Example 9]

<화합물 (1-11-5)를 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-11-5) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-11-5)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 3.88 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 93시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-11-5). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test starting voltage was 3.88 V, and the time for maintaining the luminance of 90% or more of the initial value was 93 hours.

[실시예 10][Example 10]

<화합물 (1-11-39)를 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-11-39) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-11-39)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 4.16 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 74시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-11-39). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test start voltage was 4.16 V, and the time for maintaining the luminance of 90% or more of the initial value was 74 hours.

[실시예 11][Example 11]

<화합물 (1-14-2)를 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-14-2) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-14-2)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 3.61 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 76시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-14-2). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test starting voltage was 3.61 V, and the time to maintain the luminance of 90% or more of the initial value was 76 hours.

[실시예 12][Example 12]

<화합물 (1-14-3)을 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-14-3) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-14-3)으로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 3.85 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 141시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-14-3). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test starting voltage was 3.85 V, and the time for maintaining the luminance of 90% or more of the initial value was 141 hours.

[실시예 13][Example 13]

<화합물 (1-14-11)을 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-14-11) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-14-11)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 4.16 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 162시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-14-11). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test starting voltage was 4.16 V, and the time for maintaining the luminance of 90% or more of the initial value was 162 hours.

[실시예 14][Example 14]

<화합물 (1-14-12)를 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-14-12) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-14-12)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 3.87 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 75시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-14-12). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test start voltage was 3.87 V, and the time for maintaining the luminance of 90% or more of the initial value was 75 hours.

[실시예 15][Example 15]

<화합물 (1-14-14)를 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-14-14) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-14-14)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 3.82 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 227시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-14-14). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test start voltage was 3.82 V, and the time for maintaining the luminance of 90% or more of the initial value was 227 hours.

[실시예 16][Example 16]

<화합물 (1-14-15)를 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-14-15) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-14-15)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 3.98 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 101시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-14-15). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test starting voltage was 3.98 V, and the time for maintaining the luminance of 90% or more of the initial value was 101 hours.

[실시예 17][Example 17]

<화합물 (1-14-16)을 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-14-16) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-14-16)으로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 4.25 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 70시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-14-16). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test starting voltage was 4.25 V, and the time for maintaining the luminance of 90% or more of the initial value was 70 hours.

[실시예 18][Example 18]

<화합물 (1-14-18)을 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-14-18) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-14-18)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 3.75 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 125시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-14-18). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test starting voltage was 3.75 V, and the time for maintaining the luminance of 90% or more of the initial value was 125 hours.

[실시예 19][Example 19]

<화합물 (1-14-20)을 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-14-20) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-14-20)으로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 4.19 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 63시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-14-20). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test starting voltage was 4.19 V, and the time for maintaining the luminance of 90% or more of the initial value was 63 hours.

[실시예 20][Example 20]

<화합물 (1-11-18)을 전자 수송층에 사용한 소자>&Lt; Device using Compound (1-11-18) as electron transport layer &gt;

화합물 (1-11-1)을 화합물 (1-11-18)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 구동 시험 개시 전압은 4.29 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 60시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (1-11-18). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . The driving test starting voltage was 4.29 V, and the time for maintaining the luminance of 90% or more of the initial value was 60 hours.

[비교예 3][Comparative Example 3]

화합물 (1-11-1)을 화합물 (G)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 그 결과, 구동 시험 개시 전압은 5.36 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 2시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (G). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . As a result, the driving test starting voltage was 5.36 V, and the time for maintaining the luminance of 90% or more of the initial value was 2 hours.

[비교예 4][Comparative Example 4]

화합물 (1-11-1)을 화합물 (H)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 그 결과, 구동 시험 개시 전압은 4.12 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 26시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (H). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . As a result, the driving test starting voltage was 4.12 V, and the time for maintaining the luminance of 90% or more of the initial value was 26 hours.

[비교예 5][Comparative Example 5]

화합물 (1-11-1)을 화합물 (I)로 변경한 점 이외는 실시예 5에 준한 방법으로 유기 EL 소자를 얻었다. ITO 전극을 양극, 마그네슘/은 전극을 음극으로 하여, 초기 휘도 2000 cd/m2를 얻기 위한 전류 밀도에 의해, 정전류 구동 시험을 실시하였다. 그 결과, 구동 시험 개시 전압은 4.15 V이며, 초기값의 90% 이상의 휘도를 유지하는 시간은 30시간이었다.An organic EL device was obtained in the same manner as in Example 5 except that the compound (1-11-1) was changed to the compound (I). A constant current driving test was carried out by using the ITO electrode as a positive electrode and the magnesium / silver electrode as a negative electrode at a current density for obtaining an initial luminance of 2000 cd / m 2 . As a result, the driving test starting voltage was 4.15 V, and the time for maintaining the luminance of 90% or more of the initial value was 30 hours.

이상의 결과를 표 4에 정리하였다.Table 4 summarizes the above results.

[표 4][Table 4]

Figure 112013039443236-pct00106
Figure 112013039443236-pct00106

[산업상의 이용 가능성][Industrial Availability]

본 발명의 바람직한 태양에 의하면, 특히 발광 소자의 수명을 향상시키고, 구동 전압과의 밸런스도 우수한 유기 전계 발광 소자, 그것을 구비한 표시 장치 및 그것을 구비한 조명 장치 등을 제공할 수 있다.According to a preferred embodiment of the present invention, it is possible to provide an organic electroluminescent device which improves the lifetime of the light emitting device, and which is excellent in balance with the driving voltage, a display device including the organic electroluminescent device, and a lighting device including the same.

Claims (18)

하기 식 (1-7) 또는 (1-8)로 표시되는 화합물:
Figure 112017115201956-pct00113

상기 식 (1-7) 및 (1-8)에 있어서,
Py는 하기 식 (2), (3) 또는 (4)로 표시되는 기이며;
Figure 112017115201956-pct00114

R은 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬이며;그리고, p는 1∼5의 정수임.
A compound represented by the following formula (1-7) or (1-8):
Figure 112017115201956-pct00113

In the above formulas (1-7) and (1-8)
Py is a group represented by the following formula (2), (3) or (4);
Figure 112017115201956-pct00114

R is alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms; and p is an integer of 1 to 5.
하기 식 (1-9) 또는 (1-10)으로 표시되는 화합물:
Figure 112017115201956-pct00115

상기 식 (1-9) 및 (1-10)에 있어서,
Py는 하기 식 (2), (3) 또는 (4)로 표시되는 기이며;
Figure 112017115201956-pct00116

R은 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬이며;그리고, q는 1∼5의 정수임.
A compound represented by the following formula (1-9) or (1-10):
Figure 112017115201956-pct00115

In the above formulas (1-9) and (1-10)
Py is a group represented by the following formula (2), (3) or (4);
Figure 112017115201956-pct00116

R is alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms; and q is an integer of 1 to 5.
하기 식 (1-11) 또는 (1-12)로 표시되는 화합물:
Figure 112017115201956-pct00117

상기 식 (1-11) 및 (1-12)에 있어서,
Py1은 하기 식 (2'), (3') 또는 (4')로 표시되는 기이며;
Figure 112017115201956-pct00118

상기 식 (2'), (3') 및 (4')에 있어서, R은 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬이며;그리고, s는 1∼4의 정수임.
A compound represented by the following formula (1-11) or (1-12):
Figure 112017115201956-pct00117

In the above formulas (1-11) and (1-12)
Py 1 is a group represented by the following formula (2 '), (3') or (4 ');
Figure 112017115201956-pct00118

In the above formulas (2 '), (3') and (4 '), R is alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms; and s is an integer of 1 to 4.
하기 식 (1-13) 또는 (1-14)로 표시되는 화합물:
Figure 112017115201956-pct00119

상기 식 (1-13) 및 (1-14)에 있어서,
Py1은 하기 식 (2'), (3') 또는 (4')로 표시되는 기이며;
Figure 112017115201956-pct00120

상기 식 (2'), (3') 또는 (4')에 있어서, R은 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬이며;그리고, s는 1∼4의 정수임.
A compound represented by the following formula (1-13) or (1-14):
Figure 112017115201956-pct00119

In the above formulas (1-13) and (1-14)
Py 1 is a group represented by the following formula (2 '), (3') or (4 ');
Figure 112017115201956-pct00120

In the formula (2 '), (3') or (4 '), R is alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms; and s is an integer of 1 to 4.
하기 식 (1-15) 또는 (1-16)으로 표시되는 화합물:
Figure 112017115201956-pct00121

상기 식 (1-15) 및 (1-16)에 있어서,
Py는 하기 식 (2), (3) 또는 (4)로 표시되는 기이며;
Figure 112017115201956-pct00122

R은 탄소수 1∼6의 알킬 또는 탄소수 3∼6의 시클로알킬이며;그리고, t는 1∼4의 정수임.
A compound represented by the following formula (1-15) or (1-16):
Figure 112017115201956-pct00121

In the above formulas (1-15) and (1-16)
Py is a group represented by the following formula (2), (3) or (4);
Figure 112017115201956-pct00122

R is alkyl having 1 to 6 carbon atoms or cycloalkyl having 3 to 6 carbon atoms; and t is an integer of 1 to 4.
하기 식 (1-7-26)으로 표시되는 화합물:
Figure 112017115201956-pct00123
.
A compound represented by the following formula (1-7-26):
Figure 112017115201956-pct00123
.
하기 식 (1-7-74)로 표시되는 화합물:
Figure 112017115201956-pct00124
.
A compound represented by the following formula (1-7-74):
Figure 112017115201956-pct00124
.
하기 식 (1-7-98)로 표시되는 화합물:
Figure 112017115201956-pct00125
.
A compound represented by the following formula (1-7-98):
Figure 112017115201956-pct00125
.
하기 식 (1-7-96)으로 표시되는 화합물:
Figure 112017115201956-pct00126
.
A compound represented by the following formula (1-7-96):
Figure 112017115201956-pct00126
.
하기 식 (1-14-14)로 표시되는 화합물:
Figure 112017115201956-pct00127
.
A compound represented by the following formula (1-14-14):
Figure 112017115201956-pct00127
.
하기 식 (1-11-1), (1-11-2), (1-11-3), (1-11-4), (1-11-5), (1-11-6), (1-11-8), (1-11-18), (1-11-39), (1-14-2), (1-14-3), (1-14-11), (1-14-12), (1-14-13), (1-14-15), (1-14-16), (1-14-17), (1-14-18), 및 (1-14-20) 중 어느 하나로 표시되는 화합물:
Figure 112017115201956-pct00128

Figure 112017115201956-pct00129
.
(1-11-1), (1-11-2), (1-11-3), (1-11-4), (1-11-5), (1-11-6), (1-11-8), (1-11-18), (1-11-39), (1-14-2), (1-14-3), (1-14-11), (1-14-13), (1-14-15), (1-14-16), (1-14-17), (1-14-18), and (1- 14-20).
Figure 112017115201956-pct00128

Figure 112017115201956-pct00129
.
제1항 내지 제11항 중 어느 한 항에 기재된 화합물을 함유하는 전자 수송 재료.An electron transporting material containing the compound according to any one of claims 1 to 11. 양극 및 음극으로 이루어지는 한쌍의 전극;
상기 한쌍의 전극 사이에 배치되는 발광층; 및
상기 음극과 상기 발광층 사이에 배치되고, 제12항에 기재된 전자 수송 재료를 함유하는 전자 수송층 및/또는 전자 주입층
을 가지는 유기 전계 발광 소자.
A pair of electrodes made of a positive electrode and a negative electrode;
A light emitting layer disposed between the pair of electrodes; And
An electron transport layer disposed between the cathode and the light emitting layer and containing an electron transporting material according to claim 12 and /
Lt; / RTI &gt;
제13항에 있어서,
상기 전자 수송층 및 전자 주입층 중 적어도 하나는, 퀴놀리놀계 금속 착체, 비피리딘 유도체, 페난트롤린 유도체 및 보란 유도체로 이루어지는 군으로부터 선택되는 적어도 하나를 더 함유하는, 유기 전계 발광 소자.
14. The method of claim 13,
Wherein at least one of the electron transporting layer and the electron injecting layer further contains at least one selected from the group consisting of a quinolinol-based metal complex, a bipyridine derivative, a phenanthroline derivative, and a borane derivative.
제13항에 있어서,
상기 전자 수송층 및 전자 주입층 중 적어도 하나가, 알칼리 금속, 알칼리 토류 금속, 희토류 금속, 알칼리 금속의 산화물, 알칼리 금속의 할로겐화물, 알칼리 토류 금속의 산화물, 알칼리 토류 금속의 할로겐화물, 희토류 금속의 산화물, 희토류 금속의 할로겐화물, 알칼리 금속의 유기 착체, 알칼리 토류 금속의 유기 착체 및 희토류 금속의 유기 착체로 이루어지는 군으로부터 선택되는 적어도 하나를 더 함유하는, 유기 전계 발광 소자.
14. The method of claim 13,
Wherein at least one of the electron transporting layer and the electron injection layer is formed of an alkali metal, an alkaline earth metal, a rare earth metal, an oxide of an alkali metal, an alkali metal halide, an oxide of an alkaline earth metal, a halide of an alkaline earth metal, , At least one selected from the group consisting of a halide of a rare earth metal, an organic complex of an alkali metal, an organic complex of an alkaline earth metal, and an organic complex of a rare earth metal.
제14항에 있어서,
상기 전자 수송층 및 전자 주입층 중 적어도 하나가, 알칼리 금속, 알칼리 토류 금속, 희토류 금속, 알칼리 금속의 산화물, 알칼리 금속의 할로겐화물, 알칼리 토류 금속의 산화물, 알칼리 토류 금속의 할로겐화물, 희토류 금속의 산화물, 희토류 금속의 할로겐화물, 알칼리 금속의 유기 착체, 알칼리 토류 금속의 유기 착체 및 희토류 금속의 유기 착체로 이루어지는 군으로부터 선택되는 적어도 하나를 더 함유하는, 유기 전계 발광 소자.
15. The method of claim 14,
Wherein at least one of the electron transporting layer and the electron injection layer is formed of an alkali metal, an alkaline earth metal, a rare earth metal, an oxide of an alkali metal, an alkali metal halide, an oxide of an alkaline earth metal, a halide of an alkaline earth metal, , At least one selected from the group consisting of a halide of a rare earth metal, an organic complex of an alkali metal, an organic complex of an alkaline earth metal, and an organic complex of a rare earth metal.
삭제delete 삭제delete
KR1020137011642A 2010-11-04 2011-11-01 Electron transport material and organic electroluminescence element using same KR101835020B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010247332 2010-11-04
JPJP-P-2010-247332 2010-11-04
PCT/JP2011/075179 WO2012060374A1 (en) 2010-11-04 2011-11-01 Electron transport material and organic electroluminescence element using same

Publications (2)

Publication Number Publication Date
KR20130140709A KR20130140709A (en) 2013-12-24
KR101835020B1 true KR101835020B1 (en) 2018-03-06

Family

ID=46024488

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137011642A KR101835020B1 (en) 2010-11-04 2011-11-01 Electron transport material and organic electroluminescence element using same

Country Status (5)

Country Link
JP (1) JP5737294B2 (en)
KR (1) KR101835020B1 (en)
CN (2) CN104744349B (en)
TW (1) TWI508949B (en)
WO (1) WO2012060374A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5799772B2 (en) * 2010-11-25 2015-10-28 Jnc株式会社 Electron transport material and organic electroluminescent device using the same
CN103958471B (en) 2012-02-03 2016-08-17 捷恩智株式会社 Anthracene derivant and use its organic electric field luminescence assembly, electron transport material, display device and lighting device
JP6136311B2 (en) * 2012-02-06 2017-05-31 Jnc株式会社 Electron transport material and organic electroluminescent device using the same
KR102051952B1 (en) * 2013-01-08 2019-12-04 에스에프씨주식회사 Antracene derivatives having heteroaryl substituted naphthyl group and organic light-emitting diode including the same
KR102030584B1 (en) * 2013-01-08 2019-10-10 에스에프씨주식회사 Antracene derivatives having heteroaryl substituted phenyl group and organic light-emitting diode including the same
KR101492523B1 (en) * 2013-01-25 2015-02-12 에스에프씨 주식회사 Organic light-emitting diode including aryl substituted antracene derivatives
WO2014204234A1 (en) * 2013-06-19 2014-12-24 경상대학교산학협력단 Phenylanthracene derivative and organic light emitting device containing same
TWI632140B (en) * 2013-08-07 2018-08-11 捷恩智股份有限公司 Compound for electron transport materials,electron transport materials and organic electroluminescent elements using the same
CN105658606B (en) * 2013-10-29 2018-01-09 捷恩智株式会社 Anthracene based compound, luminescent layer material, use its organic electroluminescent device, display device and lighting device
JP6927497B2 (en) * 2016-02-10 2021-09-01 学校法人関西学院 Delayed fluorescent organic electroluminescent device
US20240206219A1 (en) * 2022-12-06 2024-06-20 Samsung Display Co., Ltd. Electron transport layer including mixed composition, method of manufacturing light-emitting device including the electron transport layer, and light-emitting device and electronic device using the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004002297A (en) 2002-04-11 2004-01-08 Idemitsu Kosan Co Ltd New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101219987A (en) * 2003-01-10 2008-07-16 出光兴产株式会社 Nitrogen-containing heterocyclic derivative and organic electroluminescent element using same
JP4788202B2 (en) * 2004-07-09 2011-10-05 Jnc株式会社 Luminescent material and organic electroluminescent device using the same
KR100878115B1 (en) * 2005-10-21 2009-01-14 주식회사 엘지화학 New binaphthalene derivatives, preparation method thereof and organic electronic device using the same
US8367220B2 (en) * 2007-10-30 2013-02-05 Samsung Electronics Co., Ltd. Anthracene-based compound and organic light emitting device employing the same
JP5353233B2 (en) * 2007-12-27 2013-11-27 Jnc株式会社 Anthracene derivative compound having pyridylphenyl group and organic electroluminescence device
KR101058103B1 (en) * 2008-04-15 2011-08-24 삼성모바일디스플레이주식회사 An organic light emitting device comprising a bipyridine compound and an organic film including the same
CN101570536B (en) * 2008-04-28 2014-08-20 三星显示有限公司 Anthracene-based compound and organic light emitting device employing the same
KR100974125B1 (en) * 2008-05-14 2010-08-04 주식회사 두산 A method for manufacturing asymmetric anthracene derivatives and application for oled device using the same
KR101507166B1 (en) * 2008-12-08 2015-04-30 엘지디스플레이 주식회사 Blue Color Emitting Compounds And Organic Light Emitting Diode Comprising Thereof
EP2372803A4 (en) * 2008-12-26 2012-07-04 Idemitsu Kosan Co Material for organic electroluminescent element, and organic electroluminescent element
JP5210187B2 (en) * 2009-01-22 2013-06-12 ユー・ディー・シー アイルランド リミテッド Organic electroluminescence device
CN104292152A (en) * 2009-05-29 2015-01-21 Jnc株式会社 Electron transporting material and organic electroluminescent device using same
CN101597259B (en) * 2009-07-07 2012-11-07 清华大学 Organic material and application thereof in organic electroluminescence device (OELD)
JP5807637B2 (en) * 2010-07-05 2015-11-10 Jnc株式会社 Electron transport material and organic electroluminescent device using the same
JP5799637B2 (en) * 2010-08-26 2015-10-28 Jnc株式会社 Anthracene derivative and organic electroluminescence device using the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004002297A (en) 2002-04-11 2004-01-08 Idemitsu Kosan Co Ltd New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same

Also Published As

Publication number Publication date
KR20130140709A (en) 2013-12-24
TW201226394A (en) 2012-07-01
JPWO2012060374A1 (en) 2014-05-12
CN104744349B (en) 2017-09-22
WO2012060374A1 (en) 2012-05-10
JP5737294B2 (en) 2015-06-17
CN103189355B (en) 2015-08-26
CN104744349A (en) 2015-07-01
TWI508949B (en) 2015-11-21
CN103189355A (en) 2013-07-03

Similar Documents

Publication Publication Date Title
KR101835020B1 (en) Electron transport material and organic electroluminescence element using same
JP5533863B2 (en) Electron transport material and organic electroluminescent device using the same
KR101418840B1 (en) Electron transporting material and organic electroluminescent device using the same
JP5353233B2 (en) Anthracene derivative compound having pyridylphenyl group and organic electroluminescence device
JP5807637B2 (en) Electron transport material and organic electroluminescent device using the same
JP5799637B2 (en) Anthracene derivative and organic electroluminescence device using the same
TWI491602B (en) Benzo(c)carbazole compound having substituent including pyridine and organic electroluminescent device
WO2011105373A1 (en) Substituted pyridyl compound and organic electroluminescent element
JP5673362B2 (en) Benzo [c] carbazole compound having a substituent containing pyridine and organic electroluminescent device
JP5907069B2 (en) Electron transport material and organic electroluminescent device using the same
TW200903878A (en) Light emitting element material and light emitting element
JP5799772B2 (en) Electron transport material and organic electroluminescent device using the same
JP5807601B2 (en) Anthracene derivative and organic electroluminescence device using the same
JP6428762B2 (en) Electron transport material and organic electroluminescent device using the same
JP2013227251A (en) Electron transport material and organic electroluminescent element using the same
JP6136311B2 (en) Electron transport material and organic electroluminescent device using the same
JP5549270B2 (en) Anthracene derivative and organic electroluminescence device using the same
JP6070047B2 (en) Electron transport material and organic electroluminescent device using the same
JPWO2014030554A1 (en) Compound having triphenylsilylpyridyl group and carbazole ring structure and organic electroluminescence device
JP2016074623A (en) Compound having alkyl-substituted azole, electron transport material including the compound and organic electroluminescent element using the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right